{"title":"Renal medicine \u0026 nephrology","description":"Books on the subject of Renal medicine \u0026amp; nephrology","products":[{"product_id":"silvas-diagnostic-renal-pathology-9780521877022","title":"Silva's Diagnostic Renal Pathology () 9780521877022","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eSilva's Diagnostic Renal Pathology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThis book includes more than 1,000 photomicrographs to diagnose a wide range of kidney diseases through every diagnostic modality.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eXin J. Zhou (Edited by), Zoltan Laszik (Edited by), Tibor Nadasdy (Edited by), Vivette D'Agati (Edited by), Fred G. Silva (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521877022, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e, published 27 April 2009\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e636 pages, 236 b\/w illus.  888 colour illus.  30 tables\u003cbr\u003e28.7 x 22 x 3 cm, 2.01 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e'This is an excellent book, and even though there are several very good textbooks of renal pathology already on the market, it has the potential of becoming the best of the bunch. The authors and editors obviously … know how to present and transfer their knowledge to their readers. A lot of thought went into the preparation of the book and the final product shows clearly that the editors and the authors have worked hand in hand to enforce a unified approach, which is applied to all the chapters, including the one on tumors. The illustrations are well chosen and complement the text, which is very informative and to the point. There are no significant omissions. The book deserves the highest marks for its content, approach, and pictorial material. It is a book that can be used equally well by a novice eager to learn renal pathology and a seasoned pathologist for expert consultation. Nephropathologists will find it in unexpected pearls and I predict that even these highly specialized experts will embrace it. I recommend it most enthusiastically to practicing pathologists and their trainees, as well as clinical nephrologists, but I also feel that it belongs in all major medical libraries.' Doody's\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThe kidneys are responsible for many key bodily functions, but their primary role as a filter of toxins makes them extremely susceptible to disease. Often these diseases can only be diagnosed through a renal biopsy, a complicated procedure requiring ancillary immunologic and molecular diagnostic techniques. This book covers all methods used by renal pathologists to diagnose a wide range of kidney diseases. Unlike most literature on renal pathology, this book is situated on the midpoint between encyclopedic and superficial coverage, written for the signing-out pathologist. While focusing on tumors and transplantation rejection, a full spectrum of infectious, inflammatory, and congenital disorders is covered in both pediatric and adult populations and is analyzed not only by light microscopy but by each applicable diagnostic modality available. The text is illustrated with more than 1,000 photomicrographs and diagrams, including a CD-ROM of all images.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1. Renal anatomy William A. Clapp\u003cbr\u003e 2. Renal biopsy: the nephrologist's viewpoint Robert D. Toto\u003cbr\u003e 3. Algorithmic approach to the interpretation of renal biopsy Xin J. Zhou, Zoltan Laszik, and Fred G. Silva\u003cbr\u003e 4. Glomerular diseases associated with the nephritic syndrome and proteinuria Michael B. Stokes, Glen S. Markowitz, and Vivette D. D'Agati\u003cbr\u003e 5. Glomerular diseases associated primarily with asymptomatic or gross hematuria Randolph A. Hennigar and James A. Tumlin\u003cbr\u003e 6. Glomerular diseases associated with nephritic syndrome and\/or rapidly progressive glomerulonephritis Thomas D. Rogers, Dinesh Rakheja, and Xin J. Zhou\u003cbr\u003e 7. Systematic lupus erythematosus and other autoimmune diseases (mixed connective tissue disease, rheumatoid arthritis, and Sjogren's syndrome) Michael B. Stokes, Samih H. Nasr, and Vivette D. D'Agati\u003cbr\u003e 8. Renal diseases associated with metabolic and storage disorders Zoltan Laszik and Lukas Harrigan\u003cbr\u003e 9. Thrombotic microangiopathies Zoltan Laszik and Fred G. Silva\u003cbr\u003e 10. Renal diseases associated with hematopoietic disorders or organized deposits Guillermo A. Herrera\u003cbr\u003e 11. Tubulointerstitial diseases Shane M. Meehan and Tibor Nadasdy\u003cbr\u003e 12. Hypertension and vascular diseases of the kidney Michael D. Hughson\u003cbr\u003e 13. Cystic and developmental diseases Arthur G. Weinberg\u003cbr\u003e 14. The aging kidney Xin J. Zhou, Dinesh Rakheja, and Fred G. Silva\u003cbr\u003e 15. End stage kidney disease Steven A. Bigler and Michael G. Hughson\u003cbr\u003e 16. Pathology of renal transplantation Tibor Nadasdy, Anjali Satoskar, and Gyongyi Nadasdy\u003cbr\u003e 17. Tumors of the kidney Satish K. Tickoo, Pedram Argani, and Mahul B. Amin.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Pathology [\u003ca title=\"See our other books on Pathology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pathology%20%5BMMF%5D%22\"\u003eMMF\u003c\/a\u003e], Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46004978876696,"sku":"9780521877022","price":165.19,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521877022i_658fdc2c-8875-43a8-8a89-2adc2f553147.jpg?v=1691358744"},{"product_id":"urodynamics-illustrated-paperback-9781906985110","title":"Urodynamics Illustrated (Paperback \/ softback) 9781906985110","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eUrodynamics Illustrated\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThis book is a practical guide to setting up urodynamic equipment and performing urodynamic techniques.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eRanee Thakar (Edited by), Philip Toosz-Hobson (Edited by), Lucia Dolan (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781906985110, Royal College of Obstetricians and Gynaecologists (RCOG)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 1 October 2011\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e159 pages\u003cbr\u003e21.7 x 13.8 x 0.8 cm, 0.24 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThis book provides a practical guide for anyone performing or training to perform urodynamic studies. Details on how to set up urodynamic equipment and perform individual urodynamic techniques are discussed, ranging from basic tests such as uroflowmetry and subtracted cystometry through to the more complex videocystometry, ambulatory monitoring and urethral function tests. Many of the chapters include case studies to place the investigations within the context of a symptom complex. This book has a place in every urodynamics laboratory as an easy reference guide and is an essential illustrative text for teaching the fundamentals of good urodynamic practice.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1. Introduction\u003cbr\u003e 2. Setting up the equipment Lucy Swithinbank\u003cbr\u003e 3. Flow rate testing Marcus Drake and Ahmed Shaban\u003cbr\u003e 4. Cystometry Gordon Hosker and Joanne Townsend\u003cbr\u003e 5. Videocystourethrography Sushma Srikrishna and Dudley Robinson\u003cbr\u003e 6. Ambulatory urodynamic monitoring Kate Anders and Philip Toozs-Hobson\u003cbr\u003e 7. Urodynamic artefacts Reeba Oliver and Ranee Thakar\u003cbr\u003e 8. Assessment of urethral function J. Robert Sherwin and Mark Slack\u003cbr\u003e 9. Bladder diaries Matthew Parsons\u003cbr\u003e 10. Pad testing Emmanuel Karatanis\u003cbr\u003e 11. Pre-test assessment using questionnaires Ramandeep Basra, Nikki Cotterill, Swati Jha, Cornelius J. Kelleher and Stephen Radley\u003cbr\u003e 12. Ultrasound as a tool in urodynamics Demetri C. Panayi and Vikram Khullar\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Gynaecology \u0026amp; obstetrics [\u003ca title=\"See our other books on Gynaecology \u0026amp; obstetrics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Gynaecology%20\u0026amp;%20obstetrics%20%5BMJT%5D%22\"\u003eMJT\u003c\/a\u003e], Urology \u0026amp; urogenital medicine [\u003ca title=\"See our other books on Urology \u0026amp; urogenital medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Urology%20\u0026amp;%20urogenital%20medicine%20%5BMJS%5D%22\"\u003eMJS\u003c\/a\u003e], Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e], Medicine [\u003ca title=\"See our other books on Medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medicine%20%5BM%5D%22\"\u003eM\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Royal College of Obstetricians and Gynaecologists","offers":[{"title":"Default Title","offer_id":46005105000728,"sku":"9781906985110","price":41.89,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9781906985110i.jpg?v=1696598741"},{"product_id":"comprehensive-clinical-nephrology-hardback-9780323825924","title":"Comprehensive Clinical Nephrology (Hardback) 9780323825924","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eComprehensive Clinical Nephrology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003ePractical, authoritative coverage of nephrology in an easily accessible format\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eRichard J. Johnson (Author), Jurgen Floege (Author), Marcello Tonelli (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323825924\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 5 May 2023\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1328 pages, 1215 illustrations (1215 in full color)\u003cbr\u003e27.6 x 21.6 x 5.9 cm, 3.85 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003ci\u003e\"This comprehensive book covers medical topics relevant to today's clinicians. It is divided into five sections, including diseases and disorders, differential diagnosis, clinical algorithms, laboratory tests and interpretation of results, and clinical practice guidelines. The Ebook contains additional content on clinical topics as well as patient teaching guides.\" \u003c\/i\u003e©Doody’s Review Service, 2023, Mark Cason Rudy, MD (University of Kentucky College of Medicine) \u003cb\u003eDoody's Score: 5 Stars!\u003c\/b\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eWritten for fellows, practicing nephrologists, and internists who treat patients with disorders affecting the renal system, Comprehensive Clinical Nephrology, 7th Edition, offers a practical approach to this complex field, supported by underlying scientific facts and pathophysiology. World leaders in nephrology provide current information on clinical procedures and conditions, covering everything from fluid and electrolyte disorders to hypertension, diabetes, dialysis, transplantation, and more—all in a single, convenient volume.\u003cul\u003e \u003cli\u003e  \u003cp\u003eProvides a \"just right\" amount of basic science and practical clinical guidance to help you make efficient and informed decisions.  \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eContains new chapters on Blood Pressure Management in the Dialysis Patient, Kidney Diseases Associated with Corona Viruses, Ultrasound Imaging in Nephrology, and Radiologic and Nuclear Imaging in Nephrology. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eIncludes more than 1,500 full-color illustrations that highlight key topics and detail pathogenesis for a full range of kidney conditions and clinical management. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eCovers key topics such as COVID-19, chronic kidney disease, end stage kidney disease, kidney transplantation, glomerular disease, onco-nephrology, dialysis, and much more. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eFeatures popular, color-coded algorithms that provide easy access to important content: yellow boxes for general information, green boxes for therapeutic intervention, and blue boxes for necessary investigations. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eIncludes quick-reference boxes with links to clinical guidelines in all relevant chapters, plus self-assessment questions online. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eAn eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cb\u003eSECTION I Essential Renal Anatomy and Physiology\u003c\/b\u003e\u003cbr\u003e1 Renal Anatomy\u003cbr\u003e2 Renal Physiology\u003cbr\u003e\u003cb\u003eSECTION II Investigation of Renal Disease\u003c\/b\u003e\u003cbr\u003e3 Assessment of Glomerular Filtration Rate\u003cbr\u003e4 Urinalysis\u003cbr\u003e5 Point of Care Ultrasound in Nephrology\u003cbr\u003e6 Radiologic and Nuclear Imaging in Nephrology\u003cbr\u003e7 Kidney Biopsy\u003cbr\u003e\u003cb\u003eSECTION III Fluid and Electrolyte Disorders\u003c\/b\u003e\u003cbr\u003e8 Disorders of Extracellular Volume\u003cbr\u003e9 Disorders of Water Metabolism\u003cbr\u003e10 Disorders of Potassium Metabolism\u003cbr\u003e11 Disorders of Calcium, Phosphate, and Magnesium Metabolism\u003cbr\u003e12 Normal Acid-Base Balance\u003cbr\u003e13 Metabolic Acidosis\u003cbr\u003e14 Metabolic Alkalosis\u003cbr\u003e15 Respiratory Acidosis, Respiratory Alkalosis, and Mixed Acid-Base Disorders\u003cbr\u003e\u003cb\u003eSECTION IV Glomerular Disease\u003c\/b\u003e\u003cbr\u003e16 Introduction to Glomerular Disease: Clinical Presentations\u003cbr\u003e17 Introduction to Glomerular Disease: Histologic Classification and Pathogenesis\u003cbr\u003e18 Minimal Change Disease\u003cbr\u003e19 Primary and Secondary (Nongenetic) Causes of Focal and Segmental Glomerulosclerosis\u003cbr\u003e20 Inherited Causes of Nephrotic Syndrome\u003cbr\u003e21 Membranous Nephropathy\u003cbr\u003e22 Immunoglobulin-Mediated Glomerulonephritis With a Membranoproliferative Pattern of Injury and Cryoglobulinemic Glomerulonephritis\u003cbr\u003e23 Glomerulonephritis Associated With Complement Disorders\u003cbr\u003e24 Immunoglobulin A Nephropathy and Immunoglobulin A Vasculitis (Henoch-Schönlein Purpura)\u003cbr\u003e25 Anti–Glomerular Basement Membrane Disease and Goodpasture Disease\u003cbr\u003e26 Renal and Systemic Vasculitis\u003cbr\u003e27 Lupus Nephritis\u003cbr\u003e28 Monoclonal Immunoglobulin–Related Glomerular Diseases and Renal Amyloidosis\u003cbr\u003e29 Rare Glomerular Disorders\u003cbr\u003e30 Thrombotic Microangiopathies, Including Hemolytic Uremic Syndrome\u003cbr\u003e\u003cb\u003eSECTION V Diabetic Kidney Disease\u003c\/b\u003e\u003cbr\u003e31 Pathogenesis, Clinical Manifestations, and Natural History of Diabetic Kidney Disease\u003cbr\u003e32 Prevention and Treatment of Diabetic Kidney Disease\u003cbr\u003e33 Management of Patients With Diabetes and Chronic Kidney Disease\u003cbr\u003e\u003cb\u003eSECTION VI Hypertension\u003c\/b\u003e\u003cbr\u003e34 Normal Blood Pressure Control and the Evaluation of Hypertension\u003cbr\u003e35 Primary Hypertension\u003cbr\u003e36 Nonpharmacologic Prevention and Treatment of Hypertension\u003cbr\u003e37 Pharmacologic Treatment of Hypertension\u003cbr\u003e38 Evaluation and Treatment of Hypertensive Urgencies and Emergencies\u003cbr\u003e39 Endocrine Causes of Hypertension: Aldosterone\u003cbr\u003e40 Other Endocrine Causes of Hypertension\u003cbr\u003e41 Neurogenic Hypertension, Including Hypertension Associated With Stroke or Spinal Cord Injury\u003cbr\u003e42 Blood Pressure Management in the Dialysis Patient\u003cbr\u003e\u003cb\u003eSECTION VII Renovascular Disease\u003c\/b\u003e\u003cbr\u003e43 Renovascular Hypertension, Atherosclerotic Renal Vascular Disease, and Thromboembolic Kidney Disease\u003cbr\u003e\u003cb\u003eSECTION VIII Pregnancy and Renal Disease\u003c\/b\u003e\u003cbr\u003e44 Kidney Physiology and Complications in Normal Pregnancy\u003cbr\u003e45 Pregnancy With Preexisting Kidney Disease\u003cbr\u003e\u003cb\u003eSECTION IX Hereditary and Congenital Diseases of the Kidney\u003c\/b\u003e\u003cbr\u003e46 Autosomal Dominant Polycystic Kidney Disease\u003cbr\u003e47 Other Cystic Kidney Diseases\u003cbr\u003e48 Alport Syndrome and Other Familial Glomerular Syndromes\u003cbr\u003e49 Inherited Disorders of Sodium and Water Handling\u003cbr\u003e50 Fanconi Syndrome and Other Proximal Tubule Disorders\u003cbr\u003e51 Sickle Cell Diseases and the Kidney\u003cbr\u003e52 Congenital Anomalies of the Kidney and Urinary Tract\u003cbr\u003e\u003cb\u003eSECTION X Infectious Diseases and the Kidney\u003c\/b\u003e\u003cbr\u003e53 Urinary Tract Infections in Adults\u003cbr\u003e54 Tuberculosis of the Urinary Tract\u003cbr\u003e55 Fungal Infections of the Urinary Tract\u003cbr\u003e56 The Kidney in Schistosomiasis\u003cbr\u003e57 Glomerular Diseases Associated With Infection\u003cbr\u003e58 Human Immunodeficiency Virus Infection and the Kidney\u003cbr\u003e59 Kidney Diseases Associated With Coronaviruses\u003cbr\u003e\u003cb\u003eSECTION XI Urologic Disorders\u003c\/b\u003e\u003cbr\u003e60 Nephrolithiasis and Nephrocalcinosis\u003cbr\u003e61 Urinary Tract Obstruction\u003cbr\u003e62 Primary Vesicoureteral Reflux and Reflux Nephropathy\u003cbr\u003e63 Urologic Issues for the Nephrologist\u003cbr\u003e\u003cb\u003eSECTION XII Tubulointerstitial and Vascular Diseases\u003c\/b\u003e\u003cbr\u003e64 Acute Interstitial Nephritis\u003cbr\u003e65 Chronic Interstitial Nephritis\u003cbr\u003e66 Endemic Nephropathies\u003cbr\u003e\u003cb\u003eSECTION XIII Renal Disease and Cancer\u003c\/b\u003e\u003cbr\u003e67 Oncology: Kidney Disease in Cancer Patients\u003cbr\u003e68 Myeloma and the Kidney\u003cbr\u003e69 Kidney Disease in Liver, Cardiac, Lung, and Hematopoietic Stem Cell Transplantation\u003cbr\u003e\u003cb\u003eSECTION XIV Acute Kidney Injury\u003cbr\u003e\u003c\/b\u003e70 Pathophysiology and Etiology of Acute Kidney Injury\u003cbr\u003e71 Acute Kidney Injury in the Tropics\u003cbr\u003e72 Diagnosis and Clinical Evaluation of Acute Kidney Injury\u003cbr\u003e73 Epidemiology and Prognostic Impact of Acute Kidney Injury and Acute Kidney Disease\u003cbr\u003e74 Prevention and Nondialytic Management of Acute Kidney Injury\u003cbr\u003e75 Extracorporeal Therapies for Acute Kidney Injury and Heart Failure\u003cbr\u003e76 Hepatorenal Syndrome\u003cbr\u003e\u003cb\u003eSECTION XV Drug Therapy in Kidney Disease\u003c\/b\u003e\u003cbr\u003e77 Principles of Drug Therapy, Dosing, and Prescribing in Chronic Kidney Disease and Kidney Replacement Therapy\u003cbr\u003e78 Common Issues in Prescribing in Kidney Disease and Kidney Replacement Therapy\u003cbr\u003e79 Herbal and Over-the-Counter Medicines and the Kidney\u003cbr\u003e\u003cb\u003eSECTION XVI Chronic Kidney Disease and Uremic Syndrome\u003cbr\u003e\u003c\/b\u003e80 Epidemiology of Chronic Kidney Disease and Dialysis\u003cbr\u003e81 Pathophysiology of Disease Progression in Proteinuric and Nonproteinuric Kidney Disease\u003cbr\u003e82 Slowing the Progression of Kidney Disease\u003cbr\u003e83 Clinical Evaluation and Management of Chronic Kidney Disease\u003cbr\u003e84 Pathogenesis and Risk of Cardiovascular Disease in Chronic Kidney Disease\u003cbr\u003e85 Practical Management of Cardiovascular Disease in Chronic Kidney Disease\u003cbr\u003e86 Anemia in Chronic Kidney Disease\u003cbr\u003e87 Other Blood and Immune Disorders in Chronic Kidney Disease\u003cbr\u003e88 Bone and Mineral Disorders in Chronic Kidney Disease\u003cbr\u003e89 Neurologic Complications of Chronic Kidney Disease\u003cbr\u003e90 Nutrition in Chronic Kidney Disease\u003cbr\u003e91 Dermatologic Manifestations of Chronic Kidney Disease\u003cbr\u003e92 Acquired Cystic Kidney Disease and Malignant Neoplasms\u003cbr\u003e\u003cb\u003eSECTION XVII Geriatric and Palliative Nephrology\u003c\/b\u003e\u003cbr\u003e93 Geriatric Nephrology\u003cbr\u003e94 Palliative Nephrology\u003cbr\u003e\u003cb\u003eSECTION XVIII Dialytic Therapies\u003c\/b\u003e\u003cbr\u003e95 Approach to Kidney Replacement Therapy\u003cbr\u003e96 Vascular Access for Hemodialysis\u003cbr\u003e97 Diagnostic and Interventional Nephrology\u003cbr\u003e98 Hemodialysis\u003cbr\u003e99 Hemodialysis\u003cbr\u003e100 Acute Complications During Hemodialysis\u003cbr\u003e101 Peritoneal Dialysis: Principles, Techniques, and Adequacy\u003cbr\u003e102 Complications of Peritoneal Dialysis\u003cbr\u003e103 Extracorporeal Therapies for Drug Overdose and Poisoning\u003cbr\u003e104 Plasma Exchange\u003cbr\u003e\u003cb\u003eSECTION XIX Transplantation\u003c\/b\u003e\u003cbr\u003e105 Immunologic Principles in Kidney Transplantation\u003cbr\u003e106 Immunosuppressive Medications in Kidney Transplantation\u003cbr\u003e107 Evaluation and Preoperative Management of Kidney Transplant Recipient and Donor\u003cbr\u003e108 Kidney Transplantation Surgery\u003cbr\u003e109 Prophylaxis and Treatment of Kidney Transplant Rejection\u003cbr\u003e110 Infections and Malignancies in the Kidney Transplant Recipient\u003cbr\u003e111 Cardiovascular Disease and Metabolic Abnormalities in the Kidney Transplant Recipient\u003cbr\u003e112 Chronic Allograft Injury\u003cbr\u003e113 Recurrent Disease in Kidney Transplantation\u003cbr\u003e114 Outcomes of Kidney Transplantation: Identification, Measures, and Evaluation\u003cbr\u003e\u003cb\u003eIndex\u003c\/b\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e], Clinical \u0026amp; internal medicine [\u003ca title=\"See our other books on Clinical \u0026amp; internal medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Clinical%20\u0026amp;%20internal%20medicine%20%5BMJ%5D%22\"\u003eMJ\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648072569112,"sku":"9780323825924","price":156.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323825924.jpg?v=1694992117"},{"product_id":"the-kidney-from-normal-development-to-congenital-disease-hardback-9780127224411","title":"The Kidney; From Normal Development to Congenital Disease (Hardback) 9780127224411","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eThe Kidney\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eFrom Normal Development to Congenital Disease\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003ePeter D. Vize (Edited by), Adrian S. Woolf (Edited by), Jonathan B.L. Bard (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780127224411, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 14 March 2003\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e592 pages, Approx. 200 illustrations (100 in full color)\u003cbr\u003e27.8 x 21.5 x 3.3 cm, 1.55 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"It is well written and will be useful both for students and researchers in developmental biology, as well as clinical nephrologists and urologists. This book clearly outlines the development of the human kidney from an evolutionary perspective. In addition, it describes the pronephros and the mesonephros in great detail...The book concludes with an excellent review of therapies for congenital kidney diseases, including gene-transfer techniques and cell-based therapies. Overall, The Kidney is well organized and well written...an excellent resource for the researcher in kidney development and developmental diseases, and an outstanding reference for clinical pediatric nephrologists and urologists.\" \u003cb\u003e--TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"finding this book was like driving to the top of a small hill only to find a magnificent, snow-capped mountain range rising a dozen or so miles ahead, begging to be explored. ...an excellent point of departure for laboratory trainees, as well as more senior scientists, who may want to catch up on the fundamentals of renal development in the modern era without much of a struggle.\" \u003cb\u003e--AMERICAN JOURNAL OF KIDNEY DISEASES, August 2003\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"The book is well organized, lucidly written, and superbly illustrated. ...does a fine job of emphasizing that the kidney is a wonderful system in which to study many critical issues in cellular and developmental biology.\"  \u003cb\u003e--THE NEW ENGLAND JOURNAL OF MEDICINE, November 2003\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"Recommended for medical and academic libraries and renal specialists.\"  \u003cb\u003e--E-STREAMS, September 2003\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"This reader appreciates the imaginative handling of the illustrations that deal with pronephic, mesonephric, and metanephric development in a way that complements the excellent text descriptions...this book is an excellent point of departure for labratory trainees, as well as more senior scientists, like me, who may want to catch up on the fundamentals of renal development in the modenrn era without much of a struggle\" \u003cb\u003e-KIDNEY INSTITUTE, UNIVERSITY OF KANSAS MEDICAL CENTER, 2003\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eOrganogenesis of the kidney has been intensely studied for over a century. In recent years advances in molecular techniques have not only made great inroads into exploring the genetic regulation of this complex process but also began to unravel the molecular basis of many forms of congenital kidney disease. This book is a comprehensive study on these findings and the only book available with such in depth coverage of the kidney.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eSECTION 1: EMBRYONIC KIDNEYS AND MODELS\u003c\/b\u003e 1. Introduction: the embryonic kidneys and other nephrogenic models  2. Development of the Malpighian tubules in Drosophila melanogaster  3. Induction, development and physiology of the pronephric tubules  4. Formation of the nephric duct  5. The pronephric glomus and vasculature 6. Development of the mesonephric kidney  7. 3-Dimensional anatomy of mammalian mesonephroi 8. The Molecular control of pronephros development- an Overview  9. Embryological, genetic and molecular tools for investigating embryonic kidney development\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION 2: THE ADULT KIDNEYS\u003c\/b\u003e 10. Introduction  11. Anatomy and Histology of the Human Urinary System 12. Development of the Ureteric Bud  13. The Fates of the Metanephric Mesenchyme  14. The Formation and Development of Nephrons  15. Establishment of polarity in epithelial cells of the developing nephron  16. Development of the Glomerular Capillary and its Basement Membrane  17. The development of kidney blood vessels  18. The Development of function in the metanephric kidney  19. Experimental methods for studying urogenital development  20. Overview: The Molecular Basis of Kidney Development\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION 3: CONGENITAL DISEASE\u003c\/b\u003e 21. Maldevelopment of the Human Kidney and Lower Urinary Tract: an Overview  22. Wilms' Tumor and related disorders  23. Pax-2 and Renal-Coloboma Syndrome  24. Polycystic Kidney Disease, von Hippel Lindau and Tuberous sclerosis  26. Renal Cell Carcinoma: The Human Disease  27. The Tubule  28. Diseases of the Glomerular Filtration Barrier: Alport Syndrome and Congenital Nephrosis (NPHS1) 29. Congenital Kidney Diseases: Prospects for New Therapies \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e], Physiology [\u003ca title=\"See our other books on Physiology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Physiology%20%5BMFG%5D%22\"\u003eMFG\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648097734936,"sku":"9780127224411","price":124.49,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780127224411.jpg?v=1694088272"},{"product_id":"nephrology-secrets-paperback-9780323478717","title":"Nephrology Secrets (Paperback) 9780323478717","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eNephrology Secrets\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eGet the answers you need for successful nephrology care\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eEdgar V. Lerma (Edited by), Matthew A. Sparks (Edited by), Joel M. Topf (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323478717\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 17 May 2018\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e656 pages, 50 illustrations\u003cbr\u003e21.5 x 13.3 x 4 cm, 0.59 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003e\"Having participated in numerous ward rounds, I can say with some degree of certainty that this book will be a valuable quick reference during rounds. I will not hesitate to recommend it to all nephrologists, especially those in training.\"\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e-Kenneth Kafui Afenya, MD (University of Kentucky College of Medicine) for Doody's Review Service\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eFor more than 30 years, the highly regarded Secrets Series® has provided students and practitioners in all areas of health care with \u003cb\u003econcise, focused, and engaging resources for quick reference and exam review.\u003c\/b\u003e \u003ci\u003eNephrology Secrets, 4th Edition\u003c\/i\u003e, features the Secrets’ \u003cb\u003epopular question-and-answer format\u003c\/b\u003e that also includes lists, tables, and an easy-to-read style – making reference and review quick, easy, and enjoyable.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eThe \u003cb\u003eproven Secrets® format\u003c\/b\u003e gives you the most return for your time – concise, easy to read, engaging, and highly effective.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCovers\u003cb\u003e the full range of essential topics in nephrology \u003c\/b\u003efor in-training or practicing professionals.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eWritten and fully updated by \u003cb\u003eglobal experts \u003c\/b\u003eand thought leaders in nephrology.\u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eTop 100 Secrets and \u003cb\u003eKey Points boxes\u003c\/b\u003e provide a fast overview of the secrets you must know for success in practice and on exams.\u003c\/li\u003e \u003cb\u003e \u003cli\u003ePortable size\u003c\/li\u003e\u003c\/b\u003e makes it easy to carry with you for quick reference or review anywhere, anytime.\u003c\/ul\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eNew chapters\u003c\/li\u003e\u003c\/b\u003e on home dialysis, onco-nephrology, and palliative care nephrology.\u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFully updated throughout, with clear \u003cb\u003eillustrations, figures, and flow diagrams \u003c\/b\u003ethat expedite study and review.\u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eExpert Consult™ eBook version included with purchase. This \u003cb\u003eenhanced eBook experience\u003c\/b\u003e allows you to search all of the text, figures, Q\u0026amp;As, and references from the book on a variety of devices.\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003ePART I. PATIENT ASSESSMENT\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1. History and Physical Diagnosis\u003c\/p\u003e \u003cp\u003e2. Urinalysis\u003c\/p\u003e \u003cp\u003e3. Measurement of GFR \u003c\/p\u003e \u003cp\u003e4. Imaging Techniques \u003c\/p\u003e \u003cp\u003e5. Renal Biopsy\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART II. ACUTE KIDNEY INJURY \u003c\/p\u003e \u003cp\u003e6. Epidemiology, Etiology, Pathophysiology and Diagnosis\u003c\/p\u003e \u003cp\u003e7. Management Options: CRRT\u003c\/p\u003e \u003cp\u003e8. Hepatorenal Syndrome\u003c\/p\u003e \u003cp\u003e9. Cardiorenal Syndrome\u003c\/p\u003e \u003cp\u003e10. Medications\u003c\/p\u003e \u003cp\u003e11. Sepsis\u003c\/p\u003e \u003cp\u003e12. Rhabdomyolysis\u003c\/p\u003e \u003cp\u003e13. Tumor Lysis Syndrome\u003c\/p\u003e \u003cp\u003e14. Contrast-induced Nephropathy\u003c\/p\u003e \u003cp\u003e15. Acute Glomerulonephritis and RPGN\u003c\/p\u003e \u003cp\u003e16. Nephrotic Syndrome\u003c\/p\u003e \u003cp\u003e17. Obstructive Uropathy\u003c\/p\u003e \u003cp\u003e18. Nephrolithiasis\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART III. CHRONIC KIDNEY DISEASE\u003c\/p\u003e \u003cp\u003e19. Epidemiology, Etiology, Pathophysiology and Staging\u003c\/p\u003e \u003cp\u003e20. Anemia in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003e21. Renal Osteodystrophy\u003c\/p\u003e \u003cp\u003e22. Cardiovascular Disease\u003c\/p\u003e \u003cp\u003e23. Hyperlipidemia\u003c\/p\u003e \u003cp\u003e24. Nutrition\u003c\/p\u003e \u003cp\u003e25. Management of the Patient with Progressive Renal Failure\u003c\/p\u003e \u003cp\u003e26. Drug Dosing in patients with CKD\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART IV. PRIMARY GLOMERULAR DISORDERS\u003c\/p\u003e \u003cp\u003e27. Minimal Change Disease\u003c\/p\u003e \u003cp\u003e28. Focal Segmental Glomerulosclerosis\u003c\/p\u003e \u003cp\u003e29. Membranous Nephropathy\u003c\/p\u003e \u003cp\u003e30. IgA Nephropathy and Henoch Schonlein Disease\u003c\/p\u003e \u003cp\u003e31. Membranoproliferative Glomerulonephritis\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART V. SECONDARY GLOMERULAR DISORDERS\u003c\/p\u003e \u003cp\u003e32. Diabetic Nephropathy\u003c\/p\u003e \u003cp\u003e33. Lupus Nephritis\u003c\/p\u003e \u003cp\u003e34. Dysproteinemias or Light Chain Diseases\u003c\/p\u003e \u003cp\u003e35. Vascultides\u003c\/p\u003e \u003cp\u003e36. Thrombotic Microangiopathies\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART VI. INFECTION ASSOCIATED GLOMERULEONEPHRITIDES\u003c\/p\u003e \u003cp\u003e37. Post-infectious Glomereulonephritis\u003c\/p\u003e \u003cp\u003e38. Viral Hepatitis-Associated Glomerulonephritis\u003c\/p\u003e \u003cp\u003e39. HIV-Associated Renal Disorders\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART VII. OTHER RENAL PARENCHYMAL DISEASES\u003c\/p\u003e \u003cp\u003e40. Fabry Disease\u003c\/p\u003e \u003cp\u003e41. Cystic Diseases of the Kidneys\u003c\/p\u003e \u003cp\u003e42. Other Hereditary Renal Disorders\u003c\/p\u003e \u003cp\u003e43. Tubulointerstitial Diseases\u003c\/p\u003e \u003cp\u003e44. Urinary Tract Infections\u003c\/p\u003e \u003cp\u003e45. Renal Neoplasias\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003eVIII. RENAL DISEASES IN SPECIAL POPULATIONS\u003c\/p\u003e \u003cp\u003e46. Renal Disease and Hypertension in Pregnancy\u003c\/p\u003e \u003cp\u003e47. Sickle Cell Nephropathy\u003c\/p\u003e \u003cp\u003e48. Renal Disease in the Elderly\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART IX. TREATMENT OPTIONS\u003c\/p\u003e \u003cp\u003e49. Hemodialysis\u003c\/p\u003e \u003cp\u003e50. Home Dialysis\u003c\/p\u003e \u003cp\u003e51. Peritoneal Dialysis\u003c\/p\u003e \u003cp\u003e52. Therapeutic Plasma Exchange (Plasmapheresis)\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART X. TRANSPLANTATION\u003c\/p\u003e \u003cp\u003e53. Epidemiology and Outcomes\u003c\/p\u003e \u003cp\u003e54. Donor and Recipient Evaluation\u003c\/p\u003e \u003cp\u003e55. Immunosuppression\u003c\/p\u003e \u003cp\u003e56. Rejection of the Renal Transplant\u003c\/p\u003e \u003cp\u003e57. Post-Transplant Malignancies\u003c\/p\u003e \u003cp\u003e58. Post-Transplant Infections\u003c\/p\u003e \u003cp\u003e59. Primary Care of the Renal Transplant Patient\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART XI. HYPERTENSION\u003c\/p\u003e \u003cp\u003e60. Primary Hypertension\u003c\/p\u003e \u003cp\u003e61. Renal Parenchymal Hypertension\u003c\/p\u003e \u003cp\u003e62. Renovascular Disease\u003c\/p\u003e \u003cp\u003e63. Endocrine Hypertension\u003c\/p\u003e \u003cp\u003e64. Other Forms of Secondary Hypertension\u003c\/p\u003e \u003cp\u003e65. Renal Diseases in African-Americans\u003c\/p\u003e \u003cp\u003e66. Resistant Hypertension\u003c\/p\u003e \u003cp\u003e67. Hypertensive Emergencies\u003c\/p\u003e \u003cp\u003e68. Pharmacologic Treatment of Hypertension\u003c\/p\u003e \u003cp\u003e69. Non-pharmacologic Treatment of Hypertension\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART XII. ACID-BASE AND ELECTROLYTE DISORDERS\u003c\/p\u003e \u003cp\u003e70. Volume Disorders\u003c\/p\u003e \u003cp\u003e71. Genetic Disorders of Na Transport\u003c\/p\u003e \u003cp\u003e72. Hyponatremia and Hypernatremia\u003c\/p\u003e \u003cp\u003e73. Hypokalemia and Hyperkalemia\u003c\/p\u003e \u003cp\u003e74. Hypocalcemia and Hypercalcemia\u003c\/p\u003e \u003cp\u003e75. Disorders of Phosphorus Metabolism\u003c\/p\u003e \u003cp\u003e76. Disorders of Magnesium Metabolism\u003c\/p\u003e \u003cp\u003e77. Metabolic Acidosis\u003c\/p\u003e \u003cp\u003e78. Metabolic Alkalosis\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART XIII. ONCONEPHROLOGY\u003c\/p\u003e \u003cp\u003e79. Onconephrology\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART XIV. PALLIATIVE CARE NEPHROLOGY\u003c\/p\u003e \u003cp\u003e80. Palliative Care Nephrology\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART XV. NEPHROLOGY BEGINNINGS\u003c\/p\u003e \u003cp\u003e81. Nephrology Beginnings\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePART XVI. NEPHROLOGY TRIVIA\u003c\/p\u003e \u003cp\u003e82. Nephrology Trivia \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648115888408,"sku":"9780323478717","price":26.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323478717.jpg?v=1694088396"},{"product_id":"sleisenger-and-fordtrans-gastrointestinal-and-liver-disease-2-volume-set-pathophysiology-diagnosis-management-9780323609623","title":"Sleisenger and Fordtran's Gastrointestinal and Liver Disease- 2 Volume Set; Pathophysiology, Diagnosis, Management (Multiple-component retail product) 9780323609623","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eSleisenger and Fordtran's Gastrointestinal and Liver Disease- 2 Volume Set\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003ePathophysiology, Diagnosis, Management\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eTrust the gastroenterology reference with an outstanding global reputation for excellence\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eMark Feldman (Author), Lawrence S. Friedman (Author), Lawrence J. Brandt (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323609623, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eMultiple-component retail product, published 23 June 2020\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e2488 pages, 2350 illustrations (1900 in full color)\u003cbr\u003e28.1 x 22.2 x 9.9 cm, 5.87 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003eDoody's Core Titles® 2021 Essential Purchase\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eFor nearly 50 years, \u003ci\u003eSleisenger \u0026amp; Fordtran’s Gastrointestinal and Liver Disease\u003c\/i\u003e has been the go-to reference for gastroenterology and hepatology residents, fellows, physicians, and the entire GI caregiving team. Now in a fully revised 11th Edition, this two-volume masterwork \u003cb\u003ebrings together the knowledge and expertise of hundreds of global experts\u003c\/b\u003e who keep you up to date with the \u003cb\u003enewest techniques, technologies, and treatments\u003c\/b\u003e for every clinical challenge you face in gastroenterology and hepatology. A logical organization, \u003cb\u003emore than 1,100 full-color illustrations\u003c\/b\u003e, and easy-to-use algorithms ensure that you’ll quickly and easily find the information you need.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eFeatures \u003cb\u003enew and expanded discussions\u003c\/b\u003e of chronic hepatitis B and C, Helicobacter pylori infection, colorectal cancer prevention through screening and surveillance, biologic agents and novel small molecules to treat and prevent recurrences of inflammatory bowel disease (IBD), gastrointestinal immune and autoimmune diseases, and more.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eOffers \u003cb\u003ereliable coverage of key topics\u003c\/b\u003e such as Barrett’s esophagus, gut microbiome, enteric microbiota and probiotics, fecal microbiota transplantation, and hepatic, pancreatic, and small bowel transplantation.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eProvides \u003cb\u003emore quick-reference algorithms\u003c\/b\u003e that summarize clinical decision making and practical approaches to patient management.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eEmploys a \u003cb\u003econsistent, templated, format\u003c\/b\u003e throughout for quick retrieval of information.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes \u003cb\u003emonthly updates online\u003c\/b\u003e, as well as \u003cb\u003emore than 20 procedural videos\u003c\/b\u003e.\u003c\/li\u003e \u003cb\u003e \u003cli\u003eExpert Consult™ eBook version included with purchase.\u003c\/li\u003e\u003c\/b\u003e This \u003cb\u003eenhanced eBook experience\u003c\/b\u003e allows you to search all of the text, figures, and references from the book on a variety of devices. \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eVOLUME 1   Part I Biology of the Gastrointestinal tract\u003c\/b\u003e 1 Cellular Growth and Neoplasia, 1 \u003ci\u003eEzra Burstein\u003c\/i\u003e 2 Mucosal Immunology and Inflammation, 13 \u003ci\u003eCIharles O. Elson and Phillip D. Smith\u003c\/i\u003e 3 The Enteric Microbiota, 24 \u003ci\u003eEugene B. Chang and Purna Kashyap \u003c\/i\u003e4 Gut Sensory Transduction, 34 \u003ci\u003eDiego V. Bohórquez and Rodger A. Liddle\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II Nutrition in Gastroenterology \u003c\/b\u003e5 Nutritional Principles and Assessment of the Gastroenterology Patient, 52 \u003ci\u003eJoel B. Mason \u003c\/i\u003e6 Nutritional Management, 74 \u003ci\u003eAngela K. Pham and Stephen A. McClave\u003c\/i\u003e 7 Obesity, 92 \u003ci\u003eRekha B. Kumar and Louis J. Aronne\u003c\/i\u003e 8 Surgical and Endoscopic Treatment of Obesity, 101 \u003ci\u003eShelby Sullivan, Steven A. Edmundowicz, and John Magaña Morton\u003c\/i\u003e 9 Feeding and Eating Disorders, 117 \u003ci\u003eDebra K. Katzman and Mark L. Norris\u003c\/i\u003e 10 Food Allergies,   133 \u003ci\u003eJ. Andrew Bird\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III Symptoms, Signs, and Biopsychosocial Issues\u003c\/b\u003e 11 Acute Abdominal Pain, 144 \u003ci\u003eFrederick H. Millham\u003c\/i\u003e 12 Chronic Abdominal Pain, 158 \u003ci\u003eJoseph C. Yarze and Lawrence S. Friedman \u003c\/i\u003e13 Symptoms of Esophageal Disease, 168 \u003ci\u003eKenneth R. DeVault\u003c\/i\u003e 14 Dyspepsia,177 \u003ci\u003eJan Tack\u003c\/i\u003e 15 Nausea and Vomiting, 191 \u003ci\u003eArvind Rengarajan and C. Prakash Gyawali \u003c\/i\u003e16 Diarrhea, 204 \u003ci\u003eLawrence R. Schiller and Joseph H. Sellin\u003c\/i\u003e 17 Intestinal Gas,224 \u003ci\u003eFernando Azpiroz\u003c\/i\u003e 18 Fecal Incontinence,232 \u003ci\u003eSatish S.C. Rao\u003c\/i\u003e 19 Constipation,250 \u003ci\u003eJohanna C. Iturrino and Anthony J. Lembo\u003c\/i\u003e 20 Gastrointestinal Bleeding, 276 \u003ci\u003eThomas J. Savides and Dennis M. Jensen \u003c\/i\u003e21 Jaundice, 313 \u003ci\u003eSteven D. Lidofsky\u003c\/i\u003e 22 Biopsychosocial Issues in Gastroenterology,324 \u003ci\u003eDouglas A. Drossman and Laurie Keefer\u003c\/i\u003e 23 Factitious Gastrointestinal Disease,340 \u003ci\u003eJohn S. Fordtran and Anahit A. Zeynalyan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV topics Involving Multiple Organs\u003c\/b\u003e 24 Oral Diseases and Oral Manifestations of Gastrointestinal and Liver Diseases, 350 \u003ci\u003eKimberly L. Pham and Ginat W. Mirowski\u003c\/i\u003e 25 Cutaneous Manifestations of Gastrointestinal and Liver Diseases, 359 \u003ci\u003eLawrence A. Mark\u003c\/i\u003e 26 Diverticula of the Pharynx, Esophagus, Stomach, and Small Intestine, 372 \u003ci\u003eKerry B. Dunbar and D. Rohan Jeyarajah \u003c\/i\u003e27 Abdominal Hernias and Gastric Volvulus, 381 \u003ci\u003eD. Rohan Jeyarajah and Kerry B. Dunbar\u003c\/i\u003e 28 Foreign Bodies, Bezoars, and Caustic Ingestions, 399 \u003ci\u003ePatrick R. Pfau and Mark Benson \u003c\/i\u003e29 Abdominal Abscesses and Gastrointestinal Fistulas, 411 \u003ci\u003eGregory dePrisco, Scott Celinski, and Cedric W. Spak \u003c\/i\u003e30 Eosinophilic Disorders of the Gastrointestinal Tract, 424 \u003ci\u003eMarc E. Rothenberg and Vidhya Kunnathur \u003c\/i\u003e31 Protein-Losing Gastroenteropathy, 435 \u003ci\u003eDavid A. Greenwald\u003c\/i\u003e 32 Gastrointestinal Lymphomas, 442 \u003ci\u003ePraveen Ramakrishnan Geethakumari and Syed Mujtaba Rizvi \u003c\/i\u003e33 Gastrointestinal Stromal Tumors, 458 \u003ci\u003eMargaret von Mehren \u003c\/i\u003e34 Neuroendocrine Tumors, 472 \u003ci\u003eJonathan R. Strosberg and Taymeyah Al-Toubah\u003c\/i\u003e 35 Gastrointestinal Consequences of Infection with Human Immunodeficiency Virus, 498 \u003ci\u003eC. Mel Wilcox\u003c\/i\u003e 36 Gastrointestinal and Hepatic Complications of Solid Organ and Hematopoietic Cell Transplantation, 510 \u003ci\u003eAnne M. Larson, Rachel B. Issaka, and David M. Hockenbery\u003c\/i\u003e 37 Gastrointestinal and Hepatic Manifestations of Systemic Diseases, 532 \u003ci\u003eFrederick Weber\u003c\/i\u003e 38 Vascular Lesions of the Gastrointestinal Tract, 561 \u003ci\u003eJoann Kwah and Lawrence J. Brandt \u003c\/i\u003e39 Surgical Peritonitis and Other Diseases of the Peritoneum, Mesentery, Omentum, and Diaphragm, 580 \u003ci\u003eJeffrey B. Matthews and Kiran Turaga\u003c\/i\u003e 40 Gastrointestinal and Hepatic Disorders in the Pregnant Patient, 593 \u003ci\u003eShilpa Mehra and John F. Reinus \u003c\/i\u003e41 Acute and Chronic Gastrointestinal Side Effects of Radiation Therapy, 606 \u003ci\u003eJarred P. Tanksley, Christopher G. Willett, Brian G. Czito, and Manisha Palta\u003c\/i\u003e 42 Preparation for and Complications of Gastrointestinal Endoscopy, 619 \u003ci\u003eAravind Sugumar and John J. Vargo II\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart V Esophagus\u003c\/b\u003e 43 Anatomy, Histology, Embryology, and Developmental Anomalies of the Esophagus,627 \u003ci\u003eRyan D. Madanick and Vishal Kaila\u003c\/i\u003e 44 Esophageal Neuromuscular Function and Motility Disorders, 638 \u003ci\u003eJohn E. Pandolfino and Peter J. Kahrilas\u003c\/i\u003e 45 Esophageal Disorders Caused by Medications, Trauma, and Infection, 661 \u003ci\u003eDavid A. Katzka \u003c\/i\u003e46 Gastroesophageal Reflux Disease, 670 \u003ci\u003eJoel E. Richter and Michael F. Vaezi\u003c\/i\u003e 47 Barrett Esophagus, 691 Stuart Jon Spechler and Rhonda F. Souza \u003ci\u003e48 Esophageal Tumors, 700\u003c\/i\u003e Hazem Hammad and Sachin Wani\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VI Stomach and Duodenum \u003c\/b\u003e49 Anatomy, Histology and Developmental Anomalies of the Stomach and Duodenum, 720 \u003ci\u003eM. Gaith Semrin \u003c\/i\u003e50 Gastric Neuromuscular Function and Neuromuscular Disorders, 735 \u003ci\u003eKenneth L. Koch \u003c\/i\u003e51 Gastric Secretion,764 Mitchell L. Schubert and Jonathan D. Kaunitz52 Gastritis and Gastropathy, 781 \u003ci\u003eMark Feldman, Pamela J. Jensen, and Colin W. Howden\u003c\/i\u003e 53 Peptic Ulcer Disease, 806 \u003ci\u003eFrancis K.L. Chan and James Y.W. Lau \u003c\/i\u003e54 Adenocarcinoma of the Stomach and Other Gastric Tumors, 820 \u003ci\u003eMichael Quante and Jan Bornschein\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VII  Pancreas\u003c\/b\u003e 55 Anatomy, Histology, Embryology, and Developmental Anomalies of the Pancreas, 842 \u003ci\u003eMegha S. Mehta, Bradley A. Barth, and Sohail Z. Husain \u003c\/i\u003e56 Pancreatic Secretion, 853 \u003ci\u003eStephen J. Pandol\u003c\/i\u003e 57 Genetic Disorders of the Pancreas and Pancreatic Disorders in Childhood, 862 \u003ci\u003eDavid C. Whitcomb and Mark E. Lowe \u003c\/i\u003e58 Acute Pancreatitis, 893 \u003ci\u003eSanthi Swaroop Vege \u003c\/i\u003e59 Chronic Pancreatitis, 917 \u003ci\u003eChris E. Forsmark \u003c\/i\u003e60 Pancreatic Cancer, Cystic Pancreatic Neoplasms, and Other Nonendocrine Pancreatic Tumors, 947 \u003ci\u003eBijal Modi and G. Thomas Shires \u003c\/i\u003e61 Endoscopic Treatment of Pancreatic Disease, 965 \u003ci\u003eRyan Law and Todd H. Baron\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VIII  Biliary tract\u003c\/b\u003e 62 Anatomy, Histology, Embryology, Developmental Anomalies, and Pediatric Disorders of the Biliary Tract, 973 \u003ci\u003eFrederick J. Suchy and Cara L. Mack\u003c\/i\u003e 63 Biliary Tract Motor Function and Dysfunction, 995 \u003ci\u003eB. Joseph Elmunzer and Grace H. Elta\u003c\/i\u003e 64 Bile Secretion and the Enterohepatic Circulation, 1001 \u003ci\u003ePeter Fickert and Paul A. Dawson\u003c\/i\u003e 65 Gallstone Disease, 1016 \u003ci\u003eDavid Q.-H. Wang and Nezam H. Afdhal\u003c\/i\u003e 66 Treatment of Gallstone Disease, 1047 \u003ci\u003eRobert E. Glasgow\u003c\/i\u003e 67 Acalculous Biliary Pain, Acute Acalculous Cholecystitis, Cholesterolosis, Adenomyomatosis, and Gallbladder Polyps, 1064 \u003ci\u003eKarin L. Andersson and Lawrence S. Friedman \u003c\/i\u003e68 Primary and Secondary Sclerosing Cholangitis, 1077 \u003ci\u003eCynthia Levy and Christopher L. Bowlus\u003c\/i\u003e 69 Tumors of the Bile Ducts, Gallbladder, and Ampulla, 1096 \u003ci\u003eSumera H. Rizvi and Gregory J. Gores\u003c\/i\u003e 70 Endoscopic and Radiologic Treatment of Biliary Disease, 1113 \u003ci\u003eTheodore W. James and Todd H. Baron\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eVOLUME 2 \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IX  Liver\u003c\/b\u003e 71 Embryology, Anatomy, Histology, and Developmental Anomalies of the Liver,1129 \u003ci\u003eRicard Masia and Joseph Misdraji\u003c\/i\u003e 72 Liver Physiology and Energy Metabolism, 1135 Namita Roy-Chowdhury and Jayanta Roy-Chowdhury73 Liver Chemistry and Function Tests, 1154 \u003ci\u003eDaniel S. Pratt\u003c\/i\u003e 74 Overview of Cirrhosis, 1164 \u003ci\u003ePatrick S. Kamath and Vijay H. Shah \u003c\/i\u003e75 Hemochromatosis, 1172 \u003ci\u003eBruce R. Bacon and Robert E. Fleming \u003c\/i\u003e76 Wilson Disease, 1180 \u003ci\u003eEve A. Roberts\u003c\/i\u003e 77 Other Inherited Metabolic Disorders of the Liver, 1189 \u003ci\u003eJames E. Squires and William F. Balistreri \u003c\/i\u003e78 Hepatitis A, 1210 \u003ci\u003eMaria H. Sjogren and Joseph G. Cheatham \u003c\/i\u003e79 Hepatitis B, 1216 \u003ci\u003eHarry L.A. Janssen and Scott Fung\u003c\/i\u003e 80 Hepatitis C, 1243 \u003ci\u003eJacinta A. Holmes and Raymond T. Chung \u003c\/i\u003e81 Hepatitis D, 1283 \u003ci\u003eMarc G. Ghany\u003c\/i\u003e 82 Hepatitis E, 1292 \u003ci\u003eRakesh Aggarwal\u003c\/i\u003e 83 Hepatitis Caused by Other Viruses, 1298 \u003ci\u003eJordan J. Feld\u003c\/i\u003e 84 Bacterial, Parasitic, and Fungal Infections of the Liver, Including Liver Abscesses, 1303 \u003ci\u003eArthur Y. Kim and Raymond T. Chung \u003c\/i\u003e85 Vascular Diseases of the Liver, 1321 \u003ci\u003eFilipe Gaio Nery and Dominique Charles Valla\u003c\/i\u003e 86 Alcohol-Associated Liver Disease, 1336 \u003ci\u003eGyongyi Szabo and Craig J. McClain\u003c\/i\u003e 87 Nonalcoholic Fatty Liver Disease, 1354 \u003ci\u003eDawn M. Torres and Stephen A. Harrison\u003c\/i\u003e 88 Liver Disease Caused by Drugs, 1367 \u003ci\u003eShivakumar Chitturi, Narci C. Teoh, and Geoffrey C. Farrell \u003c\/i\u003e89 Liver Disease Caused by Anesthetics, Chemicals, Toxins, and Herbal and Dietary Supplements, 1399 \u003ci\u003eJames H. Lewis \u003c\/i\u003e90 Autoimmune Hepatitis, 1415 \u003ci\u003eAlbert J. Czaja\u003c\/i\u003e 91 Primary Biliary Cholangitis, 1433 \u003ci\u003eJohn E. Eaton and Keith D. Lindor \u003c\/i\u003e92 Portal Hypertension and Variceal Bleeding, 1443 \u003ci\u003eVijay H. Shah and Patrick S. Kamath\u003c\/i\u003e 93 Ascites and Spontaneous Bacterial Peritonitis, 1471 \u003ci\u003eElsa Solà and Pere Ginès \u003c\/i\u003e94 Hepatic Encephalopathy, Hepatorenal Syndrome, Hepatopulmonary Syndrome, and Other Systemic Complications of Liver Disease, 1486 \u003ci\u003eShivang S. Mehta and Michael B. Fallon \u003c\/i\u003e95 Acute Liver Failure, 1499 \u003ci\u003eJohn O’Grady and William Bernal \u003c\/i\u003e96 Hepatic Tumors and Cysts, 1509 \u003ci\u003eAdrian M. Di Bisceglie and Alex S. Befeler \u003c\/i\u003e97 Liver Transplantation, 1533 \u003ci\u003eAndres F. Carrion and Paul Martin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart X Small and Large Intestine\u003c\/b\u003e 98 Anatomy, Histology, Embryology, and Developmental Anomalies of the Small and Large Intestine, 1551 \u003ci\u003eLee M. Bass and Barry K. Wershil\u003c\/i\u003e 99 Small Intestinal Motor and Sensory Function and Dysfunction, 1580 \u003ci\u003eChristopher K. Rayner and Patrick A. Hughes \u003c\/i\u003e100 Colonic Motor and Sensory Function and Dysfunction, 1595 \u003ci\u003ePhilip G. Dinning, Marcello Costa, and Simon J.H. Brookes \u003c\/i\u003e101 Intestinal Electrolyte Absorption and Secretion, 1611 \u003ci\u003eMrinalini C. Rao and Jayashree Sarathy \u003c\/i\u003e102 Digestion and Absorption of Carbohydrate, Protein, and Fat, 1636 \u003ci\u003eYangzom D. Bhutia and Vadivel Ganapathy \u003c\/i\u003e103 Digestion and Absorption of Micronutrients, 1657 \u003ci\u003eMichelle Pearlman and Jaime Almandoz \u003c\/i\u003e104 Maldigestion and Malabsorption, 1677 \u003ci\u003eChristoph Höegenauer and Heinz F. Hammer\u003c\/i\u003e 105 Small Intestinal Bacterial Overgrowth, 1711 \u003ci\u003eBrian E. Lacy and John K. DiBaise \u003c\/i\u003e106 Short Bowel Syndrome, 1720 \u003ci\u003eAlan L. Buchman \u003c\/i\u003e107 Celiac Disease,   1736 \u003ci\u003eBenjamin Lebwohl and Peter H.R. Green\u003c\/i\u003e 108 Tropical Diarrhea and Malabsorption, 1756 \u003ci\u003eBalakrishnan S. Ramakrishna \u003c\/i\u003e109 Whipple Disease, 1769 \u003ci\u003eMatthias Maiwald, Axel von Herbay, and David A. Relman\u003c\/i\u003e 110 Infectious Enteritis and Proctocolitis, 1779 \u003ci\u003eJoanna M.P. Melia and Cynthia L. Sears\u003c\/i\u003e 111 Food Poisoning, 1810 \u003ci\u003eJennifer Katz\u003c\/i\u003e 112 Antibiotic-Associated Diarrhea and Clostridioides difficile Infection, 1818 \u003ci\u003eCiarán P. Kelly and Sahil Khanna \u003c\/i\u003e113 Intestinal Protozoa, 1834 \u003ci\u003eChristopher D. Huston \u003c\/i\u003e114 Intestinal Worms, 1847 \u003ci\u003eM. Nedim Ince and David E. Elliott \u003c\/i\u003e115 Epidemiology, Pathogenesis, and Diagnosis of Inflammatory Bowel Diseases, 1868 \u003ci\u003eGilaad G. Kaplan and Siew C. Ng\u003c\/i\u003e 116 Management of Inflammatory Bowel Diseases, 1898 \u003ci\u003eAshwin N. Ananthakrishnan and Miguel D. Regueiro\u003c\/i\u003e 117 Ileostomies, Colostomies, Pouches, and Anastomoses, 1930 \u003ci\u003eAhsan Raza and Farshid Araghizadeh\u003c\/i\u003e 118 Intestinal Ischemia, 1944 \u003ci\u003ePaul Feuerstadt and Lawrence J. Brandt\u003c\/i\u003e 119 Intestinal Ulcerations, 1970 \u003ci\u003eBlair Lewis and Daniel S. Mishkin\u003c\/i\u003e 120 Appendicitis,1983 \u003ci\u003eMartin Daniel Rosenthal and George S. Sarosi, Jr\u003c\/i\u003e. 121 Diverticular Disease of the Colon, 1993 \u003ci\u003eTaft P. Bhuket and Neil H. Stollman\u003c\/i\u003e 122 Irritable Bowel Syndrome, 2008 \u003ci\u003eAlexander C. Ford and Nicholas J. Talley \u003c\/i\u003e123 Intestinal Obstruction, 2021 \u003ci\u003eWilliam Conan Mustain and Richard H. Turnage\u003c\/i\u003e 124 Ileus and Pseudo-Obstruction Syndromes, 2039 \u003ci\u003eAdil E. Bharucha and David O. Prichard\u003c\/i\u003e 125 Tumors of the Small Intestine, 2059  \u003ci\u003eBoris Blechacz and Robert Scott Bresalier\u003c\/i\u003e 126 Colonic Polyps and Polyposis Syndromes, 2076 \u003ci\u003eJohn J. Garber and Daniel C. Chung\u003c\/i\u003e 127 John J. Garber and Daniel C. Chung Colorectal Cancer, 2108 \u003ci\u003eRobert Scott Bresalier\u003c\/i\u003e 128 Other Diseases of the Colon, 2153 \u003ci\u003eDarrell S. Pardi and Thomas G. Cotter \u003c\/i\u003e129 Anal Diseases, 2169 \u003ci\u003eJ. Marcus Downs and Benjamin Kulow\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart XI additional treatments for Patients with Gastrointestinal and Liver Disease \u003c\/b\u003e130 Probiotics, 2187 \u003ci\u003eEamonn M.M. Quigley \u003c\/i\u003e131 Complementary, Alternative, and Integrative Medicine, 2192 \u003ci\u003eJill K. Deutsch and David J. Hass\u003c\/i\u003e 132 Palliative Care Medicine in Patients with Advanced Gastrointestinal and Hepatic Disease, 2206 \u003ci\u003eVyjeyanthi S. Periyakoil, Nielsen Fernandez-Becker, and Sarah E. Streett\u003c\/i\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e], Gastroenterology [\u003ca title=\"See our other books on Gastroenterology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Gastroenterology%20%5BMJH%5D%22\"\u003eMJH\u003c\/a\u003e], Clinical \u0026amp; internal medicine [\u003ca title=\"See our other books on Clinical \u0026amp; internal medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Clinical%20\u0026amp;%20internal%20medicine%20%5BMJ%5D%22\"\u003eMJ\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648118280472,"sku":"9780323609623","price":212.89,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323609623_d5d0b358-4207-4e66-bf6e-acc6fffe8694.jpg?v=1694990003"},{"product_id":"hypertension-secrets-paperback-9780323758529","title":"Hypertension Secrets (Paperback \/ softback) 9780323758529","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eHypertension Secrets\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eGet the answers you need for successful patient care\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eEdgar V. Lerma (Edited by), James M. Luther (Edited by), Swapnil Hiremath (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323758529, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 19 April 2022\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e256 pages, 10 illustrations (10 in full color)\u003cbr\u003e22.9 x 15.2 x 1.7 cm, 0.43 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eFor more than 30 years, the highly regarded Secrets Series® has provided students and practitioners in all areas of health care with concise, focused, and engaging resources for quick reference and exam review. Hypertension Secrets, 2nd Edition, offers practical, up-to-date coverage of the full range of essential topics in this dynamic field. This highly regarded resource features the Secrets’ popular question-and-answer format that also includes lists, tables, pearls, memory aids, and an easy-to-read style – making inquiry, reference, and review quick, easy, and enjoyable.\u003cul\u003e \u003cli\u003e  \u003cp\u003eThe proven Secrets Series® format gives you the most return for your time  – succinct, easy to read, engaging, and highly effective. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eCovers  the full range of pathophysiology, natural history, and diagnosis and management of hypertension for in-training or practicing professionals. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eFully revised and updated, including protocols and guidelines that are continuously evolving and that increasingly dictate best practices. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eIncludes chapters on obstructive sleep apnea; drug- or alcohol-induced hypertension; hypertension and diabetes, the obese individual,  African Americans, the elderly, thyroid disorders, and pregnancy; and the role of device therapy.  \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eTop 100 Secrets and Key Points boxes provide a fast overview of the secrets you must know for success in practice and on exams. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eBulleted lists, mnemonics, practical tips from global leaders in the field – all providing a concise overview of important board-relevant content. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003ePortable size makes it easy to carry with you for quick reference or review anywhere, anytime. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eEnhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cb\u003e \u003c\/b\u003e\u003cp\u003eHYPERTENSION SECRETS, 2\u003csup\u003end\u003c\/sup\u003e Edition\u003c\/p\u003e \u003cp\u003eEDITORS: EDGAR V. LERMA and SWAPNIL HIREMATH\u003c\/p\u003e \u003ci\u003e \u003c\/i\u003e\u003cp\u003eContents\u003c\/p\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ePATIENT ASSESSMENT\u003c\/li\u003e \u003c\/ol\u003e \u003col\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eMeasurement of Blood Pressure \u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eClinical Evaluation of Hypertension \u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertensive Crises\u003c\/li\u003e \u003c\/ol\u003e\n\u003c\/ol\u003e \u003col\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eESSENTIAL HYPERTENSION\u003c\/li\u003e \u003c\/ol\u003e \u003col\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eEpidemiology of Hypertension \u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ePathophysiology of Essential (Primary) Hypertension – Isolated Systolic HTN, Diastolic HTN\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eNatural History of Hypertension\u003c\/li\u003e \u003c\/ol\u003e\n\u003c\/ol\u003e \u003col\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eSECONDARY HYPERTENSION\u003c\/li\u003e \u003c\/ol\u003e \u003col\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eDefinition, Non-compliant, Screening for secondary HTN\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eRenal Parenchymal Hypertension\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eRenovascular Hypertension\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCoarctation of the Aorta\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eMineralocorticoid Excess: Primary Aldosteronism\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ePheochromocytoma\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eGlucocorticoid Excess: Cushing’s Syndrome and Congenital Adrenal Hyperplasia\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eObstructive Sleep Apnea\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eDrug or Alcohol-induced\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eThyroid Disorders\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ePrimary Hyperparathyroidism \u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eAcromegaly\u003c\/li\u003e \u003c\/ol\u003e\n\u003c\/ol\u003e \u003col\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHYPERTENSION IN SPECIFIC POPULATIONS \u003c\/li\u003e \u003c\/ol\u003e \u003col\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertension in the Pediatric Population \u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertension in Chronic Kidney Disease and End Stage Kidney Disease\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertension in Obese Individuals\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertension in African Americans\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertension in the Elderly\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertension in Pregnancy\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertension after Kidney Transplantation\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertension in the patient with Acute MI, CHF, Stable CAD\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertension in the patient with CVA (Ischemic, Hemorrhagic)\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertension in the patient with a VAD\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eResistant Hypertension\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHypertension in Patients with Diabetes Mellitus\u003c\/li\u003e \u003c\/ol\u003e\n\u003c\/ol\u003e \u003col\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eTHERAPEUTIC PRINCIPLES\u003c\/li\u003e \u003c\/ol\u003e \u003col\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eLifestyle Modifications – Diet (Na, Mediterranean)\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eTreatment Goals\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCombination Drug Therapy\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eTreatment of Hypertensive Crises\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eDiuretics\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eß-Blockers\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ea-Blockers\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCalcium Channel Blockers\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ePeripheral Adrenergic Inhibitors, Centrally Acting Sympatholytics and Vasodilators\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eAngiotensin Converting Enzyme inhibitors and Angiotension II Receptor Blockers\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eRenal Denervation\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eBP Vaccines\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eApplication of Therapeutic Principles\u003c\/li\u003e \u003c\/ol\u003e\n\u003c\/ol\u003e \u003col\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003e[Title TBD]\u003c\/li\u003e \u003c\/ol\u003e \u003col\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eOrthostatic Hypotension\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eBaroreceptor Dysfunction\u003c\/li\u003e \u003c\/ol\u003e\n\u003c\/ol\u003e \u003col\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eTRIVIA \u003c\/li\u003e \u003c\/ol\u003e \u003col\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHistorical snippets\/oddities, e.g., Stephen Hales’ first BP measurement in a horse, etc.\u003c\/li\u003e \u003c\/ol\u003e\n\u003c\/ol\u003e \u003cp\u003eStill to place: Genetic (Monogenic) causes of Hypertension \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648232902936,"sku":"9780323758529","price":32.75,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323758529_97749e43-3e58-4c5d-98ae-89ea6c3683ab.jpg?v=1694990243"},{"product_id":"fluid-electrolyte-and-acid-base-physiology-a-problem-based-approach-paperback-9780323355155","title":"Fluid, Electrolyte and Acid-Base Physiology; A Problem-Based Approach (Paperback \/ softback) 9780323355155","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eFluid, Electrolyte and Acid-Base Physiology\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eA Problem-Based Approach\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eAn \u003cb\u003eessential companion\u003c\/b\u003e for nephrologists and emergency practitioners.\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eKamel S. Kamel (Author), Mitchell L. Halperin (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323355155, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 9 December 2016\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e528 pages, 230 illustrations (230 in full color)\u003cbr\u003e26 x 18.3 x 3.3 cm, 0.86 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003e\"One of the strengths of this book is the educational format, which promotes gradual learning, yet it also provides a quick reference with its diagnostic charts and algorithms and its comprehensive index. The case studies and reviews are methods that ensure clinical application of the information, and the integration of margin notes and colored key point boxes assists in clarifying the information.\"\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e- Taha Ayach, MD (University of Kentucky College of Medicine) for Doody’s Review Services\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eWith a \u003cb\u003estrong focus on problem solving and clinical decision making\u003c\/b\u003e, \u003ci\u003eFluid, Electrolyte, and Acid-Base Physiology\u003c\/i\u003e is your comprehensive, go-to guide on the diagnosis and management of fluid, electrolytes, and acid-base disorders. This\u003cb\u003e in-depth reference\u003c\/b\u003e moves smoothly from basic physiology to practical clinical guidance, taking into account \u003cb\u003enew discoveries; new understanding of fluid, acid-base, and electrolyte physiology; and new treatment options\u003c\/b\u003e available to today’s patients. An essential resource for nephrologists and emergency practitioners, this \u003cb\u003eextensively revised\u003c\/b\u003e edition helps you make the best management decisions based on the most current knowledge.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003ePresents \u003cb\u003equestions and explanations throughout\u003c\/b\u003e that let you test your knowledge and hone your skills.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eHigh-yield margin notes \u003c\/b\u003eand\u003cb\u003e key point boxes \u003c\/b\u003emake essential information easy to review.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eNumerous line drawings, diagnostic algorithms, \u003c\/b\u003eand\u003cb\u003e tables\u003c\/b\u003e facilitate reference.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eDistinguished authors\u003c\/b\u003e apply their extensive experience in research, clinical practice, and education to make \u003cb\u003etheoretical and clinical knowledge\u003c\/b\u003e easy to understand and apply.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eExpert Consult eBook version included with purchase. \u003c\/li\u003e\u003c\/b\u003eThis\u003cb\u003e enhanced eBook experience \u003c\/b\u003eallows you to search all of the text, figures, images, and references from the book on a variety of devices.  \u003cli\u003e\n\u003cb\u003eMore patient-based problem solving\u003c\/b\u003e illustrates how key principles of renal physiology, biochemistry, and metabolic regulation are applied in practice, challenging you to test your knowledge and hone your decision-making skills.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eHighlights updated clinical approaches\u003c\/b\u003e to the diagnosis and management of fluid, electrolyte, and acid-base disorders based on current research and understanding.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eIntegrative whole-body physiology \u003c\/b\u003eprovides a more comprehensive grasp\u003cb\u003e \u003c\/b\u003eof the pathophysiology of fluid, electrolyte, and acid-base disorders. \u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eSection One Acid Base\u003c\/p\u003e \u003cp\u003eChapter 1 Principles of Acid-Base Physiology\u003c\/p\u003e \u003cp\u003eChapter 2 Tools to Use to Diagnose Acid-Base Disorders\u003c\/p\u003e \u003cp\u003eChapter 3 Metabolic Acidosis: Clinical Approach\u003c\/p\u003e \u003cp\u003eChapter 4 Metabolic Acidosis caused by a Deficit of NaHCO\u003csub\u003e3\u003c\/sub\u003e\u003c\/p\u003e \u003cp\u003eChapter 5 Ketoacidosis\u003c\/p\u003e \u003cp\u003eChapter 6 Metabolic Acidosis: Acid Gain Types \u003c\/p\u003e \u003cp\u003eChapter 7 Metabolic Alkalosis \u003c\/p\u003e \u003cp\u003eChapter 8 Respiratory Acid-Base Disturbances \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection Two Salt and Water\u003c\/p\u003e \u003cp\u003eChapter 9 Sodium and Water Physiology \u003c\/p\u003e \u003cp\u003eChapter10 Hyponatremia\u003c\/p\u003e \u003cp\u003eChapter 11 Hypernatremia\u003c\/p\u003e \u003cp\u003eChapter 12 Polyuria \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection Three Potassium\u003c\/p\u003e \u003cp\u003eChapter 13 Potassium Physiology \u003c\/p\u003e \u003cp\u003eChapter 14 Hypokalemia\u003c\/p\u003e \u003cp\u003eChapter 15 Hyperkalemia\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection Four Integrative Physiology\u003c\/p\u003e \u003cp\u003eChapter 16 Hyperglycemia\u003c\/p\u003e  \u003cp\u003eList of Cases \u003c\/p\u003e \u003cp\u003eList of Flow Charts \u003c\/p\u003e  \u003cb\u003e \u003c\/b\u003e\u003cp\u003eIndex\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648247157016,"sku":"9780323355155","price":47.89,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323355155.jpg?v=1694988946"},{"product_id":"national-kidney-foundation-primer-on-kidney-diseases-paperback-9780323791229","title":"National Kidney Foundation Primer on Kidney Diseases (Paperback \/ softback) 9780323791229","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eNational Kidney Foundation Primer on Kidney Diseases\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eTrusted by nephrologists at all levels of experience for more than 25 years\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eScott F. Gilbert (Edited by), Daniel E. Weiner (Edited by),  (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323791229\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 4 May 2022\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e688 pages\u003cbr\u003e27.6 x 21.6 x 4.2 cm, 1.47 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003ci\u003e\"This book offers a thorough understanding of kidney diseases, including basic anatomy and physiology and the management of complex renal conditions. It emphasizes evidence-based medicine, offering up-to-date information on research findings, clinical guidelines, and treatment protocols for effective management of kidney disease.\" \u003c\/i\u003e©Doody’s Review Service, 2023, Amandeep Singh, MD (University of Kentucky College of Medicine) Doody's Core Titles® 2022\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eWell organized and highly readable, the National Kidney Foundation Primer on Kidney Diseases has offered clear, comprehensive coverage of adult and pediatric kidney diseases for more than 25 years. The thoroughly revised 8th Edition of this authoritative, practical reference covers every relevant topic in the field, making it an excellent resource for residency, fellowship, clinical practice, and board review. It brings you completely up to date with key topics in this fast-changing field, including ongoing clinical research and changing treatment protocols. \u003c\/p\u003e \u003cp\u003eThis powerful learning tool and clinical reference is a joint publication of Elsevier and the National Kidney Foundation. \u003c\/p\u003e\n\u003cul\u003e \u003cli\u003e  \u003cp\u003eCovers every relevant topic in nephrology—from anatomy, physiology, and pathophysiology to diagnosis and management of kidney disease, to fluid and electrolyte disorders, hypertension, dialysis, and renal transplantation. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003ePresents complex material in a clear, easy-to-understand manner that is both accessible for residents and fellows and comprehensive enough for practicing nephrologists. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eOffers new guidance for management of COVID-19 in the Viral Nephropathies chapter. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eContains two new chapters on Global Kidney Disease, and Conservative Kidney Management (CKM), a palliative care option for treating kidney failure without dialysis. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eEnhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eStructure and Function of the Kidney\u003c\/p\u003e \u003cp\u003e1. Overview of Kidney Structure and Function\u003c\/p\u003e \u003cp\u003e2. Kidney development\u003c\/p\u003e \u003cp\u003e3. Assessment of Kidney Function in Acute and Chronic Settings \u003c\/p\u003e \u003cp\u003e4. Urinalysis and Urine Microscopy \u003c\/p\u003e \u003cp\u003e5. Hematuria and Proteinuria\u003c\/p\u003e \u003cp\u003e6. Imaging the Kidneys\u003c\/p\u003e \u003cp\u003eAcid\/Base and Electrolytes\u003c\/p\u003e \u003cp\u003e7. Hyponatremia and Hypoosmolar Disorders\u003c\/p\u003e \u003cp\u003e8. Hypernatremia\u003c\/p\u003e \u003cp\u003e9. Volume, Edema and the Clinical Use of Diuretics\u003c\/p\u003e \u003cp\u003e10. Disorders of Potassium Metabolism\u003c\/p\u003e \u003cp\u003e11. Disorders of Calcium, Phosphorus, \u0026amp; Magnesium Homeostasis\u003c\/p\u003e \u003cp\u003e12. Approach to Acid-Base Disorders\u003c\/p\u003e \u003cp\u003e13. Metabolic Acidosis\u003c\/p\u003e \u003cp\u003e14. Metabolic Alkalosis\u003c\/p\u003e \u003cp\u003e15. Respiratory Acidosis and Alkalosis\u003c\/p\u003e \u003cp\u003eGlomerular Diseases\u003c\/p\u003e \u003cp\u003e16. Glomerular Clinicopathologic Syndromes\u003c\/p\u003e \u003cp\u003e17. Minimal Change Nephrotic Syndrome\u003c\/p\u003e \u003cp\u003e18. Focal Segmental Glomerulosclerosis\u003c\/p\u003e \u003cp\u003e19. Membranous Nephropathy\u003c\/p\u003e \u003cp\u003e20. Immunoglobulin A Nephropathy and Related Disorders\u003c\/p\u003e \u003cp\u003eKidney in Systemic Diseases\u003c\/p\u003e \u003cp\u003e21. COMPLEMENT-MEDIATED GLOMERULONEPHRITIS AND THROMBOTIC MICROANGIOPATHY \u003c\/p\u003e \u003cp\u003e22. Infection-related Glomerulonephritis\u003c\/p\u003e \u003cp\u003e23. Viral Nephropathies: Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus \u003c\/p\u003e \u003cp\u003e24. Kidney Involvement in Systemic Vasculitis\u003c\/p\u003e \u003cp\u003e25. Systemic Lupus Erythematosus and the Kidney\u003c\/p\u003e \u003cp\u003e26. Pathogenesis, Pathophysiology, and Treatment of Diabetic Nephropathy\u003c\/p\u003e \u003cp\u003e27. The Kidney in Malignancy\u003c\/p\u003e \u003cp\u003e28. Myeloma, Amyloid and other Dysproteinemias\u003c\/p\u003e \u003cp\u003e29. Acute Cardiorenal Syndrome \u003c\/p\u003e \u003cp\u003e30. Hepatorenal Syndrome and Other Liver-Related Kidney Diseases\u003c\/p\u003e \u003cp\u003eAcute Kidney Injury\u003c\/p\u003e \u003cp\u003e31. Clinical Approach to the Diagnosis of Acute Kidney Injury\u003c\/p\u003e \u003cp\u003e32. Acute Tubular Injury and Acute Tubular Necrosis\u003c\/p\u003e \u003cp\u003e33. Acute Interstitial Nephritis\u003c\/p\u003e \u003cp\u003e34. Management of Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eDrugs and the Kidney\u003c\/p\u003e \u003cp\u003e35. Kidney Disease Caused by Therapeutic Agents\u003c\/p\u003e \u003cp\u003e36. Principles of Drug Therapy in Patients with Reduced Kidney Function\u003c\/p\u003e \u003cp\u003eHereditary Kidney Disease\u003c\/p\u003e \u003cp\u003e37. Genetics and Kidney Disease (APOL1)\u003c\/p\u003e \u003cp\u003e38. Genetically Based Renal Transport Disorders\u003c\/p\u003e \u003cp\u003e39. Sickle Cell Nephropathy\u003c\/p\u003e \u003cp\u003e40. Polycystic and Other Cystic Kidney Diseases\u003c\/p\u003e \u003cp\u003e41. Nephronophthisis and Medullary Cystic Kidney Disease\u003c\/p\u003e \u003cp\u003e42. Alport's Syndrome and Thin Basement Membrane Dz\u003c\/p\u003e \u003cp\u003e43. Fabry Disease\u003c\/p\u003e \u003cp\u003eTubulointerstitial Diseases\u003c\/p\u003e \u003cp\u003e44. Chronic Tubulointerstitial Disease\u003c\/p\u003e \u003cp\u003e45. Obstructive Uropathy\u003c\/p\u003e \u003cp\u003e46. Nephrolithiasis\u003c\/p\u003e \u003cp\u003e47. Urinary Tract Infection and Pyelonephritis\u003c\/p\u003e \u003cp\u003eSpecial Circumstances\u003c\/p\u003e \u003cp\u003e48. Kidney Diseases in Infants and Children\u003c\/p\u003e \u003cp\u003e49. The Kidney in Pregnancy\u003c\/p\u003e \u003cp\u003e50. Kidney Disease in the Elderly\u003c\/p\u003e \u003cp\u003e51. Global Kidney Disease\u003c\/p\u003e \u003cp\u003eChronic Kidney Disease\u003c\/p\u003e \u003cp\u003e52. Development and Progression of Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003e53. Staging and Management of Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003e54. Nutrition and Kidney Disease\u003c\/p\u003e \u003cp\u003e55. Bone Disorders in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003e56. Cardiac Function and Cardiovascular Disease in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003e57. Anemia and Other Hematologic Complications of Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eDialysis and Transplantation\u003c\/p\u003e \u003cp\u003e58. Hemodialysis and Hemofiltration\u003c\/p\u003e \u003cp\u003e59. Peritoneal Dialysis\u003c\/p\u003e \u003cp\u003e60. Outcome of End-Stage Renal Disease Therapies\u003c\/p\u003e \u003cp\u003e61. Selection of Prospective Kidney Transplant Recipients and Donors\u003c\/p\u003e \u003cp\u003e62. Post-transplantation Monitoring and Outcomes\u003c\/p\u003e \u003cp\u003e63. Immunosuppression\u003c\/p\u003e \u003cp\u003e64. Transplant Infectious Disease\u003c\/p\u003e \u003cp\u003eHypertension\u003c\/p\u003e \u003cp\u003e65. Pathogenesis of Hypertension\u003c\/p\u003e \u003cp\u003e66. Evaluation and Management of Hypertension\u003c\/p\u003e \u003cp\u003e67. Secondary Hypertension\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648351621400,"sku":"9780323791229","price":63.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323791229.jpg?v=1694992029"},{"product_id":"handbook-of-dialysis-therapy-paperback-9780323791359","title":"Handbook of Dialysis Therapy (Paperback \/ softback) 9780323791359","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eHandbook of Dialysis Therapy\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eComprehensive, practical guidance for every member of the dialysis team\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eAllen R. Nissenson (Edited by), Richard N. Fine (Edited by), Rajnish Mehrotra (Edited by), Joshua Zaritsky (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323791359\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 11 October 2022\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e944 pages\u003cbr\u003e27.6 x 21.6 x 5.7 cm, 1.63 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003ci\u003e\"This book provides an extensive overview of the routine care of dialysis patients, including different types of dialysis as well as how to deal with complications that can arise for dialysis patients.\" \u003c\/i\u003e©Doody’s Review Service, 2023, Tyler C Sims, MD (University of Kentucky College of Medicine) \u003cb\u003eDoody's Score: 5 Stars!\u003c\/b\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eEdited and written by top experts and pioneers in dialysis, Handbook of Dialysis Therapy, 6th Edition, provides the entire dialysis team with a comprehensive overview of this growing field. It covers traditional and advanced procedures, what pitfalls to expect and how to overcome them, and how best to treat various patient populations—all with a practical approach that can be directly applied to patient care. This must-have resource has been updated with the latest cutting-edge technology, dialysis techniques, and complications related to various diseases for both pediatric and adult patients.\u003cul\u003e \u003cli\u003e  \u003cp\u003eExplains complex dialysis concepts through abundant diagrams, photos, line drawings, and tables, while its readable, hands-on approach allows for quick review of key information. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eCovers both adult and pediatric patients in detail, and offers guidance on special populations such as the geriatric patients and the chronically ill. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eFeatures increased content on home-based dialysis modalities, new alternatives for establishing vascular access for hemodialysis, new protocols for reducing the risk of infection and complications, and advancements in establishing and managing peritoneal dialysis. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eIncludes extensive pediatric content such as prevention and treatment of bone disease, management of anemia, assessing quality of life in pediatric patients undergoing dialysis, and immunizations in children undergoing dialysis. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eDefines the quality imperatives, roles, and responsibilities of dialysis facility medical directors and attending nephrologists. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eUpdates nephrologists on the latest alternative dialysis modalities. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eEnhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cb\u003ePART I: Dialysis Therapy for Adults\u003cbr\u003eSection 1: Overview of ESKD\u003c\/b\u003e\u003cbr\u003e1 Demographics of the End-Stage Renal Disease Patient\u003cbr\u003e2 Uremic Toxicity\u003cbr\u003e3 Initiation of Dialysis Therapy\u003cbr\u003e\u003cb\u003eSection 2: Hemodialysis\u003c\/b\u003e\u003cbr\u003e4 Urea Kinetic Modeling for Guiding Hemodialysis Therapy in Adults\u003cbr\u003e5 The Dialysis Prescription\u003cbr\u003e6 Selecting a Dialyzer: Technical and Clinical Considerations\u003cbr\u003e7 Water Treatment Equipment for In-Center Hemodialysis\u003cbr\u003e8 Dialysate Composition\u003cbr\u003e9 Safety Monitors in Hemodialysis\u003cbr\u003e10 Methods of Hemodialysis Anticoagulation\u003cbr\u003e11 Common Clinical Problems in Hemodialysis\u003cbr\u003e12 Hemofiltration and Hemodiafiltration\u003cbr\u003e13 Wearable and Implantable Renal Replacement Therapy\u003cbr\u003e14 Home Preparation and Installation for Home Hemodialysis\u003cbr\u003e15 Vascular Access\u003cbr\u003e16 Cannulation of Arteriovenous Vascular Access: Science and Art\u003cbr\u003e17 Central Venous Access for Hemodialysis\u003cbr\u003e18 Noninfectious Complications From Vascular Access\u003cbr\u003e19 Infectious Complications From Vascular Access\u003cbr\u003e\u003cb\u003eSection 3: Peritoneal Dialysis\u003c\/b\u003e\u003cbr\u003e20 Determination of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Prescriptions\u003cbr\u003e21 Peritoneal Dialysis Cyclers and Other Mechanical Devices\u003cbr\u003e22 Peritoneal Dialysis Solutions\u003cbr\u003e23 Solute Management With Peritoneal Dialysis\u003cbr\u003e24 Volume Management With Peritoneal Dialysis\u003cbr\u003e25 Peritoneal Access Devices, Placement Techniques, and Maintenance\u003cbr\u003e26 Peritoneal Catheter Exit Site and Tunnel Infections\u003cbr\u003e27 Peritonitis in Peritoneal Dialysis\u003cbr\u003e28 Abdominal Hernias With Peritoneal Dialysis\u003cbr\u003e29 Dialysate Leaks with Peritoneal Dialysis\u003cbr\u003e30 Hydrothorax and Peritoneal Dialysis\u003cbr\u003e31 Abdominal Catastrophes, Peritoneal Eosinophilia, and Other Unusual Events in Peritoneal Dialysis\u003cbr\u003e32 Metabolic Complications of Peritoneal Dialysis\u003cbr\u003e\u003cb\u003eSection 4: Management of Uremic Complications\u003c\/b\u003e\u003cbr\u003e33 Acid–Base Homeostasis in Dialysis\u003cbr\u003e34 Nutritional Management of Hemodialysis Patients\u003cbr\u003e35 Intradialytic Parenteral Nutrition and Intraperitoneal Nutrition\u003cbr\u003e36 Nutritional Management in Peritoneal Dialysis\u003cbr\u003e37 Anemia and Its Treatment in Patients With End-Stage Kidney Disease\u003cbr\u003e38 Resistance to Erythropoiesis Stimulating Agent (ESA) Treatment\u003cbr\u003e39 Chronic Kidney Disease–Mineral and Bone Disorder\u003cbr\u003e40 Phosphate Management in Patients with End-Stage Kidney Disease\u003cbr\u003e41 Use of Vitamin D Sterols and Calcimimetics in Patients With End-Stage Renal Disease\u003cbr\u003e42 Parathyroidectomy\u003cbr\u003e43 Acquired Cystic Kidney Disease\u003cbr\u003e\u003cb\u003eSection 5: Management of Co-Existing Illnesses and Special Populations\u003c\/b\u003e\u003cbr\u003e44 The Challenges of Blood Pressure Control in Hemodialysis Patients\u003cbr\u003e45 Arrhythmias in Hemodialysis Patients\u003cbr\u003e46 Management of Ischemic Heart Disease, Heart Failure, and Pericarditis in Patients Undergoing Long-Term Dialysis\u003cbr\u003e47 Avoidance and Treatment of Cardiovascular Disease in Dialysis\u003cbr\u003e48 Management of Dyslipidemia in Long-Term Dialysis Patients\u003cbr\u003e49 End-Stage Kidney Failure in the Diabetic Patient\u003cbr\u003e50 Care of Elderly Dialysis and End-Stage Kidney Disease Patients\u003cbr\u003e51 Liver Disease and Gastrointestinal Disorders in Dialysis Patients\u003cbr\u003e52 Abnormalities of Thyroid Function in Chronic Dialysis Patients\u003cbr\u003e53 Care of the Human Immunodeficiency Virus–Infected End-Stage Kidney Disease Patient\u003cbr\u003e54 COVID-19 and Dialysis Patients\u003cbr\u003e55 Psychosocial Issues in Patients Treated With Dialysis\u003cbr\u003e56 Evaluation and Treatment of Sexual Dysfunction\u003cbr\u003e57 Pregnancy in Dialysis Patients\u003cbr\u003e58 Principles of Drug Usage in Dialysis Patients\u003cbr\u003e59 Medication Management\u003cbr\u003e60 Physical Activity, Function, and Exercise-Based Rehabilitation for People on Dialysis\u003cbr\u003e61 Physical, Psychosocial, and Vocational Rehabilitation of Patients Undergoing Long-Term Dialysis\u003cbr\u003e62 Preventive Care in End-Stage Renal Disease\u003cbr\u003e\u003cb\u003eSection 6: Systems Management for the Care of Dialysis Patients\u003c\/b\u003e\u003cbr\u003e63 Ethical Considerations in the Care of Dialysis Patients: The New Paradigm\u003cbr\u003e64 Improving Outcomes for End-Stage Renal Disease Patients: Shifting the Quality Paradigm\u003cbr\u003e65 Quality, Safety, Accountability, and Medical Director Responsibilities\u003cbr\u003e66 Application of Telemedicine to Kidney Failure Patients\u003cbr\u003e\u003cb\u003eSection 7: Acute Kidney Injury and Poisonings\u003c\/b\u003e\u003cbr\u003e67 Continuous Renal Replacement Therapies for Acute Kidney Injury\u003cbr\u003e68 Anticoagulation for Continuous Renal Replacement Therapy\u003cbr\u003e69 Treatment of Poisoning with Extracorporeal Methods\u003cbr\u003e\u003cb\u003ePART II: Dialysis Therapy for Children\u003c\/b\u003e\u003cbr\u003e70 Vascular Access and Peritoneal Dialysis Catheter Placement in Children\u003cbr\u003e71 Infant Hemodialysis\u003cbr\u003e72 Urea Kinetic Modeling for Hemodialysis Prescription in Children\u003cbr\u003e73 Alternate Hemodialysis Prescriptions in Children\u003cbr\u003e74 Anticoagulation in Children Undergoing Hemodialysis, Continuous Renal Replacement Therapy, or Apheresis Therapy\u003cbr\u003e75 Prescribing Peritoneal Dialysis in Children\u003cbr\u003e76 Nutritional Management of Children Undergoing Peritoneal Dialysis\u003cbr\u003e77 Peritoneal Dialysis in Neonates and Infants\u003cbr\u003e78 Dialysis for Inborn Errors of Metabolism\u003cbr\u003e79 Neurocognitive Function in Pediatric Dialysis\u003cbr\u003e80 Growth in Children With End-Stage Kidney Disease\u003cbr\u003e81 Adequacy of Peritoneal Dialysis\/Assessing Peritoneal Function in Pediatric Patients\u003cbr\u003e82 Continuous Renal Replacement Therapy in Pediatric Patients\u003cbr\u003e83 Prevention and Treatment of Bone Disease in Pediatric Dialysis Patients\u003cbr\u003e84 Management of Anemia in Children Undergoing Dialysis\u003cbr\u003e85 Prevention and Treatment of Cardiovascular Complications in Children Undergoing Dialysis\u003cbr\u003e86 Infectious Complications in Children Undergoing Dialysis\u003cbr\u003e87 Caring for the Teenager in an Adult Unit\u003cbr\u003e\u003cb\u003eIndex\u003c\/b\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648361812248,"sku":"9780323791359","price":77.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323791359.jpg?v=1694992033"},{"product_id":"diagnostic-atlas-of-renal-pathology-hardback-9780323721639","title":"Diagnostic Atlas of Renal Pathology (Hardback) 9780323721639","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eDiagnostic Atlas of Renal Pathology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003ePractical, highly visual guidance for efficient, accurate diagnosis of renal disease\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eAgnes B. Fogo (Author), Michael Kashgarian (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323721639\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 7 December 2021\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e576 pages\u003cbr\u003e27.6 x 21.6 x 3.3 cm, 1.72 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eDoody's Core Titles® 2022\u003c\/p\u003e \u003cp\u003e\u003ci\u003e\"I have reviewed previous editions of this book and I am as enthusiastic about this edition as I was about the previous ones. This is an ideal book for those starting to learn renal pathology as residents or even medical students. On the other hand, it also could serve well diagnostic pathologists who do not see too many renal biopsies in their daily practice or those who would like to learn about new developments in nephropathology. In its updated and expanded form, this book should be part pathology departmental libraries as well as central medical libraries.\"\u003c\/i\u003e \u003c\/p\u003e \u003cp\u003e©Doody’s Review Service, 2022, Ivan Damjanov, MD,PhD (University of Kansas Medical Center)\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eFor today’s nephrologist who is tasked with diagnosing a wide range of renal pathologic entities, \u003ci\u003eDiagnostic Atlas of Renal Pathology\u003c\/i\u003e is a \u003cb\u003emust-have reference for everyday use\u003c\/b\u003e. The updated 4th Edition offers an in-depth examination of \u003cb\u003epathophysiology, clinical presentations, and the latest evidence-based practices\u003c\/b\u003e. Hundreds of pertinent macro- and\/or microscopic images are presented in a user-friendly manner intended specifically for renal pathology.\u003c\/p\u003e\n\u003cul\u003e \u003cul\u003e\u003c\/ul\u003e \u003cli\u003eOffers \u003cb\u003etemplated, detailed discussions on key characteristic pathologic findings\u003c\/b\u003e and prognostic, pathogenetic, and etiologic information for each disorder.\u003c\/li\u003e  \u003cul\u003e \u003c\/ul\u003e \u003cli\u003eFeatures numerous tables and sidebars with \u003cb\u003ekey points and differential diagnoses\u003c\/b\u003e.\u003c\/li\u003e  \u003cul\u003e  \u003c\/ul\u003e \u003cli\u003eCovers \u003cb\u003emajor new advances\u003c\/b\u003e in the classification and diagnosis of select tubular cystic diseases, new advances in classification of fibrillary processes and C3 related diseases, new insights in monoclonal protein-related diseases, ongoing work in lupus, and advances in IgA nephropathy as well as transplantation.\u003c\/li\u003e  \u003cul\u003e  \u003c\/ul\u003e \u003cli\u003eContains \u003cb\u003emore than 700 high-quality representative images\u003c\/b\u003e of light, immunofluorescence, and electron microscopy, including \u003cb\u003enew colorized electron microscopy images\u003c\/b\u003e, with correlations to clinical presentation and pathogenesis.\u003c\/li\u003e  \u003cul\u003e  \u003c\/ul\u003e \u003cli\u003eFeatures \u003cb\u003enew animations\u003c\/b\u003e that clearly depict the progression of membranous nephropathy, membranoproliferative GN, and crescentic GN.\u003c\/li\u003e  \u003cul\u003e  \u003c\/ul\u003e \u003cli\u003eIncludes \u003cb\u003eschematic representations of glomerular diseases\u003c\/b\u003e, which are particularly useful for illustrating difficult concepts.\u003c\/li\u003e  \u003cul\u003e \u003cb\u003e \u003c\/b\u003e\n\u003c\/ul\u003e \u003cli\u003eEnhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.\u003c\/li\u003e  \u003cul\u003e \u003c\/ul\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e1. Approach to Diagnosis of the Kidney Biopsy\u003c\/p\u003e \u003cp\u003e2. Normal Growth and Maturation\u003c\/p\u003e \u003cp\u003e3. Glomerular Diseases \u003c\/p\u003e \u003cp\u003e4. Vascular Diseases \u003c\/p\u003e \u003cp\u003e5. Tubulointerstitial Diseases \u003c\/p\u003e \u003cp\u003e6. Endemic Nephropathies\u003c\/p\u003e \u003cp\u003e7. Chronic Kidney Disease \u003c\/p\u003e \u003cp\u003e8. Renal Transplantation\u003c\/p\u003e \u003cp\u003e9. Cystic Diseases of the Kidney \u003c\/p\u003e \u003cp\u003e10. Renal Neoplasia \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648376262936,"sku":"9780323721639","price":146.79,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323721639_73d17f55-17c7-4184-8e19-c4b2f4099c90.jpg?v=1694990160"},{"product_id":"critical-care-nephrology-hardback-9780323449427","title":"Critical Care Nephrology (Hardback) 9780323449427","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCritical Care Nephrology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eComplete, multidisciplinary coverage from experts in this fast-changing field\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eClaudio Ronco (Author), Rinaldo Bellomo (Author), John A. Kellum (Author), Zaccaria Ricci (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323449427\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 31 January 2018\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1456 pages, 500 illustrations\u003cbr\u003e28.1 x 22.2 x 6.3 cm, 2.85 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003e\"This is an excellent source of in-depth information on the intersection between critical illness and nephrology, making it a useful resource for practicing nephrologists or trainees about to enter practice given today's increasing acuity and use of the ICU. The comprehensive review of evidence is well cited, with many chapters written by recognizable field leaders, and well organized into intuitive sections. While it is a large book, its many chapters help compartmentalize information and it would work well as a quick reference guide once readers are familiar with its content. The electronic version is a nice addition and helps readers quickly search its content, but is not required. Overall, this book is an extensive and accessible review of current intensive care nephrology and would serve as an excellent resource for clinicians looking to expand their knowledge on an increasingly common intersection of practice.\"\u003c\/i\u003e \u003cb\u003eReviewed by\u003c\/b\u003e Paul Adams, BS MD (University of Kentucky College of Medicine) \u003cb\u003eDoody's Score: 93, 4 Stars!\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eComprehensive and clinically relevant, the 3rd Edition of \u003ci\u003eCritical Care Nephrology\u003c\/i\u003e provides authoritative coverage of the latest advances in critical care procedures for patients with renal diseases or disorders. Using common guidelines and standardized approaches to critically ill patients, \u003cb\u003ethis multidisciplinary reference facilitates better communication\u003c\/b\u003e among all physicians who care for critically ill patients suffering from kidney disease, electrolyte and metabolic imbalances, poisoning, severe sepsis, major organ dysfunction, and other pathological events.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eOffers \u003cb\u003edetailed discussions\u003c\/b\u003e of different forms of organ support, artificial organs, infections, acute illness occurring in chronic hemodialysis patients, and much more.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ePlaces a special emphasis on \u003cb\u003etherapeutic interventions and treatment procedures\u003c\/b\u003e for a hands on clinical reference tool.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ePresents information clearly, in a format designed for \u003cb\u003eeasy reference\u003c\/b\u003e – from basic sciences to clinical syndromes to diagnostic tools.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCovers \u003cb\u003especial populations\u003c\/b\u003e such as children, diabetic patients, and the elderly.\u003c\/li\u003e \u003cli\u003eAn exceptional resource for nephrologists, intensivists, surgeons, or critical care physicians – \u003cb\u003eanyone who treats critically ill renal patients\u003c\/b\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e \u003cli\u003eShares a combined commitment to excellence lead by Drs. Claudio Ronco, Rinaldo Bellomo, John Kellum, and Zaccaria Ricci –\u003cb\u003e unparalleled leaders in this field\u003c\/b\u003e.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eAddresses key topics with \u003cb\u003eexpanded coverage\u003c\/b\u003e of acute kidney injury, stress biomarkers, and sepsis, including the latest developments on mechanisms and management.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eProvides \u003cb\u003eup-to-date information\u003c\/b\u003e on extracorporeal therapies from new editor Dr. Zaccaria Ricci.\u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eExpert Consult™ eBook version included with purchase. This \u003cb\u003eenhanced eBook experience\u003c\/b\u003e allows you to search all of the text, figures, and references from the book on a variety of devices.\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eSection 1: Principles of Critical Care\u003c\/p\u003e \u003cp\u003eChapter 1 - The Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 2 - The Pathophysiologic Foundations of Critical Care\u003c\/p\u003e \u003cp\u003eChapter 3 - Mechanical Ventilation\u003c\/p\u003e \u003cp\u003eChapter 4 - Hemodynamic Support in the Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 5 - Monitoring Organ Dysfunction in Critical Care\u003c\/p\u003e \u003cp\u003eChapter 6 - Kidney-Specific Severity Scores\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 2: Principles of Renal Physiology\u003c\/p\u003e \u003cp\u003eChapter 7 - The Physiology of the Glomerulus\u003c\/p\u003e \u003cp\u003eChapter 8 - The Physiology of the Loop of Henle\u003c\/p\u003e \u003cp\u003eChapter 9 - Glomerular Filtration Rate, Renal Functional Reserve, and Kidney Stress Testing\u003c\/p\u003e \u003cp\u003eChapter 10 - Renal Energy Consumption and Metabolism\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 3: Epidemiology of Acute Kidney Injury in Critical Care\u003c\/p\u003e \u003cp\u003eChapter 11 - Acute Kidney Injury: From Clinical to Molecular Diagnosis\u003c\/p\u003e \u003cp\u003eChapter 12 - Community- and Hospital-Acquired Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 13 - Epidemiology of Acute Kidney Injury in Critically Ill Patients\u003c\/p\u003e \u003cp\u003eChapter 14 - Acute Kidney Injury in Patients With Chronic Kidney Disease\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 4: Exposures and Patient Susceptibility\u003c\/p\u003e \u003cp\u003eChapter 15 - Genetic Predisposition for Acute Kidney Injury (AKI)\u003c\/p\u003e \u003cp\u003eChapter 16 - Risk Factors and Risk Assessment in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 17 - Experimental Models of Acute Kidney Injury\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 5: Humoral and Cellular Mechanisms of Kidney Damage\u003c\/p\u003e \u003cp\u003eChapter 18 - Renal Blood Flow and Perfusion Pressure\u003c\/p\u003e \u003cp\u003eChapter 19 - Humoral Mediators in Sepsis\u003c\/p\u003e \u003cp\u003eChapter 20 - Cell Death Pathways: Apoptosis and Regulated Necrosis\u003c\/p\u003e \u003cp\u003eChapter 21 - Pathogen-Associated Molecular Patterns, Damage-Associated Molecular Patterns, and Their Receptors in Acute Kidney Injury\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 6: Clinical Course of Acute Kidney Injury and Biomarkers\u003c\/p\u003e \u003cp\u003eChapter 22 - Acute Kidney Disease\u003c\/p\u003e \u003cp\u003eChapter 23 - Acute Kidney Disease, Renal Recovery, and Post–Acute Kidney Injury Care\u003c\/p\u003e \u003cp\u003eChapter 24 - The Role of Biomarkers in the Diagnosis and Management of Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 25 - Functional Biomarkers\u003c\/p\u003e \u003cp\u003eChapter 26 - Damage Biomarkers\u003c\/p\u003e \u003cp\u003eChapter 27 - Kidney Stress Biomarkers\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 7: Mechanisms of Repair or Progression\u003c\/p\u003e \u003cp\u003eChapter 28 - Renal Repair and Recovery\u003c\/p\u003e \u003cp\u003eChapter 29 - Maladaptive Repair and Progression to CKD\u003c\/p\u003e \u003cp\u003eChapter 30 - Biomarkers of Recovery and\/or Repair Following Acute Kidney Injury\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 8: Renal Histopathology in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 31 - Practical Considerations of Renal Biopsies in Critical Care Patients\u003c\/p\u003e \u003cp\u003eChapter 32 - Localization of Injury and Repair Pathways\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 9: Imaging Techniques in Critical Care Nephrology\u003c\/p\u003e \u003cp\u003eChapter 33 - Ultrasonography and Doppler Techniques\u003c\/p\u003e \u003cp\u003eChapter 34 - Contrast-Enhanced Renal Ultrasound\u003c\/p\u003e \u003cp\u003eChapter 35 - Traditional Radiology, Computed Tomography, and Magnetic Resonance Imaging in Critical Care Nephrology\u003c\/p\u003e \u003cp\u003eChapter 36 - Radionuclides Diagnostic Techniques\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 10: Clinical Syndromes and Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 37 - Multiple Organ Dysfunction\u003c\/p\u003e \u003cp\u003eChapter 38 - Acute Kidney Injury in Burns and Trauma\u003c\/p\u003e \u003cp\u003eChapter 39 - Drug-Induced Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 40 - Acute Kidney Injury in Pregnancy\u003c\/p\u003e \u003cp\u003eChapter 41 - Acute Kidney Injury in Oncology and Tumor Lysis Syndrome\u003c\/p\u003e \u003cp\u003eChapter 42 - Acute Kidney Injury in Cardiac Surgery\u003c\/p\u003e \u003cp\u003eChapter 43 - Acute Kidney Injury in Major Surgery\u003c\/p\u003e \u003cp\u003eChapter 44 - Acute Kidney Injury in Heart Failure\u003c\/p\u003e \u003cp\u003eChapter 45 - Acute Kidney Injury in Cirrhosis\u003c\/p\u003e \u003cp\u003eChapter 46 - Acute Renal Failure in Kidney Transplant Recipients\u003c\/p\u003e \u003cp\u003eChapter 47 - Acute Glomerulonephritis\u003c\/p\u003e \u003cp\u003eChapter 48 - Contrast-Induced Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 49 - Abdominal Compartment Syndrome\u003c\/p\u003e \u003cp\u003eChapter 50 - Hemolytic Uremic Syndrome\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 11: Prevention and Treatment: General Treatment Concepts\u003c\/p\u003e \u003cp\u003eChapter 51 - Nonpharmacologic Management of Acute Renal Injury\u003c\/p\u003e \u003cp\u003eChapter 52 - Novel Drugs for Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 53 - Remote Ischemic Preconditioning\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 12: Fluid and Electrolytes\u003c\/p\u003e \u003cp\u003eChapter 54 - Blood Biochemistry: Measuring Major Plasma Electrolytes\u003c\/p\u003e \u003cp\u003eChapter 55 - Assessment of Urine Biochemistry\u003c\/p\u003e \u003cp\u003eChapter 56 - Disorders of Sodium and Water Balance\u003c\/p\u003e \u003cp\u003eChapter 57 - Disorders of Potassium and Magnesium\u003c\/p\u003e \u003cp\u003eChapter 58 - Calcium and Phosphate Physiology\u003c\/p\u003e \u003cp\u003eChapter 59 - Principles of Fluid Therapy\u003c\/p\u003e \u003cp\u003eChapter 60 - Blood Transfusion Therapy\u003c\/p\u003e \u003cp\u003eChapter 61 - Loop and Thiazide Diuretics\u003c\/p\u003e \u003cp\u003eChapter 62 - Vaptans and the Treatment of Hyponatremia\u003c\/p\u003e \u003cp\u003eChapter 63 - Aldosterone Antagonists, Amiloride, and Triamterene\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 13: Acid-Base\u003c\/p\u003e \u003cp\u003eChapter 64 - Laboratory Tests: Blood Gases, Anion Gap, and Strong Ion Gap\u003c\/p\u003e \u003cp\u003eChapter 65 - Acid-Base Physiology and Diagnosis of Disorders\u003c\/p\u003e \u003cp\u003eChapter 66 - Metabolic Acidosis\u003c\/p\u003e \u003cp\u003eChapter 67 - Hyperlactatemia and Lactic Acidosis\u003c\/p\u003e \u003cp\u003eChapter 68 - Renal Tubular Acidosis\u003c\/p\u003e \u003cp\u003eChapter 69 - Metabolic Alkalosis\u003c\/p\u003e \u003cp\u003eChapter 70 - Respiratory Acid-Base Disorders\u003c\/p\u003e \u003cp\u003eChapter 71 - Iatrogenic and Poison-Derived Acid Base Disorders\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 14: Metabolism and Nutrition in Critical Illness and Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 72 - Energy Requirement and Consumption in the Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 73 - Impact of Renal Replacement Therapy on Metabolism and Nutrient Requirements in the Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 74 - Amino Acid Turnover, Protein Metabolism, and Nitrogen Balance in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 75 - Carbohydrates and Lipids\u003c\/p\u003e \u003cp\u003eChapter 76 - Endocrinology of the Stress Response During Critical Illness\u003c\/p\u003e \u003cp\u003eChapter 77 - Anemia of Critical Illness\u003c\/p\u003e \u003cp\u003eChapter 78 - Management of Nutrition in Acute Kidney Injury and Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 79 - Blood Glucose Control in Critical Care\u003c\/p\u003e \u003cp\u003eChapter 80 - Enteral Nutrition\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 15: Infectious Diseases and Sepsis\u003c\/p\u003e \u003cp\u003eChapter 81 - Microbiologic Considerations in the Intensive Care Patient\u003c\/p\u003e \u003cp\u003eChapter 82 - Innate Immunity and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 83 - Adaptive Immunity and Critical Illness\u003c\/p\u003e \u003cp\u003eChapter 84 - Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome\u003c\/p\u003e \u003cp\u003eChapter 85 - Tropical Infections Causing Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 86 - Sepsis and Septic Shock\u003c\/p\u003e \u003cp\u003eChapter 87 - Complement and Its Consequences in Sepsis\u003c\/p\u003e \u003cp\u003eChapter 88 - Coagulation Abnormalities in Sepsis\u003c\/p\u003e \u003cp\u003eDysfunction of the Kidney in Sepsis\u003c\/p\u003e \u003cp\u003eBook chapterFull text access\u003c\/p\u003e \u003cp\u003eChapter 89 - Endothelial Dysfunction of the Kidney in Sepsis\u003c\/p\u003e \u003cp\u003eChapter 90 - Sepsis-Induced Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 91 - Recommendations for Sepsis Management\u003c\/p\u003e \u003cp\u003eChapter 92 - Principles of Antimicrobial Prescription in Intensive Care Unit Patients With Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 93 - Renal Replacement Therapy for Septic Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 94 - Blood Purification for Sepsis\u003c\/p\u003e \u003cp\u003eChapter 95 - Management of Infection in Patients With Kidney Transplant\u003c\/p\u003e \u003cp\u003eChapter 96 - Critical Care Viral Infections\u003c\/p\u003e \u003cp\u003eChapter 97 - Principles of Antibiotic Prescription in Intensive Care Unit Patients and Patients With Acute Renal Failure\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 16: Acute Intoxication and Poisoning\u003c\/p\u003e \u003cp\u003eChapter 98 - Drugs and Antidotes in Acute Intoxication\u003c\/p\u003e \u003cp\u003eChapter 99 - Extracorporeal Therapies in Acute Intoxication and Poisoning\u003c\/p\u003e \u003cp\u003eChapter 100 - Plasmapheresis in Acute Intoxication and Poisoning\u003c\/p\u003e \u003cp\u003eChapter 101 - Poisoning: Kinetics to Therapeutics\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 17: Acute Kidney Injury and Organ Crosstalk\u003c\/p\u003e \u003cp\u003eChapter 102 - Bleeding and Hemostasis in Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 103 - Gastrointestinal Problems in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 104 - Cardiovascular Problems in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 105 - Water and Electrolyte Disturbances in Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 106 - Neurologic Problems in Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 107 - Immunologic and Infectious Complications of Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 108 - Cellular Response to Acute Kidney Injury\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 18: Interaction of the Heart and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 109 - Heart-Kidney Cross-Talk\u003c\/p\u003e \u003cp\u003eChapter 110 - Classification of Cardiorenal Syndrome\u003c\/p\u003e \u003cp\u003eChapter 111 - Cardiorenal Syndrome Type 1\u003c\/p\u003e \u003cp\u003eChapter 112 - Cardiorenal Syndrome Type 2\u003c\/p\u003e \u003cp\u003eChapter 113 - Cardiorenal Syndrome Type 3\u003c\/p\u003e \u003cp\u003eChapter 114 - Cardiorenal Syndrome Type 4\u003c\/p\u003e \u003cp\u003eChapter 115 - Cardiorenal Syndrome Type 5\u003c\/p\u003e \u003cp\u003eChapter 116 - Renal Function During Cardiac Mechanical Support and Artificial Heart\u003c\/p\u003e \u003cp\u003eChapter 117 - The Kidney in Diastolic Dysfunction\u003c\/p\u003e \u003cp\u003eChapter 118 - Principles of Diuretic Management in Heart Failure\u003c\/p\u003e \u003cp\u003eChapter 119 - Management of Overhydration in Heart Failure Patients\u003c\/p\u003e \u003cp\u003eChapter 120 - Recent Advances for Stroke Prevention in Patients With Atrial Fibrillation and Advanced Kidney Disease\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 19: Interaction of the Lung and Kidney\u003c\/p\u003e \u003cp\u003eChapter 121 - Lung-Kidney Cross-Talk\u003c\/p\u003e \u003cp\u003eChapter 122 - The Kidney During Mechanical Ventilation\u003c\/p\u003e \u003cp\u003eChapter 123 - Extracorporeal Membrane Oxygenation and Renal Function\u003c\/p\u003e \u003cp\u003eChapter 124 - Extracorporeal Carbon Dioxide Removal\u003c\/p\u003e \u003cp\u003eChapter 125 - Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy in Adults and Children\u003c\/p\u003e \u003cp\u003eChapter 126 - Pulmonary-Renal Syndrome\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 20: The Liver and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 127 - Liver-Kidney Interaction\u003c\/p\u003e \u003cp\u003eChapter 128 - Pathophysiology and Management of the Hepatorenal Syndrome\u003c\/p\u003e \u003cp\u003eChapter 129 - Kidney Dysfunction After Liver Transplantation\u003c\/p\u003e \u003cp\u003eChapter 130 - Extracorporeal Liver Support Devices\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 21: Interaction of the Brain and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 131 - Treatment of Combined Acute Renal Failure and Cerebral Edema\u003c\/p\u003e \u003cp\u003eChapter 132 - Renal Protection in the Organ Donor\u003c\/p\u003e \u003cp\u003eChapter 133 - Effect of Extracorporeal Therapies on the Brain\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 22: Fluid Balance and its Management in the Critically Ill\u003c\/p\u003e \u003cp\u003eChapter 134 - Components of Fluid Balance and Monitoring\u003c\/p\u003e \u003cp\u003eChapter 135 - Noninvasive Methods of Fluid Status Assessment in Critically Ill Patients\u003c\/p\u003e \u003cp\u003eChapter 136 - Management of Fluid Overload in Cardiorenal Patients: The Five B Approach\u003c\/p\u003e \u003cp\u003eChapter 137 - Mechanical Fluid Removal\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 23: General Principles of Acute Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 138 - Indications for Renal Replacement Therapy in the Critically Ill\u003c\/p\u003e \u003cp\u003eChapter 139 - Principles of Extracorporeal Circulation and Transport Phenomena\u003c\/p\u003e \u003cp\u003eChapter 140 - Membranes and Filters for Use in Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 141 - Continuous Renal Replacement Therapy Machine Technology\u003c\/p\u003e \u003cp\u003eChapter 142 - Principles of Anticoagulation in Extracorporeal Circuits\u003c\/p\u003e \u003cp\u003eChapter 143 - Dialysis Solutions and Replacement Fluids\u003c\/p\u003e \u003cp\u003eChapter 144 - Starting and Stopping Renal Replacement Therapy in the Critically Ill\u003c\/p\u003e \u003cp\u003eChapter 145 - The Concept of Renal Replacement Therapy Dose and Efficiency\u003c\/p\u003e \u003cp\u003eChapter 146 - Quantification of Acute Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 147 - Principles of Pharmacodynamics and Pharmacokinetics of Drugs Used in Extracorporeal Therapies\u003c\/p\u003e \u003cp\u003eChapter 148 - Ethical Considerations in Acute Renal Replacement Therapy\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 24: Intermittent Renal Replacement Therapies\u003c\/p\u003e \u003cp\u003eChapter 149 - Intermittent Techniques for Acute Dialysis\u003c\/p\u003e \u003cp\u003eChapter 150 - Solute and Water Transport in Hemodialysis: Dialyzers, Flow Distribution, and Cross-Filtration\u003c\/p\u003e \u003cp\u003eChapter 151 - Biocompatibility of the Dialysis System\u003c\/p\u003e \u003cp\u003eChapter 152 - Composition of Hemodialysis Fluid\u003c\/p\u003e \u003cp\u003eChapter 153 - Indications for and Contraindications to Intermittent Hemodialysis in Critically Ill Patients\u003c\/p\u003e \u003cp\u003eChapter 154 - Technical and Clinical Complications of Intermittent Hemodialysis in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 155 - Correction of Water, Electrolyte, and Acid-Base Derangements by Hemodialysis and Derived Techniques\u003c\/p\u003e \u003cp\u003eChapter 156 - Urea Kinetics, Efficiency, and Adequacy of Hemodialysis and Other Intermittent Treatments\u003c\/p\u003e \u003cp\u003eChapter 157 - Assessment of Fluid Status and Body Composition and Control of Fluid Balance With Intermittent Hemodialysis in the Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 158 - Outcomes of Intermittent Hemodialysis in Critically Ill Patients With Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 159 - Hybrid Dialysis Techniques in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 160 - The Role of Plasmapheresis in Critical Illness\u003c\/p\u003e \u003cp\u003eChapter 161 - Cascade Filtration for ABO Incompatible Transplant\u003c\/p\u003e \u003cp\u003eChapter 162 - Nursing Issues and Procedures in Continuous Renal Replacement Therapy\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 25: Continuous Renal Replacement Therapies (CRRT)\u003c\/p\u003e \u003cp\u003eChapter 163 - Indications for Continuous Renal Replacement Therapy: Renal Replacement Versus Renal Support\u003c\/p\u003e \u003cp\u003eChapter 164 - Beginning and Ending Continuous Renal Replacement Therapy in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 165 - Solute and Water Kinetics in Continuous Therapies\u003c\/p\u003e \u003cp\u003eChapter 166 - Continuous Renal Replacement Therapy: Modalities and Their Selection\u003c\/p\u003e \u003cp\u003eChapter 167 - Vascular Access for Acute Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 168 - Anticoagulation Strategies for Continuous Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 169 - Nursing Strategies to Prevent Coagulation of the Extracorporeal Circuit\u003c\/p\u003e \u003cp\u003eChapter 170 - Adequacy of Continuous Renal Replacement Therapy: Prescription and Delivery\u003c\/p\u003e \u003cp\u003eChapter 171 - High-Volume Hemofiltration in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 172 - Pulse High-Volume Hemofiltration in Management of Critically Ill Patients With Severe Sepsis or Septic Shock\u003c\/p\u003e \u003cp\u003eChapter 173 - High Cutoff Membranes for Mediators Removal\u003c\/p\u003e \u003cp\u003eChapter 174 - Clinical Effects of Continuous Renal Replacement Therapies\u003c\/p\u003e \u003cp\u003eChapter 175 - Antibiotic Adjustment in Continuous Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 176 - Nomenclature: Basic Principles\u003c\/p\u003e \u003cp\u003eChapter 177 - Nomenclature: Techniques\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 26: Peritoneal Dialysis in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 178 - Peritoneal Dialysis System\u003c\/p\u003e \u003cp\u003eChapter 179 - Indications, Contraindications, and Complications of Peritoneal Dialysis in Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 180 - Solute and Water Transport Across the Peritoneal Barrier\u003c\/p\u003e \u003cp\u003eChapter 181 - Choice of Peritoneal Dialysis Technique: Intermittent or Continuous\u003c\/p\u003e \u003cp\u003eChapter 182 - Correction of Fluid, Electrolyte, and Acid-Base Derangements by Peritoneal Dialysis in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 183 - Feasibility, Efficiency, and Adequacy of Peritoneal Dialysis in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 184 - Clinical Results and Complications of Peritoneal Dialysis in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 185 - Treatment of Peritonitis and Other Clinical Complications of Peritoneal Dialysis in the Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 186 - Comparison of Peritoneal Dialysis With Other Treatments for Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 187 - Continuous-Flow Peritoneal Dialysis as Acute Therapy\u003c\/p\u003e \u003cp\u003eChapter 188 - Nursing and Procedure Issues in Peritoneal Dialysis\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 27: Extracorporeal Blood Purification Techniques Beyond Dialysis\u003c\/p\u003e \u003cp\u003eChapter 189 - Sorbents: From Basic Structure to Clinical Application\u003c\/p\u003e \u003cp\u003eChapter 190 - Therapeutic Apheresis in Critically Ill Patients: Indications, Modalities and Techniques, Clinical Results\u003c\/p\u003e \u003cp\u003eChapter 191 - Extracorporeal Blood Purification Techniques Beyond Dialysis: Coupled Plasmafiltration-Adsorption\u003c\/p\u003e \u003cp\u003eChapter 192 - Prometheus System\u003c\/p\u003e \u003cp\u003eChapter 193 - Toraymyxin and Other Endotoxin Adsorption Systems\u003c\/p\u003e \u003cp\u003eChapter 194 - Plasmafiltration-Adsorption-Dialysis System\u003c\/p\u003e \u003cp\u003eChapter 195 - Extracorporeal Membrane Oxygenation for Cardiac Support\u003c\/p\u003e \u003cp\u003eChapter 196 - Extracorporeal Membrane Oxygenation for Pulmonary Support\u003c\/p\u003e \u003cp\u003eChapter 197 - Cell-Based Therapies\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 28: Critical Care Nephrology in Pediatrics\u003c\/p\u003e \u003cp\u003eChapter 198 - Cellular and Molecular Mechanisms of Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 199 - Epidemiology of Pediatric Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 200 - Treatment of Acute Kidney Injury in Children: Conservative Management to Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 201 - Technical Aspects of Pediatric Continuous Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 202 - Multiple Organ Dysfunction in the Pediatric Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 203 - Drug Dosing in Pediatric Acute Kidney Insufficiency and Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 204 - Nutrition of Critically Ill Children With Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 205 - Outcome of Pediatric Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 206 - Renal Replacement Therapy for the Critically Ill Infant\u003c\/p\u003e \u003cp\u003eChapter 207 - Neonatal Hyperammonemia and Continuous Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 208 - Modified Ultrafiltration in Pediatric Heart Surgery\u003c\/p\u003e \u003cp\u003eChapter 209 - Techniques and Machines for Pediatric Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 210 - Antibiotics in Critically Ill Newborns and Children: Nephrotoxicity and Management During Renal Replacement Therapy\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 29: Kidney Transplantation and Critical Care\u003c\/p\u003e \u003cp\u003eChapter 211 - Patient Selection and Pretransplantation Care for Kidney Transplant Recipients\u003c\/p\u003e \u003cp\u003eChapter 212 - Kidney Support and Perioperative Care in Kidney Transplantation\u003c\/p\u003e \u003cp\u003eChapter 213 - Acute Renal Failure in Kidney Transplant Recipients\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 30: Special Kidney Problems in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 214 - Management of Chronic Kidney Disease and End-Stage Kidney Disease Patients in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 215 - Management of Patients with Diabetes in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 216 - Diagnosis and Management of Acute Kidney Injury in the Emergency Department\u003c\/p\u003e \u003cp\u003eChapter 217 - Anticancer Drugs and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 218 - Antiinflammatory Drugs and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 219 - Calcineurin Inhibitors and Other Immunosuppressive Drugs and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 220 - Alternative Medicine and Chinese Herbs and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 221 - Environment, Smoking, Obesity, and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 222 - Lead and Heavy Metals and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 223 - Statins and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 224 - Erythropoietin Therapy in Critically Ill and Acute Kidney Injury Patients\u003c\/p\u003e \u003cp\u003eChapter 225 - Vasoactive Drugs, Renal Function, and Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 226 - End Points for Clinical Trials in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 227 - Hypothermia and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 228 - Renin-Angiotensin System Blockers and Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eSection 1: Principles of Critical Care\u003c\/p\u003e \u003cp\u003eChapter 1 - The Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 2 - The Pathophysiologic Foundations of Critical Care\u003c\/p\u003e \u003cp\u003eChapter 3 - Mechanical Ventilation\u003c\/p\u003e \u003cp\u003eChapter 4 - Hemodynamic Support in the Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 5 - Monitoring Organ Dysfunction in Critical Care\u003c\/p\u003e \u003cp\u003eChapter 6 - Kidney-Specific Severity Scores\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 2: Principles of Renal Physiology\u003c\/p\u003e \u003cp\u003eChapter 7 - The Physiology of the Glomerulus\u003c\/p\u003e \u003cp\u003eChapter 8 - The Physiology of the Loop of Henle\u003c\/p\u003e \u003cp\u003eChapter 9 - Glomerular Filtration Rate, Renal Functional Reserve, and Kidney Stress Testing\u003c\/p\u003e \u003cp\u003eChapter 10 - Renal Energy Consumption and Metabolism\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 3: Epidemiology of Acute Kidney Injury in Critical Care\u003c\/p\u003e \u003cp\u003eChapter 11 - Acute Kidney Injury: From Clinical to Molecular Diagnosis\u003c\/p\u003e \u003cp\u003eChapter 12 - Community- and Hospital-Acquired Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 13 - Epidemiology of Acute Kidney Injury in Critically Ill Patients\u003c\/p\u003e \u003cp\u003eChapter 14 - Acute Kidney Injury in Patients With Chronic Kidney Disease\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 4: Exposures and Patient Susceptibility\u003c\/p\u003e \u003cp\u003eChapter 15 - Genetic Predisposition for Acute Kidney Injury (AKI)\u003c\/p\u003e \u003cp\u003eChapter 16 - Risk Factors and Risk Assessment in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 17 - Experimental Models of Acute Kidney Injury\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 5: Humoral and Cellular Mechanisms of Kidney Damage\u003c\/p\u003e \u003cp\u003eChapter 18 - Renal Blood Flow and Perfusion Pressure\u003c\/p\u003e \u003cp\u003eChapter 19 - Humoral Mediators in Sepsis\u003c\/p\u003e \u003cp\u003eChapter 20 - Cell Death Pathways: Apoptosis and Regulated Necrosis\u003c\/p\u003e \u003cp\u003eChapter 21 - Pathogen-Associated Molecular Patterns, Damage-Associated Molecular Patterns, and Their Receptors in Acute Kidney Injury\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 6: Clinical Course of Acute Kidney Injury and Biomarkers\u003c\/p\u003e \u003cp\u003eChapter 22 - Acute Kidney Disease\u003c\/p\u003e \u003cp\u003eChapter 23 - Acute Kidney Disease, Renal Recovery, and Post–Acute Kidney Injury Care\u003c\/p\u003e \u003cp\u003eChapter 24 - The Role of Biomarkers in the Diagnosis and Management of Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 25 - Functional Biomarkers\u003c\/p\u003e \u003cp\u003eChapter 26 - Damage Biomarkers\u003c\/p\u003e \u003cp\u003eChapter 27 - Kidney Stress Biomarkers\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 7: Mechanisms of Repair or Progression\u003c\/p\u003e \u003cp\u003eChapter 28 - Renal Repair and Recovery\u003c\/p\u003e \u003cp\u003eChapter 29 - Maladaptive Repair and Progression to CKD\u003c\/p\u003e \u003cp\u003eChapter 30 - Biomarkers of Recovery and\/or Repair Following Acute Kidney Injury\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 8: Renal Histopathology in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 31 - Practical Considerations of Renal Biopsies in Critical Care Patients\u003c\/p\u003e \u003cp\u003eChapter 32 - Localization of Injury and Repair Pathways\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 9: Imaging Techniques in Critical Care Nephrology\u003c\/p\u003e \u003cp\u003eChapter 33 - Ultrasonography and Doppler Techniques\u003c\/p\u003e \u003cp\u003eChapter 34 - Contrast-Enhanced Renal Ultrasound\u003c\/p\u003e \u003cp\u003eChapter 35 - Traditional Radiology, Computed Tomography, and Magnetic Resonance Imaging in Critical Care Nephrology\u003c\/p\u003e \u003cp\u003eChapter 36 - Radionuclides Diagnostic Techniques\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 10: Clinical Syndromes and Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 37 - Multiple Organ Dysfunction\u003c\/p\u003e \u003cp\u003eChapter 38 - Acute Kidney Injury in Burns and Trauma\u003c\/p\u003e \u003cp\u003eChapter 39 - Drug-Induced Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 40 - Acute Kidney Injury in Pregnancy\u003c\/p\u003e \u003cp\u003eChapter 41 - Acute Kidney Injury in Oncology and Tumor Lysis Syndrome\u003c\/p\u003e \u003cp\u003eChapter 42 - Acute Kidney Injury in Cardiac Surgery\u003c\/p\u003e \u003cp\u003eChapter 43 - Acute Kidney Injury in Major Surgery\u003c\/p\u003e \u003cp\u003eChapter 44 - Acute Kidney Injury in Heart Failure\u003c\/p\u003e \u003cp\u003eChapter 45 - Acute Kidney Injury in Cirrhosis\u003c\/p\u003e \u003cp\u003eChapter 46 - Acute Renal Failure in Kidney Transplant Recipients\u003c\/p\u003e \u003cp\u003eChapter 47 - Acute Glomerulonephritis\u003c\/p\u003e \u003cp\u003eChapter 48 - Contrast-Induced Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 49 - Abdominal Compartment Syndrome\u003c\/p\u003e \u003cp\u003eChapter 50 - Hemolytic Uremic Syndrome\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 11: Prevention and Treatment: General Treatment Concepts\u003c\/p\u003e \u003cp\u003eChapter 51 - Nonpharmacologic Management of Acute Renal Injury\u003c\/p\u003e \u003cp\u003eChapter 52 - Novel Drugs for Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 53 - Remote Ischemic Preconditioning\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 12: Fluid and Electrolytes\u003c\/p\u003e \u003cp\u003eChapter 54 - Blood Biochemistry: Measuring Major Plasma Electrolytes\u003c\/p\u003e \u003cp\u003eChapter 55 - Assessment of Urine Biochemistry\u003c\/p\u003e \u003cp\u003eChapter 56 - Disorders of Sodium and Water Balance\u003c\/p\u003e \u003cp\u003eChapter 57 - Disorders of Potassium and Magnesium\u003c\/p\u003e \u003cp\u003eChapter 58 - Calcium and Phosphate Physiology\u003c\/p\u003e \u003cp\u003eChapter 59 - Principles of Fluid Therapy\u003c\/p\u003e \u003cp\u003eChapter 60 - Blood Transfusion Therapy\u003c\/p\u003e \u003cp\u003eChapter 61 - Loop and Thiazide Diuretics\u003c\/p\u003e \u003cp\u003eChapter 62 - Vaptans and the Treatment of Hyponatremia\u003c\/p\u003e \u003cp\u003eChapter 63 - Aldosterone Antagonists, Amiloride, and Triamterene\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 13: Acid-Base\u003c\/p\u003e \u003cp\u003eChapter 64 - Laboratory Tests: Blood Gases, Anion Gap, and Strong Ion Gap\u003c\/p\u003e \u003cp\u003eChapter 65 - Acid-Base Physiology and Diagnosis of Disorders\u003c\/p\u003e \u003cp\u003eChapter 66 - Metabolic Acidosis\u003c\/p\u003e \u003cp\u003eChapter 67 - Hyperlactatemia and Lactic Acidosis\u003c\/p\u003e \u003cp\u003eChapter 68 - Renal Tubular Acidosis\u003c\/p\u003e \u003cp\u003eChapter 69 - Metabolic Alkalosis\u003c\/p\u003e \u003cp\u003eChapter 70 - Respiratory Acid-Base Disorders\u003c\/p\u003e \u003cp\u003eChapter 71 - Iatrogenic and Poison-Derived Acid Base Disorders\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 14: Metabolism and Nutrition in Critical Illness and Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 72 - Energy Requirement and Consumption in the Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 73 - Impact of Renal Replacement Therapy on Metabolism and Nutrient Requirements in the Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 74 - Amino Acid Turnover, Protein Metabolism, and Nitrogen Balance in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 75 - Carbohydrates and Lipids\u003c\/p\u003e \u003cp\u003eChapter 76 - Endocrinology of the Stress Response During Critical Illness\u003c\/p\u003e \u003cp\u003eChapter 77 - Anemia of Critical Illness\u003c\/p\u003e \u003cp\u003eChapter 78 - Management of Nutrition in Acute Kidney Injury and Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 79 - Blood Glucose Control in Critical Care\u003c\/p\u003e \u003cp\u003eChapter 80 - Enteral Nutrition\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 15: Infectious Diseases and Sepsis\u003c\/p\u003e \u003cp\u003eChapter 81 - Microbiologic Considerations in the Intensive Care Patient\u003c\/p\u003e \u003cp\u003eChapter 82 - Innate Immunity and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 83 - Adaptive Immunity and Critical Illness\u003c\/p\u003e \u003cp\u003eChapter 84 - Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome\u003c\/p\u003e \u003cp\u003eChapter 85 - Tropical Infections Causing Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 86 - Sepsis and Septic Shock\u003c\/p\u003e \u003cp\u003eChapter 87 - Complement and Its Consequences in Sepsis\u003c\/p\u003e \u003cp\u003eChapter 88 - Coagulation Abnormalities in Sepsis\u003c\/p\u003e \u003cp\u003eDysfunction of the Kidney in Sepsis\u003c\/p\u003e \u003cp\u003eBook chapterFull text access\u003c\/p\u003e \u003cp\u003eChapter 89 - Endothelial Dysfunction of the Kidney in Sepsis\u003c\/p\u003e \u003cp\u003eChapter 90 - Sepsis-Induced Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 91 - Recommendations for Sepsis Management\u003c\/p\u003e \u003cp\u003eChapter 92 - Principles of Antimicrobial Prescription in Intensive Care Unit Patients With Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 93 - Renal Replacement Therapy for Septic Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 94 - Blood Purification for Sepsis\u003c\/p\u003e \u003cp\u003eChapter 95 - Management of Infection in Patients With Kidney Transplant\u003c\/p\u003e \u003cp\u003eChapter 96 - Critical Care Viral Infections\u003c\/p\u003e \u003cp\u003eChapter 97 - Principles of Antibiotic Prescription in Intensive Care Unit Patients and Patients With Acute Renal Failure\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 16: Acute Intoxication and Poisoning\u003c\/p\u003e \u003cp\u003eChapter 98 - Drugs and Antidotes in Acute Intoxication\u003c\/p\u003e \u003cp\u003eChapter 99 - Extracorporeal Therapies in Acute Intoxication and Poisoning\u003c\/p\u003e \u003cp\u003eChapter 100 - Plasmapheresis in Acute Intoxication and Poisoning\u003c\/p\u003e \u003cp\u003eChapter 101 - Poisoning: Kinetics to Therapeutics\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 17: Acute Kidney Injury and Organ Crosstalk\u003c\/p\u003e \u003cp\u003eChapter 102 - Bleeding and Hemostasis in Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 103 - Gastrointestinal Problems in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 104 - Cardiovascular Problems in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 105 - Water and Electrolyte Disturbances in Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 106 - Neurologic Problems in Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 107 - Immunologic and Infectious Complications of Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 108 - Cellular Response to Acute Kidney Injury\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 18: Interaction of the Heart and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 109 - Heart-Kidney Cross-Talk\u003c\/p\u003e \u003cp\u003eChapter 110 - Classification of Cardiorenal Syndrome\u003c\/p\u003e \u003cp\u003eChapter 111 - Cardiorenal Syndrome Type 1\u003c\/p\u003e \u003cp\u003eChapter 112 - Cardiorenal Syndrome Type 2\u003c\/p\u003e \u003cp\u003eChapter 113 - Cardiorenal Syndrome Type 3\u003c\/p\u003e \u003cp\u003eChapter 114 - Cardiorenal Syndrome Type 4\u003c\/p\u003e \u003cp\u003eChapter 115 - Cardiorenal Syndrome Type 5\u003c\/p\u003e \u003cp\u003eChapter 116 - Renal Function During Cardiac Mechanical Support and Artificial Heart\u003c\/p\u003e \u003cp\u003eChapter 117 - The Kidney in Diastolic Dysfunction\u003c\/p\u003e \u003cp\u003eChapter 118 - Principles of Diuretic Management in Heart Failure\u003c\/p\u003e \u003cp\u003eChapter 119 - Management of Overhydration in Heart Failure Patients\u003c\/p\u003e \u003cp\u003eChapter 120 - Recent Advances for Stroke Prevention in Patients With Atrial Fibrillation and Advanced Kidney Disease\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 19: Interaction of the Lung and Kidney\u003c\/p\u003e \u003cp\u003eChapter 121 - Lung-Kidney Cross-Talk\u003c\/p\u003e \u003cp\u003eChapter 122 - The Kidney During Mechanical Ventilation\u003c\/p\u003e \u003cp\u003eChapter 123 - Extracorporeal Membrane Oxygenation and Renal Function\u003c\/p\u003e \u003cp\u003eChapter 124 - Extracorporeal Carbon Dioxide Removal\u003c\/p\u003e \u003cp\u003eChapter 125 - Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy in Adults and Children\u003c\/p\u003e \u003cp\u003eChapter 126 - Pulmonary-Renal Syndrome\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 20: The Liver and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 127 - Liver-Kidney Interaction\u003c\/p\u003e \u003cp\u003eChapter 128 - Pathophysiology and Management of the Hepatorenal Syndrome\u003c\/p\u003e \u003cp\u003eChapter 129 - Kidney Dysfunction After Liver Transplantation\u003c\/p\u003e \u003cp\u003eChapter 130 - Extracorporeal Liver Support Devices\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 21: Interaction of the Brain and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 131 - Treatment of Combined Acute Renal Failure and Cerebral Edema\u003c\/p\u003e \u003cp\u003eChapter 132 - Renal Protection in the Organ Donor\u003c\/p\u003e \u003cp\u003eChapter 133 - Effect of Extracorporeal Therapies on the Brain\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 22: Fluid Balance and its Management in the Critically Ill\u003c\/p\u003e \u003cp\u003eChapter 134 - Components of Fluid Balance and Monitoring\u003c\/p\u003e \u003cp\u003eChapter 135 - Noninvasive Methods of Fluid Status Assessment in Critically Ill Patients\u003c\/p\u003e \u003cp\u003eChapter 136 - Management of Fluid Overload in Cardiorenal Patients: The Five B Approach\u003c\/p\u003e \u003cp\u003eChapter 137 - Mechanical Fluid Removal\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 23: General Principles of Acute Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 138 - Indications for Renal Replacement Therapy in the Critically Ill\u003c\/p\u003e \u003cp\u003eChapter 139 - Principles of Extracorporeal Circulation and Transport Phenomena\u003c\/p\u003e \u003cp\u003eChapter 140 - Membranes and Filters for Use in Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 141 - Continuous Renal Replacement Therapy Machine Technology\u003c\/p\u003e \u003cp\u003eChapter 142 - Principles of Anticoagulation in Extracorporeal Circuits\u003c\/p\u003e \u003cp\u003eChapter 143 - Dialysis Solutions and Replacement Fluids\u003c\/p\u003e \u003cp\u003eChapter 144 - Starting and Stopping Renal Replacement Therapy in the Critically Ill\u003c\/p\u003e \u003cp\u003eChapter 145 - The Concept of Renal Replacement Therapy Dose and Efficiency\u003c\/p\u003e \u003cp\u003eChapter 146 - Quantification of Acute Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 147 - Principles of Pharmacodynamics and Pharmacokinetics of Drugs Used in Extracorporeal Therapies\u003c\/p\u003e \u003cp\u003eChapter 148 - Ethical Considerations in Acute Renal Replacement Therapy\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 24: Intermittent Renal Replacement Therapies\u003c\/p\u003e \u003cp\u003eChapter 149 - Intermittent Techniques for Acute Dialysis\u003c\/p\u003e \u003cp\u003eChapter 150 - Solute and Water Transport in Hemodialysis: Dialyzers, Flow Distribution, and Cross-Filtration\u003c\/p\u003e \u003cp\u003eChapter 151 - Biocompatibility of the Dialysis System\u003c\/p\u003e \u003cp\u003eChapter 152 - Composition of Hemodialysis Fluid\u003c\/p\u003e \u003cp\u003eChapter 153 - Indications for and Contraindications to Intermittent Hemodialysis in Critically Ill Patients\u003c\/p\u003e \u003cp\u003eChapter 154 - Technical and Clinical Complications of Intermittent Hemodialysis in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 155 - Correction of Water, Electrolyte, and Acid-Base Derangements by Hemodialysis and Derived Techniques\u003c\/p\u003e \u003cp\u003eChapter 156 - Urea Kinetics, Efficiency, and Adequacy of Hemodialysis and Other Intermittent Treatments\u003c\/p\u003e \u003cp\u003eChapter 157 - Assessment of Fluid Status and Body Composition and Control of Fluid Balance With Intermittent Hemodialysis in the Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 158 - Outcomes of Intermittent Hemodialysis in Critically Ill Patients With Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 159 - Hybrid Dialysis Techniques in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 160 - The Role of Plasmapheresis in Critical Illness\u003c\/p\u003e \u003cp\u003eChapter 161 - Cascade Filtration for ABO Incompatible Transplant\u003c\/p\u003e \u003cp\u003eChapter 162 - Nursing Issues and Procedures in Continuous Renal Replacement Therapy\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 25: Continuous Renal Replacement Therapies (CRRT)\u003c\/p\u003e \u003cp\u003eChapter 163 - Indications for Continuous Renal Replacement Therapy: Renal Replacement Versus Renal Support\u003c\/p\u003e \u003cp\u003eChapter 164 - Beginning and Ending Continuous Renal Replacement Therapy in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 165 - Solute and Water Kinetics in Continuous Therapies\u003c\/p\u003e \u003cp\u003eChapter 166 - Continuous Renal Replacement Therapy: Modalities and Their Selection\u003c\/p\u003e \u003cp\u003eChapter 167 - Vascular Access for Acute Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 168 - Anticoagulation Strategies for Continuous Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 169 - Nursing Strategies to Prevent Coagulation of the Extracorporeal Circuit\u003c\/p\u003e \u003cp\u003eChapter 170 - Adequacy of Continuous Renal Replacement Therapy: Prescription and Delivery\u003c\/p\u003e \u003cp\u003eChapter 171 - High-Volume Hemofiltration in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 172 - Pulse High-Volume Hemofiltration in Management of Critically Ill Patients With Severe Sepsis or Septic Shock\u003c\/p\u003e \u003cp\u003eChapter 173 - High Cutoff Membranes for Mediators Removal\u003c\/p\u003e \u003cp\u003eChapter 174 - Clinical Effects of Continuous Renal Replacement Therapies\u003c\/p\u003e \u003cp\u003eChapter 175 - Antibiotic Adjustment in Continuous Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 176 - Nomenclature: Basic Principles\u003c\/p\u003e \u003cp\u003eChapter 177 - Nomenclature: Techniques\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 26: Peritoneal Dialysis in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 178 - Peritoneal Dialysis System\u003c\/p\u003e \u003cp\u003eChapter 179 - Indications, Contraindications, and Complications of Peritoneal Dialysis in Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 180 - Solute and Water Transport Across the Peritoneal Barrier\u003c\/p\u003e \u003cp\u003eChapter 181 - Choice of Peritoneal Dialysis Technique: Intermittent or Continuous\u003c\/p\u003e \u003cp\u003eChapter 182 - Correction of Fluid, Electrolyte, and Acid-Base Derangements by Peritoneal Dialysis in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 183 - Feasibility, Efficiency, and Adequacy of Peritoneal Dialysis in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 184 - Clinical Results and Complications of Peritoneal Dialysis in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 185 - Treatment of Peritonitis and Other Clinical Complications of Peritoneal Dialysis in the Critically Ill Patient\u003c\/p\u003e \u003cp\u003eChapter 186 - Comparison of Peritoneal Dialysis With Other Treatments for Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 187 - Continuous-Flow Peritoneal Dialysis as Acute Therapy\u003c\/p\u003e \u003cp\u003eChapter 188 - Nursing and Procedure Issues in Peritoneal Dialysis\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 27: Extracorporeal Blood Purification Techniques Beyond Dialysis\u003c\/p\u003e \u003cp\u003eChapter 189 - Sorbents: From Basic Structure to Clinical Application\u003c\/p\u003e \u003cp\u003eChapter 190 - Therapeutic Apheresis in Critically Ill Patients: Indications, Modalities and Techniques, Clinical Results\u003c\/p\u003e \u003cp\u003eChapter 191 - Extracorporeal Blood Purification Techniques Beyond Dialysis: Coupled Plasmafiltration-Adsorption\u003c\/p\u003e \u003cp\u003eChapter 192 - Prometheus System\u003c\/p\u003e \u003cp\u003eChapter 193 - Toraymyxin and Other Endotoxin Adsorption Systems\u003c\/p\u003e \u003cp\u003eChapter 194 - Plasmafiltration-Adsorption-Dialysis System\u003c\/p\u003e \u003cp\u003eChapter 195 - Extracorporeal Membrane Oxygenation for Cardiac Support\u003c\/p\u003e \u003cp\u003eChapter 196 - Extracorporeal Membrane Oxygenation for Pulmonary Support\u003c\/p\u003e \u003cp\u003eChapter 197 - Cell-Based Therapies\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 28: Critical Care Nephrology in Pediatrics\u003c\/p\u003e \u003cp\u003eChapter 198 - Cellular and Molecular Mechanisms of Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 199 - Epidemiology of Pediatric Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 200 - Treatment of Acute Kidney Injury in Children: Conservative Management to Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 201 - Technical Aspects of Pediatric Continuous Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 202 - Multiple Organ Dysfunction in the Pediatric Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 203 - Drug Dosing in Pediatric Acute Kidney Insufficiency and Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 204 - Nutrition of Critically Ill Children With Acute Renal Failure\u003c\/p\u003e \u003cp\u003eChapter 205 - Outcome of Pediatric Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 206 - Renal Replacement Therapy for the Critically Ill Infant\u003c\/p\u003e \u003cp\u003eChapter 207 - Neonatal Hyperammonemia and Continuous Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 208 - Modified Ultrafiltration in Pediatric Heart Surgery\u003c\/p\u003e \u003cp\u003eChapter 209 - Techniques and Machines for Pediatric Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eChapter 210 - Antibiotics in Critically Ill Newborns and Children: Nephrotoxicity and Management During Renal Replacement Therapy\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 29: Kidney Transplantation and Critical Care\u003c\/p\u003e \u003cp\u003eChapter 211 - Patient Selection and Pretransplantation Care for Kidney Transplant Recipients\u003c\/p\u003e \u003cp\u003eChapter 212 - Kidney Support and Perioperative Care in Kidney Transplantation\u003c\/p\u003e \u003cp\u003eChapter 213 - Acute Renal Failure in Kidney Transplant Recipients\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection 30: Special Kidney Problems in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 214 - Management of Chronic Kidney Disease and End-Stage Kidney Disease Patients in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 215 - Management of Patients with Diabetes in the Intensive Care Unit\u003c\/p\u003e \u003cp\u003eChapter 216 - Diagnosis and Management of Acute Kidney Injury in the Emergency Department\u003c\/p\u003e \u003cp\u003eChapter 217 - Anticancer Drugs and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 218 - Antiinflammatory Drugs and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 219 - Calcineurin Inhibitors and Other Immunosuppressive Drugs and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 220 - Alternative Medicine and Chinese Herbs and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 221 - Environment, Smoking, Obesity, and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 222 - Lead and Heavy Metals and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 223 - Statins and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 224 - Erythropoietin Therapy in Critically Ill and Acute Kidney Injury Patients\u003c\/p\u003e \u003cp\u003eChapter 225 - Vasoactive Drugs, Renal Function, and Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 226 - End Points for Clinical Trials in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eChapter 227 - Hypothermia and the Kidney\u003c\/p\u003e \u003cp\u003eChapter 228 - Renin-Angiotensin System Blockers and Acute Kidney Injury\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648528470296,"sku":"9780323449427","price":214.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323449427.jpg?v=1694092100"},{"product_id":"onco-nephrology-hardback-9780323549455","title":"Onco-Nephrology (Hardback) 9780323549455","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eOnco-Nephrology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eDefinitive guidance at the intersection of nephrology and oncology\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eKevin W. Finkel (Author), Mark Anthony Perazella (Author), Eric P Cohen (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323549455, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 22 August 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e384 pages, 380 illustrations (270 in full color)\u003cbr\u003e27.6 x 21.5 x 2.6 cm, 1.34 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eKidney disease and cancer are frequent comorbidities that require specialized knowledge and expertise from both the nephrologist and the oncologist. Written by three pioneers in this growing subspecialty, \u003ci\u003eOnco-Nephrology\u003c\/i\u003e provides \u003cb\u003eauthoritative, definitive coverage of the mechanism and management of these two life-threatening diseases\u003c\/b\u003e. This unique, single-volume resource covers current protocols and recommends management therapies to arrest kidney failure and allow oncologic treatments to continue and succeed\u003ci\u003e.\u003c\/i\u003e\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eAddresses \u003cb\u003eacute and chronic kidney diseases that develop from a variety of cancers\u003c\/b\u003e. This includes direct kidney injury from the malignancy, paraneoplastic effects of the cancer, and various cancer agents used to treat the malignancy.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eDiscusses \u003cb\u003ekey issues regarding kidney disease in patients with cancer\u003c\/b\u003e, including conventional chemotherapeutic regimens and new novel therapies (targeted agents and immunotherapies) or the malignancies themselves that may promote kidney injury; patients with chronic kidney disease who acquire cancer unrelated to renal failure; and kidney transplantation, which has been shown to carry an increased risk of cancer.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eContains \u003cb\u003ededicated chapters for each class of the conventional chemotherapeutic agents\u003c\/b\u003e, targeted cancer agents, and cancer immunotherapies including the basic science, pathogenic mechanisms of injury, clinical manifestations, and treatment.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes \u003cb\u003especial chapters\u003c\/b\u003e devoted to the individual classes of chemotherapies that relate to kidney disease for quick reference. Discusses \u003cb\u003eincreasingly complex problems\u003c\/b\u003e due to more numerous and specialized anti-cancer drugs, as well as increased survival rates for both cancer and renal failure requiring long-term patient care.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCovers \u003cb\u003eanti-VEGF (antivascular endothelial growth factor) agents and cancer immunotherapies\u003c\/b\u003e – treatments that are being recognized for adverse kidney effects.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eUtilizes a clear, logical format \u003cb\u003ebased on the ASN Core Curriculum for Onco-Nephrology\u003c\/b\u003e, making this reference an excellent tool for board review, as well as a practical resource in daily practice.\u003c\/li\u003e \u003cb\u003e \u003cli\u003eEnhanced\u003c\/li\u003e\u003c\/b\u003e \u003cb\u003eeBook version included with purchase. \u003c\/b\u003eYour enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSECTION 1\u003cbr\u003eFluid and Electrolyte Disorders in Cancer Patients\u003cbr\u003e1 Kidney Function\u003cbr\u003e2 Dysnatremias in Cancer\u003cbr\u003e3 Potassium Disorders\u003cbr\u003e4 Calcium and Phosphorus Disorders\u003cbr\u003e5 Volume Disorders and Fluid Resuscitation\u003cbr\u003eSECTION 2\u003cbr\u003eParaprotein-Related Kidney Diseases\u003cbr\u003e6 Paraproteins\u003cbr\u003e7 Cast Nephropathy\u003cbr\u003e8 Systemic Light Chain Amyloidosis\u003cbr\u003e9 Monoclonal Immunoglobulin Deposition Disease\u003cbr\u003e10 Fibrillary and Immunotactoid Glomerulonephritis\u003cbr\u003eSECTION 3\u003cbr\u003eHematopoietic Stem Cell Associated Kidney Disease\u003cbr\u003e11 Hematopoietic Cell Transplant Associated Kidney Injury\u003cbr\u003e12 Sinusoidal Obstruction Syndrome\u003cbr\u003e13 Thrombotic Microangiopathy\u003cbr\u003e14 Graft-Versus-Host Disease\u003cbr\u003e15 Chronic Kidney Disease, End-Stage Renal Disease, and Bone Marrow Transplant\u003cbr\u003eSECTION 4\u003cbr\u003eChemotherapy and Radiation Related Kidney Diseases\u003cbr\u003e16 Conventional Chemotherapy\u003cbr\u003e17 Targeted Cancer Therapies (Biologics)\u003cbr\u003e18 Adverse Kidney Effects of Immunotherapies\u003cbr\u003e19 Chemotherapy in Chronic Kidney Disease and Dialysis\u003cbr\u003e20 Radiation Nephropathy\u003cbr\u003eSECTION 5\u003cbr\u003eParaneoplastic Glomerulopathies\u003cbr\u003e21 Paraneoplastic Glomerular Diseases\u003cbr\u003e22 Paraneoplastic Glomerulonephritis\u003cbr\u003e23 Hematologic Malignancies\u003cbr\u003e24 Cancer Screening Recommendations\u003cbr\u003eSECTION 6\u003cbr\u003eRenal Tumors\u003cbr\u003e25 Renal Cell Cancer\u003cbr\u003e26 Wilms Tumor and von Hippel Lindau Disease\u003cbr\u003e27 Tuberous Sclerosis Complex and the Kidney\u003cbr\u003e28 Evaluation of a Renal Cyst\/Mass\u003cbr\u003eSECTION 7\u003cbr\u003eAcute Kidney Injury\u003cbr\u003e29 Acute Kidney Injury Incidence, Pathogenesis, and Outcomes\u003cbr\u003e30 Tumor Lysis Syndrome\u003cbr\u003e31 Obstructive Nephropathy in Cancer\u003cbr\u003e32 Renal Replacement Therapies\u003cbr\u003eSECTION 8\u003cbr\u003eChronic Kidney Disease and Cancer\u003cbr\u003e33 Chronic Kidney Disease as a Complication of Cancer, With Special Focus on Kidney and Urothelial Tumors\u003cbr\u003e34 Incidence of Cancer and Screening Recommendations\u003cbr\u003e35 Cancer in Renal Transplant Patients\u003cbr\u003eSECTION 9\u003cbr\u003eKidney Infections\u003cbr\u003e36 Renal Infections in Cancer Patients\u003cbr\u003eSECTION 10\u003cbr\u003eInfiltrative Diseases\u003cbr\u003e37 Kidney Disease in Leukemia\u003cbr\u003e38 Kidney Disease in Lymphoma\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648835637528,"sku":"9780323549455","price":116.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323549455_1c820ccd-f19f-4397-9e92-16bc5eb3e1f1.jpg?v=1694989940"},{"product_id":"nutritional-management-of-renal-disease-hardback-9780123919342","title":"Nutritional Management of Renal Disease (Hardback) 9780123919342","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eNutritional Management of Renal Disease\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eJoel D. Kopple (Edited by), Shaul G Massry (Edited by), Kamyar Kalantar-Zadeh (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780123919342\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 29 January 2013\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e816 pages\u003cbr\u003e27.6 x 21.5 x 4.1 cm, 2.44 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"This is a useful tool for nephrologists, especially in the clinical setting. The easy readability and suggested applications will also attract medical students, internists, renal dietitians, nurse practitioners, and physician assistants…Nutrition with its emerging importance at the cellular level is sometimes overlooked in training medical students. This book provides ready access to both the science and clinical application needed to treat the CKD population.\" Rating: 3 Stars--\u003cb\u003eDoody.com, February 28, 2014\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"The Third Edition of this classic translational text offers in-depth reviews of the metabolic and nutritional disorders prevalent in patients with renal disease.\"--\u003cb\u003eDoody.com, April 24, 2013\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"This edition reflects changes in the field, such as the increased evidence on the importance of inflammatory, oxidative, and carbonyl stress, and the greater prevalence and severity of obesity and its clinical consequences; therapeutic strategies for obesity treatment in regard to chronic kidney disease prevention and treatment; the nutritional management of people receiving chronic renal replacement therapy; and methods for slowing the progression of chronic renal disease...\"--\u003cb\u003eReference and Research Book News, February 2013\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eThis translational text offers in-depth reviews of the metabolic and nutritional disorders that are prevalent in patients with renal disease. Chapter topics address the growing epidemic of obesity and metabolic syndrome. Each chapter integrates basic and clinical approaches, from cell biology and genetics to diagnosis, patient management and treatment. Chapters in sections 4-7 include new illustrative case reports, and all chapters emphasize key concepts with chapter-ending summaries. New features also include the latest National Kidney Foundation Clinical Practice Guidelines on Nutrition in Chronic Renal Failure, the most recent scientific discoveries and the latest techniques for assessing nutritional status in renal disease, and literature reviews on patients who receive continuous veno-venous hemofiltration with or without dialysis. \u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eChapter 1. The Influence of Kidney Disease on Protein and Amino Acid Metabolism\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eCKD Interrupts the Components of Protein Metabolism\u003c\/p\u003e \u003cp\u003eDefining Muscle Wasting\u003c\/p\u003e \u003cp\u003eMechanisms of Muscle Wasting\u003c\/p\u003e \u003cp\u003eThe Ubiquitin-Proteasome System\u003c\/p\u003e \u003cp\u003eSynergism of Proteolytic Pathways Causes Muscle Wasting in CKD\u003c\/p\u003e \u003cp\u003eProteolytic Activities Present in Muscles of Patients\u003c\/p\u003e \u003cp\u003eFactors Triggering Muscle Wasting in CKD and Other Catabolic States\u003c\/p\u003e \u003cp\u003eMyostatin and the Regulation of Muscle Protein Wasting\u003c\/p\u003e \u003cp\u003eMyostatin in Muscle Increases in Catabolic Conditions\u003c\/p\u003e \u003cp\u003eBeneficial Responses from Blocking Myostatin in Models of Muscle Catabolism\u003c\/p\u003e \u003cp\u003eBlocking Myostatin can Suppress CKD-Induced Muscle Wasting\u003c\/p\u003e \u003cp\u003eCKD Changes the Concentrations of Certain Amino Acids\u003c\/p\u003e \u003cp\u003eLinks Between Amino Acid and Protein Metabolism\u003c\/p\u003e \u003cp\u003eConclusion\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 2. Carbohydrate Metabolism in Kidney Disease and Kidney Failure\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eInsulin Resistance\u003c\/p\u003e \u003cp\u003eInsulin Secretion\u003c\/p\u003e \u003cp\u003eInsulin Clearance\u003c\/p\u003e \u003cp\u003eHypoglycemia\u003c\/p\u003e \u003cp\u003eCarbohydrate Metabolism in Patients with Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eTreatment of Diabetes Mellitus in Diabetics with CKD\u003c\/p\u003e \u003cp\u003eDrug Management in Diabetics with CKD (Figure 2.1)\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 3. Altered Lipid Metabolism and Serum Lipids in Kidney Disease and Kidney Failure\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003ePlasma Lipid and Lipoprotein Profile in CKD\/ESRD Patients\u003c\/p\u003e \u003cp\u003eThe Nature and Mechanisms of CKD-Induced Lipid Abnormalities\u003c\/p\u003e \u003cp\u003eThe Nature and Mechanisms of Adverse Effects of Lipid Disorders in CKD\u003c\/p\u003e \u003cp\u003eTreatment of CKD-Associated Dyslipidemia\u003c\/p\u003e \u003cp\u003ePotential Adverse Effects of Statins\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 4. Uremic Toxicity\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eUremic Symptoms and Signs\u003c\/p\u003e \u003cp\u003eToxic Effects of Uremic Plasma or Serum\u003c\/p\u003e \u003cp\u003eDefinition of a Uremic Toxin\u003c\/p\u003e \u003cp\u003eImpact of Dialysis Treatment on Uremic Toxicity\u003c\/p\u003e \u003cp\u003eToxicity of Inorganic Substances in Uremia\u003c\/p\u003e \u003cp\u003eFree Water-Soluble Low-Molecular-Weight Solutes\u003c\/p\u003e \u003cp\u003eProtein-Bound Solutes\u003c\/p\u003e \u003cp\u003eMiddle Molecules\u003c\/p\u003e \u003cp\u003eGeneral Conclusions\u003c\/p\u003e \u003cp\u003eAcknowledgement\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 5. Inflammation in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eGeneral Considerations\u003c\/p\u003e \u003cp\u003eMultifactorial Causes of Inflammation in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eInflammation as a Cause of Protein-Energy Wasting\u003c\/p\u003e \u003cp\u003eInflammation as a Catalyst of Other Risk Factors\u003c\/p\u003e \u003cp\u003eOther Consequences of Inflammation\u003c\/p\u003e \u003cp\u003eMonitoring Inflammation\u003c\/p\u003e \u003cp\u003eTreatment of Inflammation in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 6. Catalytic (Labile) Iron in Kidney Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eDefinition of Catalytic (Labile) Iron and its Importance in Tissue Injury\u003c\/p\u003e \u003cp\u003eRole of Catalytic Iron in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eGentamicin-Induced Mobilization of Iron From Renal Cortical Mitochondria\u003c\/p\u003e \u003cp\u003eEvidence Suggesting a Role for Iron in Gentamicin-Induced Acute Renal Failure in Rats\u003c\/p\u003e \u003cp\u003eCatalytic Iron in Chronic Kidney Disease (Table 6.3)\u003c\/p\u003e \u003cp\u003eCatalytic Iron in Diabetic Nephropathy\u003c\/p\u003e \u003cp\u003eCatalytic Iron in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eConcluding Comments\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 7. Carbonyl Stress in Uremia\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eIncreased Age and other Protein Modifications\u003c\/p\u003e \u003cp\u003eCarbonyl Stress\u003c\/p\u003e \u003cp\u003eClinical Consequences of Carbonyl Stress\u003c\/p\u003e \u003cp\u003eNutrition and Carbonyl Stress\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 8. Effect of Acidemia and Alkalemia on Nutrition and Metabolism\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eAcute Responses to Acidosis and Alkalosis\u003c\/p\u003e \u003cp\u003eComparing Effects of Acidemia to those of Starvation\u003c\/p\u003e \u003cp\u003eEndocrine Responses to Acidemia\u003c\/p\u003e \u003cp\u003eCalcium Metabolism\u003c\/p\u003e \u003cp\u003eProtein Malnutrition\u003c\/p\u003e \u003cp\u003eMetabolic Acidemia Stimulates the Ubiquitin\/Proteasome Proteolytic Pathway\u003c\/p\u003e \u003cp\u003eClinical Implications of Acidemia for Protein Nutrition\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 9. Prevention and Management of Cardiovascular Disease in Kidney Disease and Kidney Failure\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eCardiovascular Risk Factors\u003c\/p\u003e \u003cp\u003eManagement of CVD\u003c\/p\u003e \u003cp\u003eConclusion\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 10. Assessment of Protein and Energy Nutritional Status\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eDefinition of Protein and Energy Wasting\u003c\/p\u003e \u003cp\u003eAssessment of Protein Mass\u003c\/p\u003e \u003cp\u003eAssessment of Protein and Energy Homeostasis\u003c\/p\u003e \u003cp\u003eSummary and Recommendations\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 11. Causes of Protein-Energy Wasting in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eCauses of Pew in CKD\u003c\/p\u003e \u003cp\u003ePathophysiology of Pew in CKD\u003c\/p\u003e \u003cp\u003eEndocrine and Hormonal Disorders\u003c\/p\u003e \u003cp\u003eEffect of Volume Overload\u003c\/p\u003e \u003cp\u003eContribution of Co-Morbidities\u003c\/p\u003e \u003cp\u003eAltered Protein Kinetics in CKD\u003c\/p\u003e \u003cp\u003eNutrient Loss During Dialysis\u003c\/p\u003e \u003cp\u003eInflammation: Agent Provocateur of Pew\u003c\/p\u003e \u003cp\u003eRole of Metabolic Acidemia\u003c\/p\u003e \u003cp\u003eOxidative Stress: Other Key Pathways\u003c\/p\u003e \u003cp\u003eSummary and Conclusion\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 12. Protein-Energy Wasting as a Risk Factor of Morbidity and Mortality in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003ePertinent Outcomes in Patients with CKD\u003c\/p\u003e \u003cp\u003eAssociation of Measures of Nutrition with Outcomes\u003c\/p\u003e \u003cp\u003eNutrient Intake and Outcomes\u003c\/p\u003e \u003cp\u003eBody Size, Body Composition and Outcomes\u003c\/p\u003e \u003cp\u003eLaboratory Measures and Outcome\u003c\/p\u003e \u003cp\u003eNutritional Scoring Systems and Outcomes\u003c\/p\u003e \u003cp\u003eNutritional Interventions and Outcomes\u003c\/p\u003e \u003cp\u003eConclusions\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 13. Effect of Nutritional Status and Changes in Protein Intake on Renal Function\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eRole of Specific AA\u003c\/p\u003e \u003cp\u003eFactors Mediating the Renal Response to Protein and Amino Acids\u003c\/p\u003e \u003cp\u003eHumoral Mediators\u003c\/p\u003e \u003cp\u003eLocal Mediators\u003c\/p\u003e \u003cp\u003eIntrinsic Renal Mechanisms\u003c\/p\u003e \u003cp\u003eEffects of Nutritional Status or Protein Deprivation on Renal Function\u003c\/p\u003e \u003cp\u003eLevels of Plasma Creatinine and Serum Urea Nitrogen in Patients with Protein-Energy Malnutrition\u003c\/p\u003e \u003cp\u003eConcentration and Dilution of the Urine in Patients with Protein-Energy Malnutrition\u003c\/p\u003e \u003cp\u003eAcid Excretion and Acid-Base Balance in Patients with Calorie-Protein Malnutrition\u003c\/p\u003e \u003cp\u003eEffects of Chronic Protein-Energy Malnutrition on Renal Sodium Excretion\u003c\/p\u003e \u003cp\u003eEffects of Maternal Nutrition on Renal Development\u003c\/p\u003e \u003cp\u003eProtein Energy Wasting in Advanced Renal Disease\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 14. Low Protein, Amino Acid and Ketoacid Diets to Slow the Progression of Chronic Kidney Disease and Improve Metabolic Control of Uremia\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eAssessing the Progression of Chronic Renal Insufficiency\u003c\/p\u003e \u003cp\u003eProtein Intake and Chronic Renal Insufficiency: Experimental Data\u003c\/p\u003e \u003cp\u003eDietary Protein Intake: Clinical Studies\u003c\/p\u003e \u003cp\u003eClinical Evidence of the Effects of Low Protein Diets\u003c\/p\u003e \u003cp\u003eConclusion\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 15. Reducing Tryptophan Metabolites to Reduce Progression in Chronic Kidney Failure\u003c\/p\u003e \u003cp\u003eSearch for Uremic Toxins\u003c\/p\u003e \u003cp\u003eMetabolism of Indoxyl Sulfate, a Tryptophan Metabolite\u003c\/p\u003e \u003cp\u003eProtein Metabolite Theory as a Mechanism of CKD Progression\u003c\/p\u003e \u003cp\u003eIndoxyl Sulfate Induces Reactive Oxygen Species (ROS) in the Kidney\u003c\/p\u003e \u003cp\u003eRole of Organic Anion Transporters in Nephrotoxicity of Indoxyl Sulfate\u003c\/p\u003e \u003cp\u003eIndoxyl Sulfate Reduces Klotho and Induces Senescence in the Kidney\u003c\/p\u003e \u003cp\u003eVascular Toxicity of Indoxyl Sulfate\u003c\/p\u003e \u003cp\u003eClinical Effects of AST-120\u003c\/p\u003e \u003cp\u003eConclusion\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 16. Altering Serum Lipids to Reduce Progression of Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eKidney Disease and Dyslipidemia\u003c\/p\u003e \u003cp\u003eLipid Lowering and Pleiotropic Effects of Statins\u003c\/p\u003e \u003cp\u003eStatins in Experimental Kidney Disease\u003c\/p\u003e \u003cp\u003eEffects of Dyslipidemia and Statins on the Progression of Kidney Disease in Human Subjects\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 17. Disorders of Phosphorus Homeostasis: Emerging Targets for Slowing Progression of Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eRole of Dietary Phosphorus Intake in Disturbances of Mineral Metabolism in CKD\u003c\/p\u003e \u003cp\u003eDisorders of Phosphorus Homeostasis and Kidney Disease Progression\u003c\/p\u003e \u003cp\u003eDietary Phosphorus Restriction in CKD: Practical Considerations Moving Forward\u003c\/p\u003e \u003cp\u003eConclusions\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 18. Alkalinization to Retard Progression of Chronic Kidney Failure\u003c\/p\u003e \u003cp\u003eEpidemiology of Metabolic Acidosis in Kidney Disease\u003c\/p\u003e \u003cp\u003eMechanism of Acidosis in CKD\u003c\/p\u003e \u003cp\u003eAnimal Models of Kidney Damage With Acidosis\u003c\/p\u003e \u003cp\u003eAnimal Models of Treatment\u003c\/p\u003e \u003cp\u003eObservational Studies in Humans\u003c\/p\u003e \u003cp\u003eRecommendations\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 19. Calcium, Phosphate, PTH, Vitamin D and FGF-23 in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eCalcium Metabolism\u003c\/p\u003e \u003cp\u003eVitamin D\u003c\/p\u003e \u003cp\u003ePhosphate Metabolism\u003c\/p\u003e \u003cp\u003eParathyroid Hormone\u003c\/p\u003e \u003cp\u003eFibroblast Growth Factor 23 (FGF-23)\u003c\/p\u003e \u003cp\u003eAlterations in Mineral Metabolism in Ckd\u003c\/p\u003e \u003cp\u003ePhosphate and Cardiovascular Disease (CVD)\u003c\/p\u003e \u003cp\u003ePhosphate and Vascular Calcifications\u003c\/p\u003e \u003cp\u003eControl of Serum Phosphate in CKD\u003c\/p\u003e \u003cp\u003eDietary Phosphorus Restriction\u003c\/p\u003e \u003cp\u003eInorganic Phosphorus and Food Additives\u003c\/p\u003e \u003cp\u003eDietary Phosphorus, Protein Intake and Phosphorus-Protein Ratio\u003c\/p\u003e \u003cp\u003ePhosphorus Removal With Dialysis\u003c\/p\u003e \u003cp\u003ePhosphate Binders\u003c\/p\u003e \u003cp\u003eTherapy With Vitamin D Sterols\u003c\/p\u003e \u003cp\u003eCalcimimetics\u003c\/p\u003e \u003cp\u003eConclusion\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 20. Phosphate Metabolism and Fibroblast Growth Factor 23 in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003ePhosphate Metabolism in Health\u003c\/p\u003e \u003cp\u003ePhosphate Metabolism Across the Spectrum of CKD\u003c\/p\u003e \u003cp\u003eThe Role of Phosphate and FGF-23 Excess in the Pathophysiology of CKD Outcomes\u003c\/p\u003e \u003cp\u003eTherapeutic Approaches to Lowering Phosphate and FGF-23 Excess\u003c\/p\u003e \u003cp\u003eImpact of Dietary Phosphate on Phosphate\/FGF-23 Excess\u003c\/p\u003e \u003cp\u003eQuestions and Controversies\u003c\/p\u003e \u003cp\u003eConclusions\u003c\/p\u003e \u003cp\u003eAcknowledgments\u003c\/p\u003e \u003cp\u003eDisclosures\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 21. Vitamin D in Kidney Disease\u003c\/p\u003e \u003cp\u003eNormal Vitamin D Metabolism\u003c\/p\u003e \u003cp\u003ePrevalence and Etiology of Deficiency in The Vitamin D Axis in CKD\u003c\/p\u003e \u003cp\u003eImplications\u003c\/p\u003e \u003cp\u003eInterventions\u003c\/p\u003e \u003cp\u003eOther Compounds\u003c\/p\u003e \u003cp\u003eTherapeutic Considerations\u003c\/p\u003e \u003cp\u003eSummary\u003c\/p\u003e \u003cp\u003eAcknowledgement\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 22. Nutritional Management of Water, Sodium, Potassium, Chloride, and Magnesium in Kidney Disease and Kidney Failure\u003c\/p\u003e \u003cp\u003eSodium and Chloride\u003c\/p\u003e \u003cp\u003eWater\u003c\/p\u003e \u003cp\u003ePotassium\u003c\/p\u003e \u003cp\u003eMagnesium\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 23. Trace Elements, Toxic Metals, and Metalloids in Kidney Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eAlterations in Essential Trace Elements in Patients With Kidney Disease\u003c\/p\u003e \u003cp\u003eAlterations in Nonessential Trace Elements, Metals, and Metalloids in Patients With Kidney Disease\u003c\/p\u003e \u003cp\u003eTrace Element Abnormalities in Renal-Specific Syndromes\u003c\/p\u003e \u003cp\u003eDiagnostic and Therapeutic Approaches\u003c\/p\u003e \u003cp\u003eConclusions\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 24. Vitamin Metabolism and Requirements in Renal Disease and Renal Failure\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eStructure and Physiological Role of Vitamins\u003c\/p\u003e \u003cp\u003eVitamin Intake in Chronic Renal Disease\u003c\/p\u003e \u003cp\u003eVitamins Status in Chronic Renal Disease\u003c\/p\u003e \u003cp\u003eVitamins as Therapy for People with Kidney Disease\u003c\/p\u003e \u003cp\u003eRecommendations for Vitamin Supplementation and Vitamin Therapy in Renal Diseases\u003c\/p\u003e \u003cp\u003eConclusions\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 25. Nutrition and Anemia in End-stage Renal Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eIron\u003c\/p\u003e \u003cp\u003eVitamin C\u003c\/p\u003e \u003cp\u003eVitamin D\u003c\/p\u003e \u003cp\u003eFolic Acid\u003c\/p\u003e \u003cp\u003eVitamin B6 (Pyridoxine)\u003c\/p\u003e \u003cp\u003eVitamin B12\u003c\/p\u003e \u003cp\u003eCarnitine\u003c\/p\u003e \u003cp\u003eGrowth Hormone and Insulin-Like Growth Factor-I (IGF-I)\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 26. Nutritional and Non-nutritional Management of the Nephrotic Syndrome\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eDietary Protein\u003c\/p\u003e \u003cp\u003eAlbumin Homeostasis in the Nephrotic Syndrome\u003c\/p\u003e \u003cp\u003eDietary Protein and Renal Injury\u003c\/p\u003e \u003cp\u003eEffects of the Nephrotic Syndrome on Solid Tissue Proteins\u003c\/p\u003e \u003cp\u003eDietary Proteins as Potential Allergens Responsible for Renal Disease\u003c\/p\u003e \u003cp\u003eDietary Fat\u003c\/p\u003e \u003cp\u003eThe Effect of Altered Glomerular Permselectivity on Lipid Metabolism\u003c\/p\u003e \u003cp\u003eCardiovascular Effects of Hyperlipidemia in the Nephrotic Syndrome\u003c\/p\u003e \u003cp\u003eThromboembolic Complications\u003c\/p\u003e \u003cp\u003eEffects of Lipids on Renal Disease\u003c\/p\u003e \u003cp\u003ePolyunsaturated Fatty Acids\u003c\/p\u003e \u003cp\u003eDerangements in Divalent Cation Metabolism in the Nephrotic Syndrome\u003c\/p\u003e \u003cp\u003eDerangements in Salt and Water Metabolism in the Nephrotic Syndrome (Volume Homeostasis)\u003c\/p\u003e \u003cp\u003eRecommendations for Nutritional and Non-Nutritional Treatment of the Nephrotic Syndrome\u003c\/p\u003e \u003cp\u003eAcknowledgements\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 27. Nutrition and Blood Pressure\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eObesity and Energy Intake\u003c\/p\u003e \u003cp\u003eIndividual Nutrients, Miscellaneous Substances and Blood Pressure\u003c\/p\u003e \u003cp\u003eNutritional Management Strategies for The Prevention or Treatment of Hypertension\u003c\/p\u003e \u003cp\u003eHealth Enhancing Diets and Lifestyles\u003c\/p\u003e \u003cp\u003eLong-Term Adherence and Blood Pressure Responses to Health Enhancing Lifestyles\u003c\/p\u003e \u003cp\u003eChallenges to Diet and Lifestyle Approaches for Preventing and Treating Hypertension\u003c\/p\u003e \u003cp\u003eConclusions and Recommendations\u003c\/p\u003e \u003cp\u003eKey Points\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 28. Effect of Obesity and the Metabolic Syndrome on Incident Kidney Disease and the Progression to Chronic Kidney Failure\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eDefinitions of Obesity\/Metabolic Syndrome\u003c\/p\u003e \u003cp\u003eObesity and Metabolic Syndrome as Risk Factors for Incident CKD\u003c\/p\u003e \u003cp\u003eObesity and Metabolic Syndrome as Risk Factors for Progression of CKD\u003c\/p\u003e \u003cp\u003ePathophysiology of Obesity on the Kidney\u003c\/p\u003e \u003cp\u003eEffect of Weight Loss Interventions on Kidney Disease\u003c\/p\u003e \u003cp\u003eConclusion\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 29. Nutritional and Metabolic Management of Obesity and the Metabolic Syndrome in the Patient with Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eObesity-Related Chronic Kidney Disease (CKD)\u003c\/p\u003e \u003cp\u003eObesity-Related Glomerulopathy\u003c\/p\u003e \u003cp\u003eMeasuring GFR\u003c\/p\u003e \u003cp\u003eMetabolic Syndrome\u003c\/p\u003e \u003cp\u003eTreatment of Obesity and Obesity-Related Kidney Disease\u003c\/p\u003e \u003cp\u003eBariatric Surgery (see also Chapter 28)\u003c\/p\u003e \u003cp\u003eMetabolic Syndrome\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 30. Bariatric Surgery and Renal Disease\u003c\/p\u003e \u003cp\u003eMagnitude of Problem\u003c\/p\u003e \u003cp\u003ePathogenesis of Obesity\u003c\/p\u003e \u003cp\u003eClinical Manifestations\u003c\/p\u003e \u003cp\u003eMedical Therapy\u003c\/p\u003e \u003cp\u003eRole of Bariatric Surgery in Treatment of Morbid Obesity\u003c\/p\u003e \u003cp\u003eSurgical Techniques of Bariatric Surgery (see Figure 30.1)\u003c\/p\u003e \u003cp\u003eOutcomes of Bariatric Surgery\u003c\/p\u003e \u003cp\u003eRenal Disease and Morbid Obesity\u003c\/p\u003e \u003cp\u003ePathogenesis of Renal Disease in Obesity\u003c\/p\u003e \u003cp\u003eRole of Bariatric Surgery in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eRole of Bariatric Surgery in Transplant Candidates\u003c\/p\u003e \u003cp\u003eBariatric Surgery and Nephrolithiasis\u003c\/p\u003e \u003cp\u003eOther Renal Effects of Bariatric Surgery\u003c\/p\u003e \u003cp\u003eFuture Research\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 31. Nutritional and Metabolic Management of the Diabetic Patient with Chronic Kidney Disease and Chronic Renal Failure\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eGlucose\/Insulin Homeostasis\u003c\/p\u003e \u003cp\u003eValue of Glycemic Control, and its Determination in CKD\u003c\/p\u003e \u003cp\u003eHypoglycemia\u003c\/p\u003e \u003cp\u003eDiabetes\/Bone and Mineral Metabolism\u003c\/p\u003e \u003cp\u003eDietary Protein Intake and Diabetic Kidney Disease\u003c\/p\u003e \u003cp\u003eSalt Intake and Diabetic Kidney Disease\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 32. Nutritional Management of Maintenance Hemodialysis Patients\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eFactors Altering Nutrient Intake in Maintenance Hemodialysis Patients\u003c\/p\u003e \u003cp\u003eLoss of Nutrients During Maintenance Hemodialysis Treatment\u003c\/p\u003e \u003cp\u003eImportance of Pew and Diet as Patients Approach Esrd and Commence MHD\u003c\/p\u003e \u003cp\u003eAssessment of Nutritional Status in MHD Patients\u003c\/p\u003e \u003cp\u003eAcidemia and Protein Wasting\u003c\/p\u003e \u003cp\u003eGoals of Nutritional Management of MHD Patients\u003c\/p\u003e \u003cp\u003eDietary Nutrient Requirements (see Table 32.3)\u003c\/p\u003e \u003cp\u003eManagement of Pew in MHD Patients\u003c\/p\u003e \u003cp\u003eTreatment of Acute Catabolic Illness\u003c\/p\u003e \u003cp\u003eDaily or Long Duration Hemodialysis and Nutritional Status\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 33. Nutritional Management of End-Stage Renal Disease Patients Treated with Peritoneal Dialysis\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eType of Peritoneal Dialysis\u003c\/p\u003e \u003cp\u003ePeritoneal Dialysis Solutions\u003c\/p\u003e \u003cp\u003eSpecific Effects of Peritoneal Dialysis on Nutritional Status and Metabolism\u003c\/p\u003e \u003cp\u003eDietary Recommendations for ESRD Patients Undergoing Peritoneal Dialysis\u003c\/p\u003e \u003cp\u003eProtein-Energy Wasting in Peritoneal Dialysis Patients\u003c\/p\u003e \u003cp\u003eManagement of Protein-Energy Wasting in Patients Treated with Peritoneal Dialysis\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 34. Nutritional Management of Kidney Transplant Recipients\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eAnemia\u003c\/p\u003e \u003cp\u003eBone Disease\u003c\/p\u003e \u003cp\u003eDiabetes Mellitus\u003c\/p\u003e \u003cp\u003eDyslipidemia\u003c\/p\u003e \u003cp\u003eHypertension\u003c\/p\u003e \u003cp\u003eFood Safety\u003c\/p\u003e \u003cp\u003eHypophosphatemia\u003c\/p\u003e \u003cp\u003eOverweight\/Obesity\u003c\/p\u003e \u003cp\u003eMalnutrition\u003c\/p\u003e \u003cp\u003eProtein and Energy Requirements\u003c\/p\u003e \u003cp\u003eNutritional Management\u003c\/p\u003e \u003cp\u003ePretransplant Status and Posttransplant Outcome\u003c\/p\u003e \u003cp\u003eConclusion\u003c\/p\u003e \u003cp\u003eAcknowledgements\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 35. Nutritional Management of the Child with Kidney Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eEtiology of Protein-Energy Wasting\u003c\/p\u003e \u003cp\u003eAssessment of Nutritional Status\u003c\/p\u003e \u003cp\u003eNutritional Requirements\u003c\/p\u003e \u003cp\u003eBone Mineral Metabolism\u003c\/p\u003e \u003cp\u003eAcid–Base and Electrolytes\u003c\/p\u003e \u003cp\u003eVitamins and Micronutrients\u003c\/p\u003e \u003cp\u003eNutrition Management\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 36. Nutritional Management of Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eMetabolic Environment of the Patient with AKI\u003c\/p\u003e \u003cp\u003eMetabolic Alterations Specifically Attributable to AKI\u003c\/p\u003e \u003cp\u003eMetabolic Interventions of Controlling Catabolism\u003c\/p\u003e \u003cp\u003eClinical Studies on Protein Catabolism in AKI\u003c\/p\u003e \u003cp\u003eAmino Acid\/Protein Requirements in Patients with AKI\u003c\/p\u003e \u003cp\u003eCarbohydrate Metabolism\u003c\/p\u003e \u003cp\u003eLipid Metabolism\u003c\/p\u003e \u003cp\u003eMicronutrients and the Antioxidant System in AKI\u003c\/p\u003e \u003cp\u003eElectrolytes\u003c\/p\u003e \u003cp\u003eMetabolic and Nutritional Factors and the Prevention and Therapy of AKI\u003c\/p\u003e \u003cp\u003eImpact of Renal Replacement Therapy (RRT) on Metabolism and Nutrient Balances\u003c\/p\u003e \u003cp\u003eThe Effect of Nutrition Status and Nutrient Supply on Prognosis\u003c\/p\u003e \u003cp\u003ePractice of Clinical Nutrition in Patients with AKI\u003c\/p\u003e \u003cp\u003eOral Nutrition in Patients with AKI\u003c\/p\u003e \u003cp\u003eNutritional Support in Patients with AKI\u003c\/p\u003e \u003cp\u003eEnteral Nutrition in AKI\u003c\/p\u003e \u003cp\u003eParenteral Nutrition in AKI\u003c\/p\u003e \u003cp\u003eComplications of Nutritional Support\u003c\/p\u003e \u003cp\u003eMonitoring of Nutrition Support in Patient with AKI\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 37. Nutritional Management of Patients Treated with Continuous Renal Replacement Therapy\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eModes of CRRT\u003c\/p\u003e \u003cp\u003eGeneric Effects of CRRT on Energy Metabolism\u003c\/p\u003e \u003cp\u003eSpecific Effects on Nutrient Balance\u003c\/p\u003e \u003cp\u003eRecommendations on Nutritional Therapy\u003c\/p\u003e \u003cp\u003eConclusion\u003c\/p\u003e \u003cp\u003eAcknowledgements\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 38. Anorexia and Appetite Stimulants in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eGeneral Considerations\u003c\/p\u003e \u003cp\u003ePrevalence of Anorexia, Methods of Assessment and Clinical Implications\u003c\/p\u003e \u003cp\u003ePathogenesis of Anorexia in CKD\u003c\/p\u003e \u003cp\u003eTreatment of Anorexia in CKD\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 39. Oral and Enteral Supplements in Kidney Disease and Kidney Failure\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eOral and Enteral (Tube Feeding) Nutrition in CKD Patients\u003c\/p\u003e \u003cp\u003eOral and Enteral Nutrition for Patients with Nephrotic Syndrome\u003c\/p\u003e \u003cp\u003eOral and Enteral Nutrition in Chronic Dialysis Patients\u003c\/p\u003e \u003cp\u003eOral and Enteral Nutrition in Acute Kidney Injury\u003c\/p\u003e \u003cp\u003eConclusions\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 40. Intradialytic Parenteral Nutrition, Intraperitoneal Nutrition and Nutritional Hemodialysis\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eIntradialytic Parenteral Nutrition (IDPN)\u003c\/p\u003e \u003cp\u003eRandomized Prospective Controlled Trials of IDPN\u003c\/p\u003e \u003cp\u003eAdvantages and Disadvantages of IDPN\u003c\/p\u003e \u003cp\u003eIndications for IDPN\u003c\/p\u003e \u003cp\u003eIDPN in the United States\u003c\/p\u003e \u003cp\u003eNutritional Hemodialysis and Intraperitoneal Nutrition\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 41. Therapeutic Use of Growth Factors in Renal Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eTreatment of Protein-Energy Wasting (PEW) in ESRD Patients\u003c\/p\u003e \u003cp\u003eTherapeutic Use of Growth Factors in Renal Disease\u003c\/p\u003e \u003cp\u003eGrowth Factors in the Management of Wasting in Renal Disease\u003c\/p\u003e \u003cp\u003eConclusion\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 42. Nutritional Prevention and Treatment of Kidney Stones\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003ePathophysiology of Kidney Stone Formation\u003c\/p\u003e \u003cp\u003eGeneral Dietary Effects on Kidney Stones\u003c\/p\u003e \u003cp\u003eEffect of Diet Based on Urinary Findings\u003c\/p\u003e \u003cp\u003eDietary Recommendations Based on Stone Type\u003c\/p\u003e \u003cp\u003eObesity and Kidney Stones\u003c\/p\u003e \u003cp\u003eMelamine Stones\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 43. Herbal Supplements in Patients with Kidney Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eAcute Kidney Injury\u003c\/p\u003e \u003cp\u003eChronic Kidney Disease\u003c\/p\u003e \u003cp\u003eFive Herbals with Some Proven Efficacy\u003c\/p\u003e \u003cp\u003eTransplant\u003c\/p\u003e \u003cp\u003eClinical Implications\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 44. Drug–Nutrient Interactions in Renal Failure\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eEffect of Food Intake on Drug Absorption\u003c\/p\u003e \u003cp\u003eEffects of Nutrients on Drug Metabolism\u003c\/p\u003e \u003cp\u003eInteractions of Food Supplements with Drugs\u003c\/p\u003e \u003cp\u003eDrug-Induced Nutritional Deficiencies\u003c\/p\u003e \u003cp\u003eTaurine and ACE-Inhibitor Effects\u003c\/p\u003e \u003cp\u003eNutrient Interactions with Oral Anticoagulants\u003c\/p\u003e \u003cp\u003eInteractions of Calcineurin Inhibitors with Nutrients\u003c\/p\u003e \u003cp\u003eEnteral Tube Feeding and Oral Drug Administration\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 45. Exercise Training for Individuals with Advanced Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eCharacteristics of Advanced CKD Patients\u003c\/p\u003e \u003cp\u003eValue of Exercise and Physical Activity in Advanced CKD\u003c\/p\u003e \u003cp\u003ePrinciples of Exercise Training\u003c\/p\u003e \u003cp\u003ePatient Assessment\u003c\/p\u003e \u003cp\u003eComponents of the Exercise Training Prescription\u003c\/p\u003e \u003cp\u003eExercise Training Program Design for Patients with Advanced CKD\u003c\/p\u003e \u003cp\u003eComponents of the Exercise Training Session\u003c\/p\u003e \u003cp\u003eRisks of Exercise in the Advanced CKD Patient\u003c\/p\u003e \u003cp\u003eUrgent Need for Development of Renal Rehabilitation Programs\u003c\/p\u003e \u003cp\u003eSummary\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eChapter 46. Motivating the Kidney Disease Patient to Nutrition Adherence and Other Healthy Lifestyle Activities\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003eWhat is Motivational Interviewing?\u003c\/p\u003e \u003cp\u003eWhat isn’t Motivational Interviewing?\u003c\/p\u003e \u003cp\u003ePrinciples\u003c\/p\u003e \u003cp\u003eHandling Resistance\u003c\/p\u003e \u003cp\u003eEmpirical Support\u003c\/p\u003e \u003cp\u003eApplications in Kidney Disease Management\u003c\/p\u003e \u003cp\u003eLearning Motivational Interviewing\u003c\/p\u003e \u003cp\u003eDissemination of Motivational Interviewing\u003c\/p\u003e \u003cp\u003eFuture Research Directions in Kidney Disease Management\u003c\/p\u003e \u003cp\u003eConclusions\u003c\/p\u003e \u003cp\u003eReferences\u003c\/p\u003e \u003cp\u003eColor Plates\u003c\/p\u003e \u003cp\u003eIndex\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Food \u0026amp; beverage technology [\u003ca title=\"See our other books on Food \u0026amp; beverage technology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Food%20\u0026amp;%20beverage%20technology%20%5BTDCT%5D%22\"\u003eTDCT\u003c\/a\u003e], Pharmacology [\u003ca title=\"See our other books on Pharmacology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pharmacology%20%5BMMG%5D%22\"\u003eMMG\u003c\/a\u003e], Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648990236952,"sku":"9780123919342","price":76.59,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780123919342_8a7cdc49-4abd-4c13-a1a4-70f41cd4463e.jpg?v=1694352185"},{"product_id":"textbook-of-nephro-endocrinology-hardback-9780123738707","title":"Textbook of Nephro-Endocrinology (Hardback) 9780123738707","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eTextbook of Nephro-Endocrinology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eAjay K. Singh (Edited by), Gordon H. Williams (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780123738707, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 23 December 2008\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e522 pages\u003cbr\u003e27.6 x 21.5 x 3.1 cm, 1.69 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"This well-written, relatively concise, and current book will find a home on the shelves of many nephrologists and endocrinologists. Because it is so readable, it should be useful for students, experts, and those in between. I know I will consult my copy on a frequent basis - an unusual event in this era of online material.\" \u003cb\u003e--N Engl J Med, 2009\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"All in all, this is a solid book that provides substantial up-todate information on endocrine aspects of the kidney. I will be glad to pull it down from my shelf rather than one of the true heavyweights to which I would previously have gone for this kind of reading.\" \u003cb\u003e--Kidney International, 2009\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"Written by multidisciplinary experts from several countries, this book is divided into 2 parts and 7 sections. A very useful volume. Each chapter is richly referenced.\" \u003cb\u003e--Pediatric Endocrinology Reviews\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThe \u003ci\u003eTextbook of Nephro-Endocrinology\u003c\/i\u003e is the definitive translational reference in the field of nephro-endocrinology, investigating both the endocrine functions of the kidneys and how the kidney acts as a target for hormones from other organ systems. It offers researchers and clinicians expert, gold-standard analyses of nephro-endocrine research and translation into the treatment of diseases such as anemia, chronic kidney disease (CKD), rickets, osteoporosis, and, hypoparathyroidism.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003ePart 1: The Kidney as an Endocrine Organ \u003c\/b\u003e\u003ci\u003eSection 1: Erythropoietin  \u003c\/i\u003e1. Erythropoientin: An Historical Overview of Physiology, Molecular Biology And Gene Regulation  2.Erythropoiesis: The Role of Erythropoietin and Iron 3.Extra-Hematopoietic Action of Erythropoietin 4.Development of Recombinant Erythropoietin and Erythropoietin Analogues 5.Erythropoietin Disease States \u0026amp; Resistance \u003ci\u003eSection 2: Vitamin D, PTH and Novel Regulators of Phosphate \u003c\/i\u003e6. Vitamin D and the Kidney: Introduction and Historical Perspective 7.Vitamin D: Molecular Biology and Gene Regulation 8.Molecular Biology of Parathyroid Hormone  9.Endocrine Regulation of Phosphate Homeostasis  \u003ci\u003eSection 3: Renin-angiotensin  \u003c\/i\u003e10.Introduction and Historical Overview 11.Molecular Biology of Renin and Regulation of Its Gene 12. Physiology and Regulation of the RAAS System 13. The Renin Angiotensin Aldosterone System and the Kidney 14. The Renin Angiotensin and the Heart  15. The Renin-Angrotensin blockade: Therapeutic Agents \u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: The Kidney as a Hormonal target \u003c\/b\u003e\u003ci\u003eSection 4: Anti-diuretic Hormone  \u003c\/i\u003e16. Vasopressin in the Kidney: Historical Aspects 17. Molecular Biology and Gene Regulation 18. Vasopressin Antagonists in Physiology and Disease  19. Diabetes Insipidus and SIADH  \u003ci\u003eSection 5: The Atrial Natriuretic Peptides  \u003c\/i\u003e20. ANP, BNP and CNP Physiology and Pharmacology of the Cardiorenal Axis \u003ci\u003eSection 6: Aldosterone  \u003c\/i\u003e21.Introduction and Historical Overview 22.Aldosterone Receptors and Their Renal Effects: Molecular Biology and Gene Regulation 23. Aldosterone and Its Cardiovascular Effects 24. Aldosterone Regulation \u003ci\u003eSection 7: Endocrine Disorders in Renal Failure \u003c\/i\u003e25. Insulin resistance  26. Growth hormone  27. Sexual Dysfunction in Men and Women with Chronic Kidney Disease  28. Thyroid Status in Chronic Renal Failure Patients  29.Metabolic Acidosis of Chronic Kidney Disease  30.Pregnancy and the Kidney \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e], Metabolism [\u003ca title=\"See our other books on Metabolism\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Metabolism%20%5BMFGM%5D%22\"\u003eMFGM\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46649278202136,"sku":"9780123738707","price":91.59,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780123738707.jpg?v=1694099469"},{"product_id":"renal-disease-in-cancer-patients-hardback-9780124159488","title":"Renal Disease in Cancer Patients (Hardback) 9780124159488","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eRenal Disease in Cancer Patients\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eFirst translational reference on the diagnosis, management, and treatment of renal disease in cancer patients\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eKevin W. Finkel (Edited by), Scott C. Howard (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780124159488\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 11 November 2013\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e312 pages\u003cbr\u003e23.4 x 19 x 2.3 cm, 0.84 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"…a translational reference detailing the nephrological problems that cancer patients face...provides a common language for nephrologists, oncologists, hematologists, and other clinicians who treat cancer patients, to discuss the development of renal diseases in the context of cancer and options for their optimum diagnosis, management, and treatment.\" --\u003cb\u003eAnticancer Research 34, 2014\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"This is a useful and up-to-date review of key areas of nephrology in cancer patients that focuses on clinical considerations…It will probably get the most use from consulting nephrologists, oncologists, and pharmacologists specifically trained in advanced cancer protocols, including stem cell transplant.\" \u003cb\u003eRating: 3 Stars --Doody.com, May 22, 2014\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eRenal Disease in Cancer Patients\u003c\/i\u003e is a translational reference detailing the nephrological problems unique to patients with cancer in an organized and authoritative fashion. This book provides a common language for nephrologists, oncologists, hematologists, and other clinicians who treat cancer patients, to discuss the development of renal diseases in the context of cancer and options for their optimum diagnosis, management, and treatment. \u003c\/p\u003e  \u003cp\u003eWith the advent of better supportive care and the era of personalized medicine, patients with cancer are living longer, and oncologists and nephrologists now recognize the serious consequences of renal disease among these patients.  Designed especially with this new need in mind, \u003ci\u003eRenal Disease in Cancer Patients\u003c\/i\u003e presents the various renal diseases affecting cancer patients in a single, authoritative volume. The book covers topics in radiation nephritis, obstructive nephropathy, drug nephropathy, graft-versus-host disease, and more. \u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e1. Introduction\u003c\/p\u003e \u003cp\u003e2. Acute Kidney Injury\u003c\/p\u003e \u003cp\u003e3. Biomarkers in Oncology and Nephrology\u003c\/p\u003e \u003cp\u003e4. Tumor Lysis Syndrome\u003c\/p\u003e \u003cp\u003e5. Multiple Myeloma\u003c\/p\u003e \u003cp\u003e6. Bone Marrow Transplantation\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e7. Radiation Nephritis\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e8. Renal Cell Carcinoma\u003c\/p\u003e \u003cp\u003e9. Renal Cancer in Children\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e10. Lymphoma\/Leukemia\u003c\/p\u003e \u003cp\u003e11. Electrolyte Disorders\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e12. Infections\u003c\/p\u003e \u003cp\u003e13. Drug Nephropathies\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e14. Paraneoplastic Glomerulonephritis\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e15. Dosing Chemo on RRT\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e16. Cancer after Renal Transplantation\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Medical toxicology [\u003ca title=\"See our other books on Medical toxicology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medical%20toxicology%20%5BMMGT%5D%22\"\u003eMMGT\u003c\/a\u003e], Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46649408258328,"sku":"9780124159488","price":82.89,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780124159488_c39f19ae-c1c5-415d-a862-fd04f915199d.jpg?v=1694352993"},{"product_id":"genetic-diseases-of-the-kidney-hardback-9780124498518","title":"Genetic Diseases of the Kidney (Hardback) 9780124498518","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eGenetic Diseases of the Kidney\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eRichard P. Lifton (Edited by), Stefan Somlo (Edited by), Gerhard H. Giebisch (Edited by), Donald W. Seldin (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780124498518, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 30 December 2008\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e848 pages\u003cbr\u003e27.6 x 21.5 x 4.2 cm, 2.58 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\"A fine book like this for nephrology is long overdue. The kidney, historically rich in its contribution to modern genetics, needs an authoritative landmark for new learning, understanding, and reference. Genetic Diseases of the Kidney is comprehensive, containing 47 well-written chapters that are edited beautifully. Clinicians, trainees, and scientists will easily marvel at seeming complexity made truly understandable. Written with clarity and acumen by leading authorities, it strikes the right balance between overview and detail. References to each chapter have been carefully selected to reflect a wealthy resource for further reading.\" \u003cb\u003e--Eric G. Neilson, MD, Hugh Jackson Morgan Professor of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA\u003cbr\u003e\u003c\/b\u003e\u003cbr\u003e\"…The field of kidney diseases has been lucky to have Richard Lifton, one of the major figures in this revolution, devote his energies to syndromes causing kidney failure and hypertension. His discoveries have energized the field, bringing into it many exciting young investigators… The new textbook Genetics Diseases of the Kidney, edited by Lifton, Somlo Giebisch and Seldin, combines the expertise of genetics and physiology in an admirable manner. The chapters cover many practical and theoretical areas: from basic principles of genetic inheritance to detailed analysis of the many newly described syndromes of genetic renal disease. For the general nephrologist or internist there is also a helpful chapter on what is available today in genetic diagnosis – this should aid the clinician in testing and making the appropriate diagnosis. The explosion of recent genetic information had made the general textbooks of genetic medicine quite unwieldy but the publication of this textbook is a welcome addition and fills a real need. The identification of the function of such medically important genes makes this book essential not only for nephrologists but for all scientists interested in the structure and function of the kidney.\" \u003cb\u003e--Qais Al-Awqati, MB, ChB, Professor of Medicine \u0026amp; Physiology, Columbia University, College of Physicians \u0026amp; Surgeons, New York, USA\u003cbr\u003e\u003cbr\u003e\u003c\/b\u003e\"This multi-authored textbook, covering almost all of the inherited disorders of the kidney, is written by specialists running in the front row of this fast moving research field. I was quite impressed with the enormous amount of literature covered in each and every chapter of the book, reflecting the fast progress in this area of medicine. In this time of information overflow it is particularly helpful for busy clinicians to read accessible reviews that summarize the mountain of articles now available on every subject, and provide the necessary links needed to understand the bigger picture. This book is a must have for all of those involved in the fundamental as well as the clinical research on kidney disease as well as doctors caring for patients.\" \u003cb\u003e--Prof.Dr. Martijn.H. Breuning, Department of Clinical Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center, The Netherlands\u003c\/b\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eGenetic approaches have revolutionized our understanding of the fundamental causes of human disease by permitting the identification of specific genes in which variation causes or contributes to susceptibility to, or protection from, disease.  More than 2,000 disease genes have been identified in the last 20 years, providing important new insight into the pathophysiology of diseases in every field of medicine.  \u003ci\u003eGenetic Diseases of the Kidney\u003c\/i\u003e offers expert insight into the role of genetic abnormalities in the pathogenesis of abnormal kidney function and kidney disease. Genetic abnormalities are carefully presented within the appropriate physiologic context so that readers will understand not only which genes are linked to which diseases but also which pathways lead from a genetic “disturbance? to the systemic appearance of disease.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cb\u003eI. General Background:\u003c\/b\u003e Principles of Mammalian Genetics. Approaches to Identification of Disease Genes. Clinical Applications of Genetics. \u003cb\u003eII. Primary Genetic Diseases of Nephron Function:\u003c\/b\u003e Logic of the Kidney. \u003ci\u003ePrimary Genetic Diseases of the Glomerulus:\u003c\/i\u003e Alport’s and Thin Basement Membrane Disease. Congenital Nephrotic Syndrome. Focal Segmental Glomerulosclerosis. Primary Genetic Diseases of the Proximal Renal Tubules. Diseases of Renal Glucose Handling. Diseases of Renal Amino Acid Handling. Primary Renal Uricosuria. Fanconi Syndrome. Proximal Renal Tubular Acidosis\t. Dent’s Disease. \u003ci\u003ePrimary Genetic Diseases of the Thick Ascending Limb of Henle:\u003c\/i\u003e Salt and Potassium Handling (Bartter’s Syndrome). Renal Mg2+ Wasting Due to Paracellin-1 Mutation. Ca2+-Sensor Receptor-related Diseases. Primary Genetic Diseases of the Distal Convoluted Tubule and Collecting Duct: Gitelman’s Syndrome. Syndrome of Hypertension Plus Hyperkalemia. Liddle’s Syndrome. The Syndrome of Apparent Mineralocorticoid Excess. Pseudohypaldosteronism Type I and Hypertension Exacerbated in Pregnancy. Distal Renal Tubular Acidosis. Nephrogenic Diabetes Insipidus: Vasopressin Receptor Defect. Nephrogenic Diabetes Insipidus: Aquaporin-2 Defect. \u003cb\u003eIII. Genetic Abnormalities of Renal Development and Morphogenesis:\u003c\/b\u003e Overview of Renal Development. Polycystic Kidney Disease. Juvenile Nephronopthisis. Medullary Cystic Disease. Renal Dysgenesis. \u003cb\u003eIV. Inherited Neoplastic Diseases Affecting the Kidney.\u003c\/b\u003e The Genetic Basis of Cancer of the Kidney. Wilm’s Tumor. Tuberous Sclerosis. \u003cb\u003eV. Systemic Diseases with Renal Involvement:\u003c\/b\u003e Monogenic Disorders. Nail-Patella Syndrome. The Systemic Anti-Inflammatory Diseases.  Renal Defects Due to Mitochondrial Mutations. Primary Hyperoxaluria. Lowe’s Syndrome. Fabry’s Disease. Hereditary Fructose Intolerance. The Branchio-Oto-Renal Syndrome. Primary Metabolic and Renal Gout. Hereditary Cystinosis. Hepatorenal Tyrosinemia. Renal Disease in Type I Glycogen Storage Disease. Wilson’s Disease. Renal Hypophosphatemia Due to Intrinsic Renal Defects. \u003cb\u003eVI. Systemic Hereditary Diseases with Renal Involvement: Multifactorial Diseases:\u003c\/b\u003e Systemic Lupus Erythematosis. IGA Nephropathy. Type I and II Diabetes Mellitus. Susceptibility to Diabetic Nephropathy. HIV-Associated Nephropathy. Hypertension.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Genetics [\u003ca title=\"See our other books on Genetics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Genetics%20%5Bnon-medical%5D%20%5BPSAK%5D%22\"\u003enon-medical PSAK\u003c\/a\u003e], Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e], Hereditary diseases \u0026amp; disorders [\u003ca title=\"See our other books on Hereditary diseases \u0026amp; disorders\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Hereditary%20diseases%20\u0026amp;%20disorders%20%5BMJCG1%5D%22\"\u003eMJCG1\u003c\/a\u003e], Medical genetics [\u003ca title=\"See our other books on Medical genetics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medical%20genetics%20%5BMFN%5D%22\"\u003eMFN\u003c\/a\u003e], Physiology [\u003ca title=\"See our other books on Physiology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Physiology%20%5BMFG%5D%22\"\u003eMFG\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46649421299992,"sku":"9780124498518","price":86.87,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780124498518.jpg?v=1694100883"},{"product_id":"chronic-kidney-disease-dialysis-and-transplantation-a-companion-to-brenner-and-rectors-the-kidney-hardback-9780323529785","title":"Chronic Kidney Disease, Dialysis, and Transplantation; A Companion to Brenner and Rector's The Kidney (Hardback) 9780323529785","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eChronic Kidney Disease, Dialysis, and Transplantation\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eA Companion to Brenner and Rector's The Kidney\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eProvide optimal care to your patients with chronic renal disease\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJonathan Himmelfarb (Author), T. Alp Ikizler (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323529785, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 2 January 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e792 pages, 135 illustrations (110 in full color)\u003cbr\u003e27.6 x 21.6 x 4 cm, 2.29 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eFrom basic science to practical clinical tools, \u003ci\u003eChronic Kidney Disease, Dialysis, and Transplantation, 4\u003csup\u003eth\u003c\/sup\u003e Edition\u003c\/i\u003e provides you with the up-to-date, authoritative guidance you need to safely and effectively manage patients with chronic renal disease. Covering all relevant clinical management issues, this companion volume to \u003ci\u003eBrenner and Rector’s The Kidney\u003c\/i\u003e presents the knowledge and expertise of renowned researchers and clinicians in the fields of \u003cb\u003ehemodialysis, peritoneal dialysis, critical care nephrology, and transplantation – for an all-in-one, indispensable guide\u003c\/b\u003e to every aspect of this fast-changing field.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eContains expanded content on \u003cb\u003eeconomics and outcomes of treatment\u003c\/b\u003e, as well as \u003cb\u003eacute kidney injury\u003c\/b\u003e.\u003c\/li\u003e \u003cli\u003eCovers hot topics such as the \u003cb\u003egenetic causes\u003c\/b\u003e of chronic kidney disease, \u003cb\u003eethical challenges and palliative care\u003c\/b\u003e, and \u003cb\u003ehome hemodialysis\u003c\/b\u003e.\u003c\/li\u003e \u003cli\u003eDiscusses the \u003cb\u003elatest advances\u003c\/b\u003e in hypertensive kidney disease, vitamin D deficiency, diabetes management, transplantation, and more.\u003c\/li\u003e \u003cli\u003eProvides a \u003cb\u003eclear visual understanding\u003c\/b\u003e of complex information with high-quality line drawings, photographs, and\u003cb\u003e diagnostic and treatment algorithms\u003c\/b\u003e.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eExpert Consult™ eBook version included with purchase.\u003c\/b\u003e This \u003cb\u003eenhanced eBook experience\u003c\/b\u003e allows you to search all of the text, figures, and references from the book on a variety of devices.\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eHimmelfarb: Chronic Kidney Disease, Dialysis, and Transplantation, 4e\u003c\/p\u003e   \u003cp\u003eSection 1: Chronic Kidney Disease \u003c\/p\u003e \u003cp\u003e1. Chronic Kidney Disease: Definitions, Epidemiology, Cost, and Outcomes\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e2. Measurement and Estimation of Kidney Function\u003c\/p\u003e \u003cp\u003e3. Diabetic Kidney Disease\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4. Hypertensive Kidney Disease\u003c\/p\u003e \u003cp\u003e5. Chronic Kidney Disease in the Elderly\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6. The Pediatric Patient with Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003e7. Genetic Causes of Chronic Kidney Disease        \u003ci\u003e Section 2: Complications and Management of Chronic Kidney Disease \u003c\/i\u003e \u003c\/p\u003e\n\u003cp\u003e8. The Role of the Chronic Kidney Disease Clinic and Multidisciplinary Team Care\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e9. Anemia in Chronic Kidney Disease\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e10. Mineral Bone Disorders in Chronic Kidney Disease\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e11. Vitamin D Disorders in Chronic Kidney Disease\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e12. Cardiovascular Disease in Chronic Kidney Disease\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e13. Nutrition, Metabolism and Hormonal Function in Chronic Kidney Disease\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e14. Inflammation in Chronic Kidney Disease\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e15. Sleep Disorders in Chronic Kidney Disease\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e16. Depression and Neurocognitive Function in Chronic Kidney Disease\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17. Medication Management in Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003e18. The Pathophysiology of Uremia\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e19. Timing and Initiation and Modality Options for Renal Replacement Therapy\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e20. Ethical Challenges and the Role of Palliative Care in Kidney Disease\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSection 3: Dialysis \u003c\/p\u003e \u003cp\u003e21. Dialysis and End Stage Kidney Disease: Epidemiology, Cost, and Outcomes\u003c\/p\u003e \u003cp\u003e\u003ci\u003e22. Principles of Hemodialysis\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23. Vascular Access\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e24. Hemodialysis Adequacy\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e25. Hemodialysis-Associated Infections\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e26. Acute Complications Associated with Hemodialysis\u003c\/p\u003e \u003cp\u003e27. Frequent Hemodialysis: Physiological, Epidemiological, and Practical Aspects\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e28. Home Hemodialysis\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e29. Peritoneal Physiology\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e30. The Utilization and Outcomes of Peritoneal Dialysis\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31. Peritoneal Dialysis Solutions, Prescription and Adequacy\u003c\/p\u003e \u003cp\u003e32. Peritoneal Dialysis-Related Infections\u003c\/p\u003e \u003cp\u003e33. Noninfectious Complications of Peritoneal Dialysis\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eSection 4: Transplantation \u003c\/p\u003e \u003cp\u003e34. Transplant epidemiology, costs and outcomes\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35. Transplantation Immunobiology\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36. Evaluation of Donors and Recipients\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37. Surgical Management of the Renal Transplant Recipient\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38. Immunosuppresive Therapy\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e39. Diagnosis and Therapy of Graft Dysfunction\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40. Infection in Renal Transplant Recipients\u003c\/p\u003e \u003cp\u003e41. Noninfectious Complications after Kidney Transplantation\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42. Recurrent and De Novo Renal Diseases after Kidney Transplantation\u003c\/p\u003e \u003cp\u003e43. Pediatric Renal Transplantation\u003c\/p\u003e \u003cp\u003e44. Chronic Kidney Disease in the Kidney Transplant Recipient\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eSection 5: Acute Kidney Injury \u003c\/p\u003e \u003cp\u003e45. Acute Kidney Injury: Epidemiology, Costs and Outcomes\u003c\/p\u003e \u003cp\u003e46. Metabolic and Nutritional Complications of Acute Kidney Injury\u003c\/p\u003e \u003cp\u003e47. Acute Kidney Injury Diagnostics and Biomarkers\u003c\/p\u003e \u003cp\u003e48. Pharmacological Interventions in Acute Kidney Injury\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e49. Dialytic Management for Acute Renal Failure\u003c\/p\u003e \u003cp\u003e50. Extracorporeal Treatment of Poisonings\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46650447036696,"sku":"9780323529785","price":108.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323529785_5c3a8631-da68-4310-bd3c-dcd08d795707.jpg?v=1694989905"},{"product_id":"nephrology-innovations-in-clinical-practice-an-issue-of-nursing-clinics-hardback-9780323643108","title":"Nephrology: Innovations in Clinical Practice, An Issue of Nursing Clinics (Hardback) 9780323643108","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eNephrology: Innovations in Clinical Practice, An Issue of Nursing Clinics\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eChita Farrar (Author), Deborah Ellison (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323643108, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 7 December 2018\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e240 pages\u003cbr\u003e28 x 19 x 2.1 cm, 0.39 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eIn consultation with Consulting Editor, Dr. Stephen Krau, Dr. Farrar and Dr. Ellison have created an issue that focuses on evidence-based clinical updates and innovations in various nephrology disorders. Top experts on the topic have contributed reviews on the follwoing topics: Kidney Influence on Fluids and Electrolytes; Renal Diet; Pharmacologic Renal Therapy; Acute Renal Therapy; Chronic Renal Therapy; Innovations in Kidney; Autoimmune Disease; Infection-Related Glomerular Disease; Sclerotic Diseases; Obstructive Renal Diseases; Chronic Renal Complications; Psychosocial Issues and Life Style Changes for the Renal Patient; and Withdrawal of Treatment (end of life decisions). Authors will come away with the clinical knowledge they need to improve outcomes in the nephrotic patient.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1. Kidney Influence on Fluid and Electrolyte Balance \u003cbr\u003e2. Renal Diet \u003cbr\u003e3. Pharmacologic Renal Therapy \u003cbr\u003e4. Acute Renal Therapy \u003cbr\u003e5. Chronic Renal Therapy \u003cbr\u003e6. Recent Innovations in Kidney Transplants \u003cbr\u003e7. The Roles of Systemic Lupus Erythematosus and IgA Nephropathy in Glomerular Disease \u003cbr\u003e8. Infection-Related Glomerular Disease \u003cbr\u003e9. Clinical Management of Glomerular Diseases \u003cbr\u003e10. Obstructive Renal Disease \u003cbr\u003e11. Complications of Kidney Disease \u003cbr\u003e12. Psychosocial Issues and Lifestyle Changes for the Renal Patient \u003cbr\u003e12. Psychosocial Issues and Lifestyle Changes for the Renal Patient \u003cbr\u003e12. Psychosocial Issues and Lifestyle Changes for the Renal Patient\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Nursing [\u003ca title=\"See our other books on Nursing\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Nursing%20%5BMQC%5D%22\"\u003eMQC\u003c\/a\u003e], Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46650718945560,"sku":"9780323643108","price":44.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323643108_8c959122-7a0d-4363-be59-08405c41d95a.jpg?v=1694990045"},{"product_id":"complementary-and-alternative-medicine-part-ii-herbal-supplements-and-vitamins-an-issue-of-nursing-clinics-hardback-9780323761178","title":"Complementary and Alternative Medicine, Part II: Herbal Supplements and Vitamins, An Issue of Nursing Clinics (Hardback) 9780323761178","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eComplementary and Alternative Medicine, Part II: Herbal Supplements and Vitamins, An Issue of Nursing Clinics\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eStephen D. Krau (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323761178, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 19 February 2021\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e240 pages\u003cbr\u003e28 x 19 x 2.1 cm, 0.41 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eIn Part II of this special issue of Nursing Clinics of North America, Dr. Krau is serving as Guest Editor again to provide information on complementary and alternative medicine with specific focus on herbal supplements and vitamins. Distinguished authors have contributed clinical reviews devoted to the following topics: Precautions when using Herbal Medications and Supplements; Vitamin B6 and its role in Women’s Health; Fat Soluble Vitamins; Vitamin D: Vitamin or Hormone; Enhancing Cognitive Function with Herbal Supplements; Herbal Medications Used in Women’s Health; Herbal Medication to Enhance or Modulate Viral Infections; Herbal Medications used to treat fevers; Traditional and Current Use of Ginseng;  Herbal Medications Used to ameliorate cardiac conditions; Cannabis, Marijuana, and CBD oil; and Highs, Lows, \u0026amp; Health Hazards of Herbology-A Review of Herbal Medications with Psychotropic Effects. Knowledge of this information is not easy to find in the nursing literature, and Dr. Krau believes readers will come away with valuable information on managing patients who use complementary and alternative herbal supplements and vitamins.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Nursing [\u003ca title=\"See our other books on Nursing\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Nursing%20%5BMQC%5D%22\"\u003eMQC\u003c\/a\u003e], Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46650729988376,"sku":"9780323761178","price":36.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323761178_e95d7bc5-5b4f-4e01-80b2-69fc9851bcae.jpg?v=1694990248"},{"product_id":"sleep-disorders-an-issue-of-nursing-clinics-hardback-9780323810661","title":"Sleep Disorders, An Issue of Nursing Clinics (Hardback) 9780323810661","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eSleep Disorders, An Issue of Nursing Clinics\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eTimely, relevant discussions of sleep disorders\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eShameka L. Cody (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323810661, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 4 June 2021\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e240 pages\u003cbr\u003e28 x 19 x 2.1 cm, 0.45 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eIn this issue of \u003ci\u003eNursing Clinics\u003c\/i\u003e, guest editor Shameka Cody brings her considerable expertise to the topic of \u003cb\u003eSleep Disorders\u003c\/b\u003e. \u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eProvides in-depth, clinical reviews on Sleep Disorders, providing actionable insights for clinical practice.\u003c\/li\u003e \u003cli\u003ePresents the \u003cb\u003elatest information on this timely, focused topic\u003c\/b\u003e under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Nursing [\u003ca title=\"See our other books on Nursing\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Nursing%20%5BMQC%5D%22\"\u003eMQC\u003c\/a\u003e], Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46650749583640,"sku":"9780323810661","price":37.79,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323810661.jpg?v=1694992085"},{"product_id":"substance-use-substance-abuse-an-issue-of-nursing-clinics-hardback-9780323940078","title":"Substance Use\/Substance Abuse, An Issue of Nursing Clinics (Hardback) 9780323940078","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eSubstance Use\/Substance Abuse, An Issue of Nursing Clinics\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eTimely, relevant discussions on substance use and abuse\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eLinda Stone (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323940078, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 11 May 2023\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e240 pages\u003cbr\u003e22.9 x 15.2 x 2.1 cm, 0.45 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eIn this issue of Nursing Clinics of North America, guest editor Dr. Linda Stone brings her considerable expertise to the topic of Substance Use and Abuse. Substance Use Disorder (SUD) has long been recognized as a serious issue in the nursing and medical professions and in healthcare in general, yet gaps in knowledge about this disease continue to exist. Education to promote SUD awareness, reduce stigma, and assist in the early recognition and intervention of impaired individuals is essential for helping nurses continue to protect patients in the healthcare environment. The clinical reviews in this issue help fill the existing knowledge gaps about SUD in the nursing profession.\u003cul\u003e \u003cli\u003e  \u003cp\u003eContains 15 practice-oriented topics including compassion fatigue and substance use disorder; the importance of a recovery-friendly environment when returning to clinical practice following SUD treatment; how workplace challenges impact the risk of SUD in a healthcare environment; why health care professionals often don’t ask for help; and more. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eProvides in-depth clinical reviews on substance use and abuse, offering actionable insights for clinical practice. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003ePresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eThe Role of Environment, Early Use, Genetic Influences, and Neurobiology in Substance Use Disorder\u003c\/p\u003e \u003cp\u003eUnderstanding Alcohol Use Disorder\u003c\/p\u003e \u003cp\u003eThe Prevalence of Comorbidities and Substance Use Disorder\u003c\/p\u003e \u003cp\u003eWhy Health-care Professionals Often Do Not Ask for Help?: Understanding the Stigma Associated with Substance Use Disorders\u003c\/p\u003e \u003cp\u003eSubstance Use Disorders and Medication-Assisted Therapies: Current Practices and Implications for Nursing\u003c\/p\u003e \u003cp\u003eHow Workplace Challenges Affect the Risk of Substance Use Disorders in a Health Care Environment\u003c\/p\u003e \u003cp\u003eHow to Conduct a Safe Intervention for Substance Use Disorder and What to Avoid\u003c\/p\u003e \u003cp\u003eSigns and Behaviors to Identify Impairment and Drug Diversion\u003c\/p\u003e \u003cp\u003eThe Importance of a Recovery Friendly Environment Following Treatment for Substance Use Disorder: A Setup for Successful Reentry for Health Care Professionals\u003c\/p\u003e \u003cp\u003ePractice Considerations for the Methamphetamine Use Disorder Patient\u003c\/p\u003e \u003cp\u003eSyringe Services Programs to Reduce Intravenous Disease Transmission in Substance Use Disorders\u003c\/p\u003e \u003cp\u003eAssessing Advanced Practice Provider Well-Being in an Academic Medical Center\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46651175993624,"sku":"9780323940078","price":31.79,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323940078_4345fb46-86c9-4a93-92eb-316fe08fb801.jpg?v=1694993576"},{"product_id":"pediatric-fluid-electrolyte-and-acid-base-disorders-a-case-based-approach-paperback-9780443111136","title":"Pediatric Fluid, Electrolyte, and Acid-Base Disorders; A Case-Based Approach (Paperback \/ softback) 9780443111136","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003ePediatric Fluid, Electrolyte, and Acid-Base Disorders\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eA Case-Based Approach\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eMore than 200 real-life case studies help you determine optimal strategies in pediatric nephrology\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eFarahnak Assadi (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780443111136, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 24 April 2023\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e248 pages\u003cbr\u003e27 x 18 x 1.7 cm, 0.27 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eComprehensive and case-based, Pediatric Fluid, Electrolyte, and Acid-Base Disorders provides a state-of-the-art overview of this complex field in a concise, authoritative format perfect for self-study or review. Real-life patient cases reflect those that are frequently encountered in clinical decision making. These narrative case studies offer a unique opportunity for readers to determine how best to diagnose, treat, and manage their patients based on the history of present illness, review of symptoms, relevant history, and physical examination findings.\u003cul\u003e \u003cli\u003e  \u003cp\u003eIncludes over 200 cases frequently seen by medical students, residents, practicing physicians, and other health care provides during routine daily clinical practice. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003ePresents cases in a consistent template including succinct summary of patient’s history, signs and symptoms, examination, and initial diagnosis\/treatment plan. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eFollows each case with questions and answers that provide a detailed discussion on each topic, with further cross-references and direction where appropriate. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eAn ideal resource for students, residents, and fellows rotating on nephrology subspecialty services, as well as for practicing physicians who need quick access to current scientific and clinical information on managing fluid, electrolyte, and acid-base disorders in children. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eAn eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1 Hyponatremia \u003cbr\u003e2 Hypernatremia\u003cbr\u003e3 Hypokalemia\u003cbr\u003e4 Hyperkalemia\u003cbr\u003e5 Metabolic Alkalosis\u003cbr\u003e6 Metabolic Acidosis\u003cbr\u003e7 Hypocalcemia\u003cbr\u003e8 Hypercalcemia\u003cbr\u003e9 Hypophosphatemia\u003cbr\u003e10 Hyperphosphatemia\u003cbr\u003e11 Hypomagnesemia\u003cbr\u003e12 Hypermagnesemia\u003cbr\u003eIndex\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46651402027288,"sku":"9780443111136","price":66.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780443111136.jpg?v=1694979777"},{"product_id":"pocket-companion-to-brenner-and-rectors-the-kidney-paperback-9781416066408","title":"Pocket Companion to Brenner and Rector's The Kidney (Paperback \/ softback) 9781416066408","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003ePocket Companion to Brenner and Rector's The Kidney\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eQuick, easy access to key information on the kidney\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eMichael R. Clarkson (Author), Barry M. Brenner (Author), Ciara Magee (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781416066408, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 6 April 2010\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e928 pages, 16 illustrations\u003cbr\u003e27 x 18 x 5.6 cm, 0.48 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"Like the other five companions to the parent textbook, this is a source of immediate, concise, current, and clinically relevant information written at an accessible level…the well-known authors address a broad audience of practitioners who treat patients with kidney diseases: medical students, residents, fellows, internists, urologists, and primary care physicians…\"- \u003cb\u003e\u003ci\u003eDoody’s Book Review- Weighted Numerical Score: 95 - 4 Stars! \u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003ePocket Companion to Brenner and Rector’s The Kidney distills the essential clinical information from the latest edition of the seminal text on kidney diseases and their management. Michael R. Clarkson, Ciara Magee, and Barry M. Brenner detail the key pathophysiologic, diagnostic, and treatment issues in clinical nephrology, including interventional nephrology, endocrine aspects of kidney disease, and plasmapheresis.\u003c\/p\u003e\n\u003cli\u003eDiagnose, treat, and manage both common and uncommon disorders.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFind clinical knowledge quickly and easily thanks to convenient tables throughout the text.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eChoose the best option of the many techniques available through discussions of indications for laboratory tests and imaging studies.\u003c\/li\u003e\n\u003cp\u003eEnhance your clinical acumen with coverage of new topics such as risk factors and kidney disease, nephron endowment, interventional nephrology, plasmapheresis, xenotransplantation, stem cells in renal biology and medicine, and more.\u003c\/p\u003e  \u003cp\u003eStay current thanks to two new sections—Epidemiology and Risk Factors in Kidney Disease and Frontiers in Kidney Disease—that include topics such as stem cell and genomics.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Saunders","offers":[{"title":"Default Title","offer_id":46651637727512,"sku":"9781416066408","price":42.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9781416066408.jpg?v=1696743584"},{"product_id":"clinical-handbook-of-nephrology-paperback-9780323847872","title":"Clinical Handbook of Nephrology (Paperback \/ softback) 9780323847872","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eClinical Handbook of Nephrology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eVital information in nephrology at your fingertips\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eRobert S. Brown (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323847872\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 16 August 2023\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e328 pages\u003cbr\u003e22.9 x 15.2 x 2.1 cm, 0.39 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eConcise and easy to navigate, Clinical Handbook of Nephrology contains vital, everyday information on renal physiology and a wide range of topics, including diagnosis and treatment of acute and chronic kidney diseases, hypertension, electrolyte and acid-base disorders, dialysis, and kidney transplantation. This fully up-to-date reference (formerly Nephrology Pocket, a textbook originally published by Börm Bruckmeier) is ideal for physicians, nurses,  dialysis center staff, medical students, and trainees, offering a practical roadmap for managing the renal disorders most likely to be encountered in clinical practice.\u003cul\u003e \u003cli\u003e  \u003cp\u003eContains dozens of diagnostic and treatment algorithms, tables, and charts that allow you to find answers quickly and easily at the point of care. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eAllows you to easily find protocols, drug information and treatment guidelines, including the latest KDIGO (Kidney Disease Improving Global Outcomes) for the evaluation and management of chronic kidney disease, glomerulonephritis, and blood pressure management.  \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eProvides sections on symptoms, signs, and differential diagnoses that allow you to quickly identify common differentials.  \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eFeatures dedicated chapters on kidney stones, dialysis, and kidney transplantation.  \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eIncludes common labs useful for ruling out other medical causes of renal disorders.  \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eAn eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eChapter 1: Introduction to Nephrology\u003c\/p\u003e\n\u003cp\u003eChapter 2: Symptoms, Signs, and Differential Diagnosis\u003c\/p\u003e\n\u003cp\u003eChapter 3: Renal Physiology\u003c\/p\u003e\n\u003cp\u003eChapter 4: Urinalysis and Diagnostic Tests\u003c\/p\u003e\n\u003cp\u003eChapter 5: Water and Electrolyte Disorders\u003c\/p\u003e\n\u003cp\u003eChapter 6: Acid-base Disorders\u003c\/p\u003e\n\u003cp\u003eChapter 7: Glomerular Diseases\u003c\/p\u003e\n\u003cp\u003eChapter 8: Interstitial, Cystic, Obstructive, and Infectious Kidney Diseases\u003c\/p\u003e\n\u003cp\u003eChapter 9: Kidney Disorders in Other Diseases\u003c\/p\u003e\n\u003cp\u003eChapter 10: Hypertension and Renal Artery Stenosis\u003c\/p\u003e\n\u003cp\u003eChapter 11: Kidney Stones\u003c\/p\u003e\n\u003cp\u003eChapter 12: Acute Kidney Injury\/Acute Renal Failure\u003c\/p\u003e\n\u003cp\u003eChapter 13: Chronic Kidney Diseases\u003c\/p\u003e\n\u003cp\u003eChapter 14: Dialysis\u003c\/p\u003e\n\u003cp\u003eChapter 15: Kidney Transplantation\u003c\/p\u003e\n\u003cp\u003eChapter 16: Lab Values for Nephrology\u003c\/p\u003e\n\u003cp\u003eAppendix\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46651790033176,"sku":"9780323847872","price":49.89,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323847872.jpg?v=1694992168"}],"url":"https:\/\/freshlyprintedbooks.co.uk\/collections\/renal-medicine-nephrology.oembed?page=2","provider":"Freshly Printed Books","version":"1.0","type":"link"}